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ABSTRACT 
Local and Long-range Regulation of Adult Neural Stem Cell Quiescence 
Alexander Jacob Paul 
 
 Quiescent neural stem cells support continuous, lifelong neurogenesis in specific regions of the 
adult mammalian brain.  The largest adult neurogenic region is the ventricular-subventricular zone (V-
SVZ), which lines the entire lateral wall of the lateral ventricles.  Quiescent neural stem cells (qNSCs) 
enter the cell cycle (activate) and give rise to new neurons during homeostasis and regeneration, 
suggesting they can potentially be harnessed for regenerating the brain after neurodegenerative disease, 
stroke, and injury.  Defining the signals that regulate NSC quiescence and activation is essential to unlock 
their potential for regenerative medicine.  NSCs residing in specific regions of the V-SVZ give rise to 
distinct subtypes of olfactory bulb interneurons.  It is unknown whether quiescence-regulating signals map 
onto the regional heterogeneity of NSCs, and might thereby underlie the production of distinct interneuron 
subtypes.   
A major limitation to our understanding of the regulation of NSC quiescence has been the lack of 
specific markers to identify qNSCs, and prospectively purify them from their in vivo niche.  Using a novel 
fluorescence-activated cell sorting (FACS) strategy that allows the purification of qNSCs from the adult 
mouse V-SVZ niche for the first time, I performed in vitro screens for quiescence-regulating signals.  
Unexpectedly, neurotransmitters emerged as the main class of qNSC-activating signals, including 
dopamine, GABA, serotonin, acetylcholine, and opioids.  Local and long-range neurons that use these 
neurotransmitters innervate the V-SVZ in unique regional patterns, suggesting these signals map onto the 
regional heterogeneity of NSCs.  Consistent with this hypothesis, infusions of cholinergic agonist and 
antagonists into the lateral ventricle resulted in regional changes in NSC proliferation.  Moreover, 
cholinergic antagonists blocked the activation of qNSCs during regeneration, providing evidence that 
neurotransmitter signaling activates qNSCs in vivo.  I then showed that hypothalamic Pomc-expressing 
neurons innervate the anterior-ventral V-SVZ and promote the activation of Nkx2.1+ qNSCs.  Ablation of 
Pomc+ neurons resulted in decreased proliferation of NSCs in the anterior-ventral, but not anterior-dorsal, 
V-SVZ.  Moreover, both the activity of Pomc+ neurons, and the proliferation of Nkx2.1+ NSCs in the 
anterior-ventral V-SVZ decreased in fasted animals, suggesting that hunger and satiety states regulation 
the generation of a single olfactory bulb interneuron subtype.  Indeed, ablation of Pomc+ neurons resulted 
in a loss of the subtype of olfactory bulb interneuron that is generated by Nkx2.1+ NSCs.  Together, my 
findings suggest that both local and long-range neurons regionally innervate the V-SVZ and mediate 
neural stem cell activation from the quiescent state. 
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 Stem cells are defined by two fundamental properties; the ability to generate another cell identical 
to itself (self-renewal), and the ability generate differentiated progeny.  Generally, stem cells are 
categorized as embryonic, or adult.  Embryonic stem cells are derived from the inner cell mass of the 
developing blastocyst, studied in vitro, and are capable of generating all tissues of the embryo.  In 
contrast, adult stem cells are restricted to generating differentiated progeny that are specific to the tissue 
in which they reside.  Adult stem cells are present in numerous organs and play essential roles in 
maintaining organ homeostasis throughout life, and regeneration following injury.  Within their tissues, 
adult stem cells reside in specialized microenvironments, termed niches, which provide molecular cues 
that regulate stem cell survival, quiescence, activation, and differentiation.  
 
Adult Neurogenesis is a Fundamental and Highly Conserved Property of Nervous Systems 
 Continuous adult neurogenesis is an ancient and fundamental property of organized nervous 
systems.  This is demonstrated by the presence of adult neurogenesis in cnidarians, which are the first 
phylum in which an organized nervous system appears in evolution, approximately 700 million years ago 
(Miljkovic-Licina et al., 2004; Ryan and Finnerty, 2003; Sakaguchi et al., 1996).  In addition to being 
evolutionarily ancient, adult neurogenesis is highly conserved.  It is present in several invertebrates, 
including cnidarians, multiple insect species, and crustaceans, and in all vertebrate taxa, including fish, 
amphibians, reptiles, birds, and mammals (Cayre et al., 2002).  Non-mammals have much more 
abundant neurogenesis in adulthood than mammals.  In songbirds, neurons can migrate throughout the 
entire brain (Nottebohm, 2004).  Fish, amphibians, and reptiles have multiple adult neurogenic niches 
(Kaslin et al., 2008).  However, in mammals adult neurogenesis is largely limited to two regions of the 
brain: the ventricular-subventricular zone (V-SVZ) which lines the lateral ventricles, and the subgranular 
zone (SGZ) of the hippocampal dentate gyrus (Doetsch and Hen, 2005).  Notably, the degree of adult 
neurogenesis in these zones varies among mammalian species (e.g. low levels in bats and primates, high 
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levels in rodents), therefore adult neurogenesis has been subject to species-specific adaptation in 
mammals (Amrein et al., 2007; 2011).  Even so, the limitation of adult neurogenesis to the V-SVZ and 
SGZ is seen in all mammalian genera studied to date, from marsupials to humans, and thus occurred 
early in mammalian evolution (Ernst et al., 2014; Grabiec et al., 2009; Harman et al., 2003; Sanai et al., 
2011; Spalding et al., 2013). 
 
A Brief Comparison of the Basic Features and Functions of the Adult Neurogenic Systems 
 Two neurogenic niches in the adult mouse brain continuously generate neurons throughout life: 
the V-SVZ of the lateral ventricles, and the SGZ of the hippocampal dentate gyrus (DG) (Figure 1.1).  
Despite differences in the size of the niches, and the amount and type of neurons generated, these two 
neurogenic systems have striking temporal, and functional similarities.  In each region, neural stem cells 
(NSCs) retain features of the radial glial progenitors from which they are derived during development, 
including the ability to generate neurons and glia, radial morphology, contact with the vasculature, and 
expression of astrocyte markers (Kriegstein and Alvarez-Buylla, 2009). 
 
Figure 1.1  The Adult Mouse Neurogenic Zones 
Sagittal view of the adult mouse brain.  The V-SVZ lines the lateral wall of the lateral ventricles (LV, blue).  
New neurons born in the V-SVZ migrate through the rostral migratory stream (RMS) to the olfactory bulb 
(OB), where they populate the layers of the OB and differentiate into interneurons (dots).   




The V-SVZ is the larger neurogenic zone. It lines the entire lateral wall of the lateral ventricles, 
and the medial wall of the septum (Mirzadeh et al., 2008).  About 30,000 new neurons are born per day 
(bilaterally) in the V-SVZ of the adult mouse (Lois and Alvarez-Buylla, 1994).  These cells migrate 3 – 8 
mm to the olfactory bulb (OB) where they differentiate and mature into several subtypes of inhibitory 
interneurons that integrate into existing olfactory circuitry (Doetsch and Alvarez-Buylla, 1996; Merkle et 
al., 2007) (discussed in more detail below).  The adult-born neurons replace the pool of embryonic- and 
early postnatal-born OB interneurons over the lifetime of the mouse at a rate of about 1% per day 
(Imayoshi et al., 2008).  It takes about 2 – 4 weeks from their birth in the V-SVZ for the new neurons to 
reach the OB and mature (Imayoshi et al., 2008).  
 The overwhelming majority of new OB interneurons die within the first several weeks after their 
birth.  Only 50% survive to 4 weeks past their birth, and less than 10% survive longer than 21 months in 
the rat (Kaplan et al., 1985; Petreanu and Alvarez-Buylla, 2002).  The survival of adult-born interneurons 
depends on olfactory sensory experience (Yamaguchi and Mori, 2005).  An enriched odor environment 
increases adult-born interneuron survival, while olfactory sensory deprivation decreases survival, though 
neither of these interventions modulates NSC proliferation in the V-SVZ (Petreanu and Alvarez-Buylla, 
2002; Rochefort et al., 2002; Yamaguchi and Mori, 2005).  Further, olfactory associative learning 
increases the survival of adult-born interneurons, and the surviving cells are spatially recruited into the 
olfactory circuits that are functionally relevant to the learning (Alonso et al., 2006).  It is supposed that the 
survival of new OB interneurons involves both competition and selection.  Surviving adult-born 
interneurons form inhibitory synapses on mitral and tufted cells, which are the main output neurons of the 
OB that project to olfactory cortical regions (Sosulski et al., 2011; Yokoi et al., 1995).  Inhibitory drive from 
adult-born interneurons on mitral/tufted cells enhances the spatial contrast and temporal coding of 
olfactory information (Abraham et al., 2010; 2004; Yokoi et al., 1995).  Further, it was recently shown that 
optogenetic activation of adult-born interneurons causally improves olfactory discrimination, learning, and 
memory (Alonso et al., 2012). 
The hippocampal adult neurogenesis system differs in its proliferative output, and the cell type 
generated, but otherwise has several similarities to the OB system.  The SGZ generates about 9000 new 
granule cell neurons per day (in the adult rat), which migrate locally within the DG, and wire into existing 
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hippocampal circuitry (Bonaguidi et al., 2011; Cameron and McKay, 2001).  In contrast to the OB system, 
adult-born DG granule cells are primary projection neurons, and their addition to the DG is additive and 
results in a net increase in granule cells with age (Imayoshi et al., 2008).  However, similar to the OB 
system, 80 – 90% of newborn granule cells die within 2 – 4 weeks of their birth (Cameron et al., 1993; 
Gould et al., 1999).  Many types of environmental modifications are known to increase the survival of 
adult-born DG neurons, and also regulate other aspects of SGZ neurogenesis (Drew et al., 2013).  For 
example, exercise increases granule cell survival and NSC proliferation in the SGZ, while enriched 
housing only increases survival (Kempermann et al., 1997).  Additionally, hippocampus-dependent types 
of associative learning increase adult-born granule cell survival (Gould et al., 1999).  Adult-born granule 
cells contribute to hippocampal forms of discrimination, learning, and memory, and are implicated to 
contribute to mood regulation (Aimone et al., 2011; Kheirbek et al., 2012; Sahay and Hen, 2007; Sahay et 
al., 2011). 
 
 For the adult mouse neurogenic systems, the homeostatic requirement the NSC niche must fulfill 
is the continual supply of new neurons, so that they can be recruited to adapt olfactory and hippocampal 
behaviors to the environment as it is being experienced.  The constant supply of new neurons 
compensates for the time lag between the birth, migration, maturation, and integration of new neurons 
into OB and hippocampal circuits, thus increasing the speed at which OB and hippocampal responses 
can adapt.  Hence, environmental enrichments tend to impinge on adult-born neuron survival (i.e. 
recruitment), rather than NSC proliferation.  However, NSC proliferation is the first level at which the 
homeostatic supply of new neurons can be regulated, specifically at the transition from NSC quiescence 
to activation.  Long-term enhancement or attenuation of NSC quiescence could lead to long-term 
changes in olfactory and hippocampal behaviors.  Identifying niche signals that regulate NSC quiescence 




Quiescence in Adult Stem Cells 
 Quiescence is an actively maintained state from which cells can re-enter the cell cycle in 
response to a combination of cell-intrinsic and environmental factors (Cheung and Rando, 2013).  
Quiescence is a basic property of cellular life that is widely conserved and used to ensure survival, proper 
development, reproduction, and regenerative capacity.  Both prokaryotic and eukaryotic microorganisms 
can remain quiescent for years without nutrients, but return to normal growth in a favorable environment 
(Gray et al., 2004).  In mammals, embryonic and adult growth must be balanced by quiescence for 
tissues to achieve and maintain normal morphology and function.  The quiescence of plant seeds is 
regulated by hormones and environmental conditions, as is that of oocytes in the mammalian ovary, and 
the budding of cherry blossoms every spring (Amen, 1968; Koutinas et al., 2014; McGee and Hsueh, 
2000).  Arguably, the amazing diversity of life on earth would not exist without the ability to reversibly 
arrest cellular growth.   
 
It is now known that many adult mammalian tissues and organs maintain populations of quiescent 
and activated stem cells, including the hematopoietic system, muscle, skin/hair follicle, small intestine, 
colon, prostate, and brain (Cheng et al., 2009; 2000; Fukada et al., 2007; Jensen et al., 2009; Lugert et 
al., 2010; Powell et al., 2012).  In these systems, quiescent stem cells maintain the lineage during 
homeostasis, and are especially activated during regeneration.  It is currently unclear whether distinct 
regulatory mechanisms, and/or pools of quiescent stem cells mediate these functions.  However, 
mounting evidence suggests that quiescence is essential for maintaining the long-term self-renewal 
capacity of adult stem cells.  
 The first evidence supporting this idea came from analyzing hematopoietic stem cells (HSCs) in 
mice mutant for the G1-checkpoint regulator p21 (Cheng et al., 2000).  Cells can enter the quiescent state 
(also called G0) before the G1-checkpoint, but if the G1-checkpoint is passed cells are committed to divide 
(Pardee, 1974).  p21 promotes cell cycle arrest by inhibiting cyclin-dependent kinases that drive 
progression through the G1-checkpoint (Brugarolas et al., 1995).  In homeostatic conditions, p21-null mice 
have less quiescent HSCs and more proliferating HSCs compared to wild type animals.  p21-null HSCs 
fail to regenerate the hematopoietic lineages over serial transplantation into irradiated hosts, leading to 
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death (Cheng et al., 2000).  Further, chronic myelotoxic injury causes HSC depletion and premature 
death in p21-null mice (Cheng et al., 2000).  Notably, V-SVZ NSCs are similarly affected by p21 deletion, 
showing increased proliferation, limited self renewal, and a rapid decline in neurogenesis with aging 
(Kippin et al., 2005).  Therefore, self-renewal and regeneration capacity are limited when quiescence is 
compromised.  Hence, maintaining adult stem cell quiescence is necessary for homeostasis, protecting 
from stem cell loss, and ensuring the lifelong ability to regenerate after injury.   
Differentiated cells are also actively maintained in quiescence, and this is crucial for organ 
homeostasis and function.  Indeed, there appears to be no truly “post-mitotic” cell, as differentiated cells 
from all major tissues can be reprogrammed to the induced pluripotent stem cell state (Liebau et al., 
2013; Takahashi and Yamanaka, 2006).  Although reprogramming is a feat of bioengineering, there are 
several naturally occurring forms deregulated quiescence.  For example, in fibrotic diseases, mature 
fibroblasts exit quiescence and proliferate in response to increased platelet-derived growth factor receptor 
(PDGFR) signaling, leading to massive internal scarring, organ dysfunction, and death (Olson and 
Soriano, 2009).  Similarly, mature astrocytes proliferate after central nervous system injury, forming a glial 
scar that inhibits neuronal regeneration (Silver and Miller, 2004).  In contrast, mature hepatocytes exit 
quiescence after partial hepatectomy and contribute to liver regeneration (Fausto, 2004).  Thus, releasing 
differentiated cells from quiescence is not always detrimental.  However, the most common naturally 
occurring and devastating form of deregulated quiescence is cancer. 
Emerging evidence suggests that adult quiescent stem cells are likely cells of origin for cancer 
(Moore and Lyle, 2011).  Like tumor cells, quiescent stem cells have long-term self-renewal ability.  
Further, because quiescent stem cells are long-lived they can potentially acquire a large number of 
transforming mutations.  Several lines of evidence support these ideas.  Quiescent HSCs use error prone 
non-homologous end joining to repair double-stranded DNA breaks, while proliferative HSCs use high-
fidelity homologous recombination (Mohrin et al., 2010).  Quiescent HSCs survived radiation, and 
acquired numerous mutations that were passed on to their progeny (Mohrin et al., 2010).  Mutating the 
tumor suppressor Pten in a quiescent population of prostate gland stem cells led to rapid tumorigenesis 
(Wang et al., 2009).  Distinct urothelial progenitors give rise to different types of tumors in a bladder 
carcinogenesis model (Van Batavia et al., 2014).  Further, tumors are thought to harbor quiescent cells 
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(so-called cancer stem cells) that survive radiation and chemotherapy and contribute to the regeneration 
of tumors (Moore and Lyle, 2011).  Of particular relevance to the brain, glioblastoma multiforme tumors 
express markers that are also expressed by proliferative NSCs, such as Sox2, nestin, and the epidermal 
growth factor receptor (EGFR) (Park et al., 2013).  Therefore, quiescent stem cells may be cells of origin 
for diverse cancers.  Actively dividing stem cells, and transit amplifying cells, may also acquire mutations 
that reduce their ability to return to quiescence, which could result in tumorigenesis.  Additionally, 
differentiated cells may acquire mutations that access mechanisms that stem cells and their progeny 
normally use to proliferate and migrate within an otherwise inhibitory tissue environment. 
 
An emerging effort in the adult stem cell fields is to understand the molecular mechanisms that 
regulate stem cell quiescence and activation.  Understanding these mechanisms will be crucial for 
unlocking their potential for regenerative medicine, and will give insights into the etiology of cancer and 
potential targets for new cancer therapies.  Importantly, the future hope of activating quiescent stem cells 
to participate in regenerative therapies must be tempered by the potential to inadvertently drive 
tumorigenesis.   
 
Adult Neurogenesis in Humans 
 Adult neurogenesis also occurs in the V-SVZ and SGZ of humans.  There is substantial adult 
neurogenesis throughout life in the human SGZ (Eriksson et al., 1998; Spalding et al., 2013).  Adult 
neurogenesis in the V-SVZ is also continuous throughout life.  There is robust generation of new neurons 
in the neonatal human V-SVZ, which decreases sharply to a low, negligible rate by 12 months of age 
(Sanai et al., 2011).  These neonatal-born neurons migrate rostrally to the olfactory bulb, and appear to 
differentiate into interneurons (Sanai et al., 2011; Wang et al., 2011).  Additionally, there is a migration of 
neonatal-born neurons to the ventromedial prefrontal cortex that ceases after 6 months of age, and which 
is not observed in mice (Sanai et al., 2011).  OB neurogenesis in adult humans is nearly, if not 
completely, absent, and thus is likely not important for human olfactory function (Bergmann et al., 2012; 
Sanai et al., 2011; Wang et al., 2011).  However, in contrast to the mouse, the human V-SVZ gives rise to 
striatal interneurons throughout adulthood, which turnover at a rate of 2.7% per year (Ernst et al., 2014). 
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Adult neurogenesis decreases in humans with neurodegenerative diseases and with aging.  
Adult-born striatal interneurons are selectively lost in Huntington’s Disease (HD) patients (Ernst et al., 
2014).   Neurogenesis is significantly reduced in the V-SVZ, and SGZ of Parkinson’s Disease (PD) 
patients (Höglinger et al., 2004).  Neurogenesis also declines with age in the V-SVZ, striatum, and SGZ 
(Ernst et al., 2014; Macas et al., 2006; Spalding et al., 2013).  Impairments in motor control and cognitive 
function are hallmarks of HD, PD, and aging, and the striatum and hippocampus mediate these functions 
(Ernst et al., 2014; Höglinger et al., 2004).  It is currently not known if decreased neurogenesis in these 
conditions is due to cell death or increased NSC quiescence.  However, proliferation and neurogenesis 
increased in old-aged individuals who had suffered strokes, suggesting that the decline in neurogenesis 
seen in aging is due to increased quiescence of NSCs that activate to participate in regeneration (Macas 
et al., 2006; Martí-Fàbregas et al., 2010).  Therefore, identifying the mechanisms that regulate NSC 
quiescence and activation may reveal strategies to combat motor and cognitive decline in aging and 
neurodegenerative disease, and improve recovery after brain injury. 
 
V-SVZ Quiescent Neural Stem Cells and Their Progeny 
Quiescent neural stem cells (qNSCs) in the V-SVZ are a subset of glial fibrillary acidic protein 
(GFAP) expressing astrocytes (Doetsch et al., 1999a; 1999b).  A large proportion of GFAP+ NSCs also 
express cell-surface protein CD133 (Beckervordersandforth et al., 2010; Mirzadeh et al., 2008).  Upon 
activation in vivo, GFAP+ qNSCs upregulate the epidermal growth factor receptor (EGFR) and undergo 
the self-renewing division, generating another NSC and an EGFR+GFAP- transit-amplifying cell (TAC) 
(Kawaguchi et al., 2013; Pastrana et al., 2009).  TACs undergo three rounds of symmetric, reductive 
divisions giving rise to neuroblasts (immature neurons) that express doublecortin (Dcx), and CD24 (Costa 
et al., 2011; Pastrana et al., 2009; Ponti et al., 2013).  A small subset of TACs give rise to 
oligodendrocytes, rather than neuroblasts (Menn, 2006; Nait-Oumesmar et al., 1999).  Neuroblasts go on 
to divide one or two times, thus a single division of an activated NSC (aNSC) results in 16 – 32 
neuroblasts (Ponti et al., 2013). Neuroblasts migrate rostrally to the OB where 95% differentiate into 
granule cell layer interneurons, and the rest become periglomerular interneurons. 
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The V-SVZ Niche 
 The V-SVZ consists of a thin layer of cells adjacent to the lumen of the lateral ventricles.  The 
niche is bounded by the ventricle, and by a planar vascular plexus within the tissue.  Multiciliated 
ependymal cells line the wall of the ventricle, and the beating of these cilia maintains the flow of the 
cerebrospinal fluid (CSF) in the rostral direction (Sawamoto, 2006).  qNSCs span the entire depth of the 
niche by virtue of their radial morphology.  They contact the lumen of the ventricle by a short apical 
process extended between ependymal cells, and the underlying vasculature by a long basal process at 
sites that lack the blood brain barrier (Mirzadeh et al., 2008; Tavazoie et al., 2008).  Between these 
bounds, qNSCs are in direct contact with their progeny, and innervation from various neuronal sources 
(discussed in detail below).  Thus, NSC quiescence and activation are potentially regulated by direct cell-
cell contacts and locally secreted factors, as well as by long-range factors in the CSF and circulation. 
 The signals that regulate NSC quiescence are only becoming to be understood.  Recent studies 
implicate all of the sources and modalities of signals in quiescence regulation mentioned above.  
Adhesion and cell-cell signaling factors are emerging as important promoters of NSC quiescence. 
Activated Notch signaling promotes NSC quiescence following the self-renewing division as Delta-like 
ligand 1 (Dll1) is asymmetrically inherited by the daughter TAC (Basak et al., 2012; Kawaguchi et al., 
2013).  Adhesion to the vasculature via α6β1-integrin promotes quiescence (Kazanis et al., 2010; Niola et 
al., 2012).  Also, the adhesion molecules Vcam1 and Ncam1 both promote NSC quiescence, and are 
important for anchoring qNSCs to the ependymal cell layer where they have access to the CSF (Kokovay 
et al., 2012; Porlan et al., 2014). The CSF is a rich cocktail of signaling molecules that can influence NSC 
quiescence and activation.  For example, the EGFR ligand TGFα and Shh in the CSF promote the 
proliferation of NSCs (Palma, 2005; Silva-Vargas et al., 2013; Tropepe et al., 1997).  Locally secreted 
factors also regulate NSC quiescence.  NT-3 secreted from local endothelial cells promotes NSC 
quiescence, while endothelial derived PIGF-1 promotes NSC proliferation (Crouch et al., 2015; Delgado 
et al., 2014).  Circulating prolactin also promotes NSC proliferation during pregnancy (Shingo et al., 




Neuronal Regulation of Adult NSC Proliferation 
 Several types of neurons from distinct sources innervate the V-SVZ, including dopaminergic, 
serotonergic, GABAergic, and cholinergic neurons.  Signaling from all of these neuron types promotes the 
proliferation of NSCs.  I briefly summarize the results of several recent studies below. 
Dopaminergic neurons in the substantia nigra (SN) innervate the dorsal V-SVZ, and 
dopaminergic neurons in the ventral tegmental area (VTA) innervate the dorsal and ventral V-SVZ 
(Höglinger et al., 2014; Lennington et al., 2011).  These projections enter the V-SVZ niche via the 
striatum. Dopaminergic neurons make synaptic contacts on proliferative V-SVZ cells, and ablation of SN 
and VTA dopaminergic neurons decreases proliferation in the V-SVZ (Höglinger et al., 2004; Lennington 
et al., 2011).  Proliferation was most dramatically decreased in the dorsal V-SVZ after SN / VTA 
dopaminergic ablation (Lennington et al., 2011). 
GABAergic medium spiny interneurons (MSN) in the striatum send projections into the V-SVZ 
(Young et al., 2014).  Although synaptic contacts from striatal MSNs on NSCs have not been reported, 
electrophysiological stimulation of MSNs induces calcium influxes in NSCs and their progeny (Young et 
al., 2014).  Inhibiting GABA-A receptor-mediated depolarization decreases the proliferation of early 
postnatal V-SVZ neural progenitors (Young et al., 2012).  Similarly, agonizing GABA-A receptors at the 
benzodiazepine-binding site promotes NSC proliferation (Alfonso et al., 2012). 
Serotonergic neurons in the dorsal raphe nucleus of the hindbrain innervate the V-SVZ (Tong et 
al., 2014).  Serotonergic projections run over the ventricular surface of the V-SVZ niche and appear to be 
uniformly distributed (Tong et al., 2014).  NSCs and ependymal cells both receive synaptic contact from 
these serotonergic projections, and infusion of a serotonergic agonist into the lateral ventricle increased 
NSC proliferation (Tong et al., 2014). 
Cholinergic interneurons reside within the V-SVZ and send projections locally within the niche 
(Paez-Gonzalez et al., 2014).  V-SVZ cholinergic interneurons make synaptic contacts on NSCs, and are 
morphologically and electrophysiologically distinct from striatal cholinergic interneurons (Paez-Gonzalez 
et al., 2014).  Optogenetic activation or silencing of V-SVZ cholinergic interneurons increases or 
decreases NSC proliferation, respectively (Paez-Gonzalez et al., 2014).  
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Regional Subtypes of V-SVZ Stem Cells 
 NSCs in the V-SVZ are regionalized, that is, NSCs in different regions of the V-SVZ give rise to 
distinct subtypes of olfactory bulb interneurons (Figure 1.2).  The adult born OB interneurons are broadly 
classified as granule cell layer (GRL) cells, and periglomerular cells (PGCs).  There are three subtypes of 
GRL interneurons that are distinguished by their soma position in the deep or superficial GRL and the 
non-overlapping expression of neurogranin (Nrgn) or calretinin (CalR) (Gribaudo et al., 2009; Merkle et 
al., 2007).  These are Nrgn+ deep GRL, Nrgn+ superficial GRL, and CalR+ superficial GRL interneurons.  
There are three subtypes of periglomerular interneurons that are distinguished by their non-overlapping 
expression of CalR, calbindin (CalB), or tyrosine-hydroxylase (TH) (Merkle et al., 2007).  NSCs in the 
ventral V-SVZ give rise to deep GRL cells and CalB+ PGCs.  Interestingly, deep GRL interneurons are 
specifically produced by Nkx2.1+ NSCs in the anterior-ventral V-SVZ (Delgado and Lim, 2015).  
Superficial GRL cells and TH+ PGCs are produced by NSCs in the dorsal V-SVZ, while all CalR+ 
subtypes are produced by NSCs in the medial septum domain of the V-SVZ (Fuentealba et al., 2015; 
Merkle et al., 2007).  Four additional rare subtypes of OB interneurons that populate the mitral and 
external plexiform layers of the OB, termed Type 1 – 4 cells, are produced by NSCs in anterior ventral V-




Figure 1.2  Adult-born Olfactory Bulb Interneuron Subtypes 
(A) Schemas showing subtypes of adult born interneuron subtypes.   
Two subtypes are generated in the medial V-SVZ: CalR+ PGCs, and CalR+ Superficial GRL cells (red).  
Two subtypes are generated in the lateral V-SVZ: CalB+ PGCs, and Nrgn+ Deep GRL cells (cyan). 
Two subtypes are generated in the dorsal V-SVZ: TH+ PGCs, and Nrgn+ Superficial GRL cells (green). 
(B) Representative image of olfactory bulb stained with Dapi to reveal layers.  PGCs are found in the 
glomerular layer (GL), and granule cells are found in the deep and superficial granule cell layer (GRL).  
EPL, external plexiform layer; MCL, mitral cell layer; IPL, internal plexiform layer; Core, olfactory bulb 
core into which neuroblasts born in the V-SVZ migrate.  Scale bar 50µm.  Schemas adapted from 




































The regionalization of NSCs is an aspect of V-SVZ biology that has largely been ignored in the 
field for the last decade.  It is exceedingly rare for studies to report regional phenotypes, suggesting that 
in many cases this aspect is not even analyzed.  However, it is crucial to understand whether distinct 
factors regulate the quiescence and activation of regional subtypes of NSCs.  The regional specification 
of NSCs occurs as early as embryonic day 11.5 – 12.5 in the mouse, and NSCs remain largely quiescent 
through development until their reactivation during adulthood (Furutachi et al., 2013; Fuentealba et al., 
2015).  Adult qNSCs in the dorsal, lateral, and septal V-SVZ are the sister cells to radial glial progenitors 
that give rise to cortical, striatal, and septal neurons during development, respectively (Fuentealba et al., 
2015).  Thus, for example, there may be fewer barriers to guiding dorsal adult NSCs to generate new 
cortical neurons for targeted regeneration of cortical injuries.  The first step in such a process would be 
applying the correct signals to activate the regional qNSC subtype desired for the targeted regenerative 
purpose.   
 
In my research presented here, I investigate whether signals that regulate quiescence and 
activation map onto the regional heterogeneity of NSCs.  In Chapter 2, I show that nestin is not expressed 
in qNSCs, but is upregulated upon activation in vivo, and in vitro.  I then use this property to develop a 
screening assay for NSC quiescence regulating signals, and I present a candidate screen for NSC 
quiescence regulating signals.  In Chapter 3, I present a small molecule screen that identified 
neurotransmitters as qNSC activating signals.  I then show that several types of neurons display unique 
regional innervation patterns in the V-SVZ, and I demonstrate that modulating cholinergic signaling in vivo 
affects regional qNSCs.  Finally, in Chapter 4, I show that hunger and satiety states regulate the 
production of deep GRL interneurons via hypothalamic Pomc-expressing neurons, which promote the 






Molecular Characterization of qNSCs 
 The data in this chapter are published in Codega et al., 2014, which is included in the Appendix.  Erika 
Pastrana, Paolo Codega, and Violeta Silva-Vargas developed the FACS strategy used to purify qNSCs and aNSCs. 
The remainder of the data presented here was gathered by Alex Paul, with contributions from Paulo Codega, Angel-
Maldonato-Soto, and Annina DeLeo. 
 
Introduction 
 Quiescent and actively dividing (activated) stem cells coexist in adult stem cell niches (Li and 
Clevers, 2010). Maintaining stem cells in a quiescent state is important for guaranteeing lifelong tissue 
renewal, providing a reserve pool of stem cells for post-injury regeneration, and protecting from 
premature stem cell loss.  
Quiescent and activated NSCs exist in the adult V-SVZ stem cell niche, however, little is known 
about the molecular mechanisms that regulate NSC quiescence and activation.  A major limitation to our 
understanding of the regulation of these states and elucidation of their functional properties has been the 
lack of specific markers to identify qNSCs and aNSCs, and prospectively purify them from their in vivo 
niche.  In this chapter, I briefly describe a fluorescence-activated cell sorting (FACS) strategy developed 
in the Doetsch laboratory that allows the purification of qNSCs and aNSCs from the adult mouse V-SVZ 
niche for the first time, and briefly summarize their functional properties.  I then describe my findings 
characterizing the expression of the canonical neural stem cell marker nestin in qNSC and aNSC states, 
as well as a simple in vitro assay using primary FACS purified qNSCs to screen for signals that regulate 
NSC quiescence, which I developed and used for several functional screens in my thesis.  In this chapter 
I present the screen I performed based on candidate G protein-coupled receptors enriched in qNSCs as 





FACS Purification of qNSCs and aNSCs 
 The Doetsch lab previously developed a FACS strategy by which activated neural stem cells 
(GFAP::GFP+; EGFR+), transit amplifying cells (EGFR+), and neuroblasts (CD24+) can be 
simultaneously isolated from the V-SVZ of adult GFAP::GFP mice (Pastrana et al., 2009).  Subsequently, 
it was shown that ependymal cells and a subset of GFAP+ stem cells express CD133 
(Beckervordersandforth et al., 2010; Coskun et al., 2008; Mirzadeh et al., 2008).  By including CD133 in 
the above FACS strategy, we are able to purify two distinct CD133+ stem cell astrocyte populations, 
which, based on the functional studies described below, we define as qNSCs (GFAP::GFP+ CD133+), 
and aNSCs (GFAP::GFP+ CD133+ EGFR+) (Figure 2.1) (Codega et al., 2014).  A third population 
containing niche and other astrocytes (GFAP::GFP+) can be purified by this method, as well as transit 




Figure 2.1  FACS Purification of qNSCs and aNSCs 
(A) Table summarizing markers used to identify and FACS purify cells of the V-SVZ lineage. 
(B) Representative FACS plots showing gating for isolation of three populations of V-SVZ astrocytes: 
GFAP::GFP+CD133+ (qNSCs, blue), GFAP::GFP+CD133+EGFR+ (aNSCs, cyan), GFAP::GFP+ (niche 
and other astrocytes, gray). 
  
niche using FACS. We previously developed a simple strategy
to simultaneously isolate activated stem cells (GFAP::GFP+
EGFR+), transit-amplifying cells (EGFR+), and neuroblasts
(CD24+) by combining EGF-A647 and CD24 in GFAP::GFP
mice (Pastrana et al., 2009). By including CD133 in this sorting
strategy, we separated two CD133+ astrocyte populations,
GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+, from the
remaining GFAP::GFP+-only cells (Figures 3A and 3B; Figures
S4A–S4I). GFAP::GFP+CD133+ (ranging from 25% to 30% of
total GFP+ cells) and GFAP::GFP+CD133+EGFR+ (20%–25% of
total GFP+ cells) were both abundant but differed in their GFP
brightness (Figure 3C).
We assessed the purity of the sorted populations using qRT-
PCR and acute immunostaining. qRT-PCR confirmed that sorted
populations were appropriately enriched in Gfap, GFP, Prom1,
and Egfr expression (Figures S4Q–S4T). Acute immunostaining
showed that both GFAP::GFP+CD133+ and GFAP::GFP+
CD133+EGFR+ populations were highly enriched in GLAST and
GLT1 (Figures S4J and S4K)—glutamate aspartate transporters
expressed in astrocytes—as well as BLBP (Figure S4M), that
they largely or completely lacked S100b (Figure S4L) and that
they were almost completely negative for the neuroblast markers
DCX and bIII tubulin (Figures S4O and S4P). Notably, more than
90% of GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+
populations expressed the NSC transcription factor Sox2
(Figures S4N and S4U). High Sox2 levels are related to a more
proliferative state (Marqués-Torrejón et al., 2013); of note,
92.8% ± 1.5% of GFAP::GFP+CD133+EGFR+ cells expressed
high levels of Sox2 protein, whereas only 38.4% ± 3.5% of
GFAP::GFP+CD133+ cells were Sox2 bright, with the remainder
being Sox2 dim. In contrast, the GFAP::GFP+-only population
was more heterogeneous with significant neuroblast contamina-
tion, likely due to perdurance of GFP in neuroblasts (Figures S4O
and S4P). We therefore focused our functional analyses below
on GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+ popu-
lations (all data regarding the GFAP::GFP+-only population are
included in Figure S6).
Purified GFAP+CD133+ V-SVZ Cells Have Different Cell
Cycle Properties
Quiescent stem cells are largely dormant and lack markers of
proliferation such as Ki67 and MCM2 that are expressed in
actively dividing cells, but not during the quiescent G0 state
(Maslov et al., 2004). Both markers are expressed during G1,
with MCM2 being expressed earlier than Ki67. Cycling GFAP+
V-SVZ cells in vivo have a fast cell cycle (Ponti et al., 2013). To
determine the cell cycle properties of CD133+ astrocyte sub-
populations in vivo, we used multiple approaches. First, we
determined the instantaneous cell cycle status of FACS-purified
cells by acute immunostaining for proliferation-associated
markers. GFAP::GFP+CD133+EGFR+ cells were highly enriched
in both Ki67 and MCM2 (64% ± 5.2% and 87.3% ± 1.2%,
Figure 3. Prospectively Purified CD133+
Astrocyte Subpopulations Exhibit Different
Cell Cycle Properties
(A and B) Representative FACS plots showing
gating strategy. In (A), the gate used to select
GFAP::GFP+CD24- cells, which are then gated on
EGF-A647 and CD133-PE-Cy7. In (B), three pop-
ulations are clearly defined: GFAP::GFP+ (gray),
GFAP::GFP+CD133+ (blue), and GFAP::GFP+
CD133+EGFR+ (cyan).
(C) Histogram showing the intensity of GFP
signal in GFAP::GFP+, GFAP::GFP+CD133+, and
GFAP::GFP+CD133+EGFR+ populations (gray,
blue, and cyan, respectively) compared to other
V-SVZ cells (GFP!, black). Note that GFAP::
GFP+CD133+EGFR+ cells are dimmer than
GFAP::GFP+ and GFAP::GFP+CD133+ cells.
(D) Proportion of each CD133+-purified astrocyte
subpopulation that expresses Ki67 and MCM2
(n = 3; **p < 0.01, unpaired Student’s t test;
mean ± SEM).
(E) Proportion of each CD133+-purified astrocyte
subpopulation labeled after a single pulse of BrdU
(light green) or after 14 days of BrdU in the drinking
water (dark green) (n = 3 and n = 4, respectively,
**p < 0.01, unpaired Student’s t test, mean ± SEM).
(F) LRC fraction in the CD133+-purified astrocyte
populations 14 or 30 days after 14 days of BrdU
administration (n = 4, mean ± SEM).
(G) Representative FACS plots of CD133+ astro-
cyte subpopulations from saline- and Ara-C-
treated mice.
(H) Summary of markers expressed by CD133+-
purified astrocytes.
See also Figures S4 and S6.
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Studies in the lab revealed that qNSCs do not express the cell cycle markers Ki67 and MCM2, 
retain BrdU label, and survive anti-mitotic drug treatment, while aNSCs exhibit the opposite 
characteristics.  Serial passaging of neurospheres derived from qNSCs and aNSCs demonstrated that 
both populations can self renew in vitro.  Moreover, re-sorting of neurospheres demonstrated that qNSCs 
and aNSCs could interconvert between quiescent and activated states in vitro.  Both qNSC and aNSC 
populations gave rise to proliferative, multipotent colonies that differentiated into astrocytes, neurons, and 
oligodendrocytes in vitro, albeit such colonies arose extremely rarely from qNSCs (1% of single cells) 
compared to aNSCs (40% of single cells).  Importantly, transplantation of genetically labeled qNSCs and 
aNSCs into WT mice revealed that both populations can generate neurons and a small number of 
oligodendrocytes in vivo, although qNSCs generate neurons with slower kinetics than aNSCs (Codega et 
al., 2014). 
 
Characterization of Nestin Expression in qNSCs and aNSCs 
 Nestin expression is widely considered a hallmark of NSCs as it is expressed in neural 
progenitors during development and adulthood (Imayoshi et al., 2011; Lendahl et al., 1990; Zimmerman 
et al., 1994).  Microarray analysis of qNSCs and aNSCs revealed that nestin mRNA was expressed by 
aNSCs, but not, or at very low levels, by qNSCs (Codega et al., 2014).  I confirmed this result by qPCR 
(Figure 2.2A), and by immunostaining acutely plated cells for nestin immediately after FACS purification.  
I found that qNSCs do not express Nestin protein (0/1582 plated cells), while about 90% of aNSCs are 
Nestin+ (Figure 2.2B). 
Nestin is an intermediate filament protein that is localized to the processes of NSCs. It is thus 
difficult to assign Nestin expression to individual NSCs in vivo without a method to visualize the 
morphology of individual NSCs.  Therefore, to visualize NSC morphology in vivo I cloned a construct that 
expresses membrane-bound mCherry under the control of a mouse minimal CD133 promoter element 
(mP2-mCherry; Figure 2.2C) (Coskun et al., 2008; Shmelkov et al., 2004).  We electroporated mP2-
mCherry into the V-SVZ of adult mice, and mCherry expression revealed the radial morphology of NSCs 
(Figure 2.2D).  We then assessed nestin expression in mCherry+ cells by immunostaining for Nestin and 
EGF-ligand-a647 to distinguish between qNSCs and aNSCs.  Nestin expression was observed in 
	 18 
ependymal cells and deeper in the SVZ, as previously reported (Figures 2.2D and 2.2E) (Doetsch et al., 
1997). 
All observed qNSCs (mP2-mCherry+ EGF-ligand-a647-negative) were Nestin negative (Figure 2.2D; 0/79 
cells in 7 whole mounts), whereas 94% of observed aNSCs (mP2-mCherry+ EGF-ligand-a647+) 
expressed Nestin (Figure 2.2E; 32/34 cells in 7 whole mounts).  
 
Figure 2.2  qNSCs Do Not Express Nestin 
(A) qPCR for nestin mRNA expression in FACS purified qNSC and aNSC populations 
(B) Quantification of Nestin and MCM2 protein expression 2hrs post FACS isolation (n=3, mean +/- SEM) 
(C) Schema of construct used to visualize NSC morphology. The mouse CD133 minimal P2 promoter 
element controlling expression of an mCherry-transferrin receptor membrane-anchor domain (TRMD) 
fusion gene. 
(D-E) Confocal images showing mP2-mCherry+ cells (red) in whole mounts stained with EGF-ligand-a647 
(green) and for Nestin (blue). In (D), two cells contact the ventricle between ependymal cells, do not bind 
EGF-ligand-a647 (arrows), and are Nestin negative in the subventricular projection. In (E), an EGF-
ligand-a647 labeled cell (arrow) also stains for nestin in the subventricular projection (arrowheads in 
inset). Notably, not all processes contained Nestin. Scale bars 30µm.  
Supplemental Information – Codega et al., 2014 S9 
 
Figure S8. Gene express on profiling and targ ted GPCR screen, related to Figure 7 
(A-B) Pie charts showing GSEA metabolism subgroups for qNSCs and aNSCs (first bars in Figure 7D) 
(C-D) Comparison of our microarray data with those of Beckervordersandforth et al. 2010. The expression of genes 
pr sent in “genes enriched in adult NSCs in comparison to diencephalic as rocytes” (C) (corresponding to Table S5 from 
Beckervordersandforth et al., 2010) and “adult NSC-enriched genes” (D) (corresponding to Table S6 from 
Beckervordersandforth et al., 2010) lists was analyzed and genes subcategorized by enrichment in qNSCs and aNSCs, 
expression in both or not present (as defined by expression in raw data < 50 for no expression). Gene lists are in 
Supplementary Table S8. 
(E-J) qRT-PCR validation of microarray genes showing fold-change of Nestin (E), Dlx2 (F), Ascl1 (G), Dll1 (H), Vcam1 (I), 
and Lrig1 (J) in qNSCs and aNSCs populations relative to sorted total SVZ cells (as gated in S4C) (n=3, mean±SEM). 
(K) Schema of experimental design for the qNSC and aNSC GPCR ligand screen.  
(L) Plot of the fold change of qNSC activated Nestin+ clones. Compounds that were statistically significant are in red (n=3, 
mean±SEM, *p<0.05, unpaired Student’s t-test). Different shades of grey demarcate compounds in the same diluent, and 
open circles are controls.  
  
Supplemental Information – Codega et al., 2014 S3 
Figure S3. In vivo validation of mP2-mCherry transgene and examples of astrocyte morphology, related to   
Figure 2 
(A) Schema of the transgene used for morphological studies. A plasmid containing an mCherry-transferrin receptor 
membrane-anchor domain (TRMD) fusion gene under the control of the mouse P2 element of the Prominin1 promoter 
was electroporated into V-SVZ cells lining the ventricle. 
(B-D) Confocal images of the ventricular (superficial) surface of whole mounts immunostained with Acetylated Tubulin (BI, 
CI, DI) and CD133 (BII, CII, DII), showing mP2-mCherry+ cells (BIII, CIII, DIII). BIV, CIV and DIV are merged images. BV, CV and 
DV are z-stack projections of the same cells through the entire depth of the V-SVZ. BVI, CVI and DVI are side views of the 
projections. The transgene is expressed in multiciliated CD133+ ependymal cells (B, asterisk), CD133+ monociliated cells 
(C, arrowhead and inset) and non-ciliated diffuse CD133+ cells (D, arrowhead). 
(E-F) Confocal images of whole mounts showing projections of EGF-ligand negative (E) and positive (F) cells labeled by 
mP2-mCherry transgene (red) and immunostained with laminin (cyan). In the insets, superficial optical slices of the same 
cells showing EGF-A647 (green) and β-Catenin (blue). 
(G-N) Confocal images of whole mounts showing examples of EGF- (G-J) and EGF+ (K-N) mP2-mCherry+ cells. Upper 
panels (GI-NI) show EGF-ligand and mP2-mCherry labeling in an optical slice at the ventricular surface. Lower panels (GII-
NII) show depth-coded projections of the same mP2-mCherry labeled cells, where orange/yellow is superficial and 
blue/violet is deep. Scale bars: 30 µm. 














activation and contribute to the lineage during regeneration
in vivo.
Gene Expression Analysis of Purified qNSCs and aNSCs
Reveals Distinct Molecular Signatures
To gain insight into the biological properties of qNSCs and to
define their molecular signatures, we performedmicroarray anal-
ysis on RNA from FACS-purified populations isolated directly
from their in vivo niche (Figure 7A; Table S1). Gene ontology
(GO) and gene set enrichment analysis (GSEA) (Subramanian
et al., 2005) revealed that qNSCs and aNSCs have distinct
molecular features (Figures 7B–7D). Confirming the actively
dividing state of aNSCs in vivo, their transcriptome was enriched
in genes involved in the cell cycle, transcription and translation,
and DNA repair (Figures 7C and 7D; Tables S2 and S3). In
contrast, qNSCs were enriched in the GO categories of cell
communication, response to stimulus, and cell adhesion (Fig-
ure 7B; Table S2), underscoring the dynamic regulation of the
quiescent state via interaction with the microenvironment.
Indeed, the most represented GSEA groups for qNSCs were
related to transport, signaling, receptors, cell surface, and extra-
cellular matrix (Figure 7D; Table S3). Notably, qNSCs and aNSCs
exhibited different metabolic profiles; themajority of the differen-
tially enriched GSEAmetabolism subsets in qNSCs were related
Figure 6. qNSCs Are Nestin Negative
(A) Proportion of acutely plated purified qNSCs and aNSCs immunopositive for MCM2 and Nestin (n = 3, mean ± SEM).
(B) Images of FACS-purified qNSCs cultured in EGF, fixed at different time points, and immunostained with EGFR, MCM2, and Nestin. Three types of cells are
present: rounded cells with a condensed nucleus that do not express EGFR, MCM2, or Nestin (type 1); rounded cells with a larger nucleus that express EGFR,
MCM2, and Nestin (type 2); and EGFR+MCM2+Nestin+ cells with elongated processes (type 3). Type 3 cells resemble aNSCs after 3 days in culture. Scale bars,
10 mm.
(C) Quantification of activated qNSCs in culture after 2 hr or after 1, 3, 5, or 7 days after plating (n = 4, mean ± SEM).
(DI–EII) Confocal imag s showing mP -mCherry+ cells (red) n whole mou t labeled with EGF-A647 (green) and immunostained for Nestin (blue). In (D), two cells
contact the ventricle between ependymal cells, do not bind EGF-A647 (DI, arrows), and are Nestin negative in the subventricular projection (DII). In (E), an EGF-
A647-labeled cell (EI, arrow) is coimmunostained with Nestin in the subventricular projection (EII, arrowheads in inset). Notably, not all processes contained
Nestin. Scale bars, 30 mm.
See also Figure S7.
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activation and contribute to the lineage during regeneration
in vivo.
Gene Expression Analysis of Purified qNSCs and aNSCs
Reveals Distinct Molecular Signatures
To gain insight into the biological properties of qNSCs and to
define their molecular sig atures, w performedmicroarray anal-
ysis on RNA from FACS-purified populations isolated directly
from their in vivo niche (Figure 7A; Table S1). Gene ontology
(GO) and gene set enrichment analysis (GSEA) (Subramanian
et al., 2005) revealed that qNSCs and aNSCs have distinct
molecular features (Figures 7B–7D). Confirming th actively
dividing state of aNSCs in vivo, their transcriptome was enriched
in genes involved in the cell cycle, transcription and translation,
and DNA repair (Figures 7C and 7D; Tables S2 and S3). In
contrast, qNSCs were enriched in the GO categories of cell
communication, response to stimulus, and cell adhesion (Fig-
ure 7B; Table S2), underscoring the dynamic regulation of the
quiescent state via int raction with th microenvironment.
Ind ed, the most represented GSEA gr ups for qNSCs were
related to transport, signaling, receptors, cell surface, and extra-
cellular matrix (Figure 7D; Table S3). Notably, qNSCs and aNSCs
exhibited different metabolic profiles; themajority of the differen-
tially enriched GSEAmetabolism subsets in qNSCs were related
Figure 6. qNSCs Are Nestin Negative
(A) Proportion of acutely plated purified qNSCs and aNSCs immunopositive for MCM2 and Nestin (n = 3, mean ± SEM).
(B) Images of FACS-purified qNSCs cultured in EGF, fixed at different time points, and immunostained with EGFR, MCM2, and Nestin. Three types of cells are
present: rounded cells with a condensed nucl us that do n t expr ss EGFR, MCM2, or Nestin (type 1); rounded cells with a larger nucleus that express EGFR,
MCM2, and Nestin (typ 2); and EGFR+MCM2+Nestin+ cells with elongated processes (type 3). Type 3 cells resemble aNSCs after 3 days in culture. Scale bars,
10 mm.
(C) Quantification of activated qNSCs in culture after 2 hr or fter 1, 3, 5, or 7 days after plating (n = 4, m an ± SEM).
(DI–EII) Confocal images showing mP2-mCherry+ cells (red) in whole mount labeled with EGF-A647 (green) and immunostained for Nestin (blue). In (D), two cells
contact the ventricle between ependymal cells, do not bind EGF-A647 (DI, arrows), and are Nestin negative in the subventricular projection (DII). In (E), an EGF-
A647-labeled cell (EI, arrow) is coimmunostained with Nestin in the subventricular projection (EII, arrowheads in inset). Notably, not all processes contained
Nestin. Scale bars, 30 mm.
See lso Figure S7.
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activation and ontribute to the lineage during regeneration
in vivo.
Gene Expression Analysis of Purified qNSC and aNSCs
Reveals Disti ct Mol cular Signatures
To gai insight into the biologic l properties of qNSCs and to
define their molecular signatures, we performedmicroarray anal-
ysis on RNA from FACS-purified populations isolated directly
from their in vivo niche (Figure 7A; Table S1). Gene ontology
(GO) and gene set enrichment analysis (GSEA) (Subramanian
et al., 2005) revealed that qNSCs an aNSCs have distinct
molecular features (Figur s 7B–7D). Confirming the actively
dividing state of aNSCs in vivo, their transcriptome was enriched
in genes involved in the cell cycle, transcription and tra slation,
and DNA repair (Figures 7C a d 7D; Tables S2 and S3). In
contrast, qNSCs were enriched in the GO categories of cell
communicatio , respo se to stimulus, and cell dhesion (Fig-
ure 7B; T ble S2), underscoring the dynamic regulation of the
quiescent state via interaction with the micr environment.
Indeed, the most repr sented GSEA groups for qNSCs were
related to transport, signaling, receptors, cell surface, and extra-
cellular matrix (Figure 7D; Table S3). Notably, qNSCs and aNSCs
exhibited different m tabolic profil s; themajority of the differen-
tially enriched GSEAmetabolism subsets in qNSCs were related
Figure 6. qNSCs Are Nestin Negative
(A) Proportion of acutely plated purified qNSCs and aNSCs immunopositive for MCM2 and Nestin (n = 3, mean ± SEM).
(B) Images of FACS-purified qNSCs cultured in EGF, fixed at different time points, and immunostained with EGFR, MCM2, and Nestin. Three types of cells are
present: rounded cells with a condensed nucleus that do not express EGFR, MCM2, or Nestin (type 1); rounded cells with a larger nucleus that express EGFR,
MCM2, and Nestin (type 2); and EGFR+MCM2+Nestin+ cells with elongated processes (type 3). Type 3 cells resemble aNSCs after 3 days in culture. Scale bars,
10 mm.
(C) Quantification of activated qNSCs in culture after 2 hr or after 1, 3, 5, or 7 days after plating (n = 4, mean ± SEM).
(DI–EII) Confocal images showing mP2-mCherry+ cells (red) in whole mount labeled with EGF-A647 (green) and immunostained for Nestin (blue). In (D), two cells
contact the ventricle between ependymal cells, do not bind EGF-A647 (DI, arrows), and are Nestin negative in the subventricular projection (DII). In (E), an EGF-
A647-labeled cell (EI, arrow) is coimmunostained with Nestin in the subventricular projection (EII, arrowheads in inset). Notably, not all processes contained
Nestin. Scale bars, 30 mm.
See also Figure S7.
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The aNSC-specific expression of nestin suggested that qNSCs upregulate nestin when they 
become activated.  GFAP+ qNSCs activate, upregulate EGFR, and regenerate the V-SVZ lineage 
following treatment with the anti-mitotic drug Ara-C (Doetsch et al., 1999a; Pastrana et al., 2009).  We 
therefore tested whether Nestin-negative qNSCs could generate Nestin+ cells and contribute to the V-
SVZ lineage during regeneration.  We genetically labeled GFAP+ NSCs in adult GFAP::CreERT2; R26-
tdTomato mice, and then infused Ara-C onto the brain surface for 6 days to ablate all dividing cells in the 
lineage (Figure 2.3A).  Immediately following Ara-C treatment, Nestin expression was largely abolished, 
and all surviving tdTomato+ qNSCs were Nestin-negative (Figure 2.3B, 0/951 cells).  Six days after Ara-C 
removal, Nestin expression recovered and numerous Nestin+tdTomato+ cells were present, as well as 
Doublecortin+tdTomato+ neuroblasts.  These data reveal that qNSCs upregulate Nestin during activation 






Figure 2.3  Nestin-negative qNSCs Upregulate Nestin Upon Activation and Contribute to the V-SVZ 
Lineage During Regeneration 
(A) Schema of the experimental design. Recombination was induced in adult GFAP::CreERT2; R26-
tdTomato mice by three tamoxifen injections 10 days before Ara-C treatment. Brains were harvested at 0 
or 6 days after terminating Ara-C treatment (red X’s). Whole mounts were immunostained for Nestin 
(green) and Doublecortin (blue).  
(B) Confocal z-stack images of whole mount preparations at 0 and 6 days after Ara-C treatment. Radial 
tdTomato+ qNSCs were all Nestin negative at 0d. Radial tdTomato+Nestin+ cells (white arrows) were 
detected at 6 days. 
(C) Confocal image of a whole mount preparation showing expression of tdTomato (red), Nestin (green), 
and Doublecortin (blue) showing tdTomato+Nestin+ cells (white arrow) and tdTomato+Doublecortin+ 
neuroblasts (open arrows) at 6 days after Ara-C removal. Scale bars 30µm.  
 
  
tdTomato Nestin Doublecortin Merge
Nestin tdTomato













Characterization of Spontaneous in vitro qNSC Activation 
 Signals that regulate transitions between the quiescent and activated neural stem cell states are 
poorly understood.  Only 1% of FACS purified single qNSCs spontaneously activate in vitro when cultured 
with EGF, and generate highly proliferative, multipotent colonies (Codega et al., 2014).  This property 
suggested the possibility to develop an in vitro assay to screen for small molecules able to increase or 
decrease spontaneous qNSC activation.  To that end, I performed time-course experiments to better 
characterize the early features of spontaneous in vitro qNSC activation.  I cultured FACS purified qNSCs 
at clonal density with EGF for 2 hours, and 1, 3, 5, or 7 days, at which points cells were fixed and 
immunostained for Nestin, EGFR, and MCM2.  At 2hrs post plating, qNSCs had small, condensed nuclei 
(60.9 +/- 0.85 µm2 mean elliptical area) and did not express Nestin, EGFR, or MCM2 (Figure 2.4A, Type 
1).  One day after plating, rare qNSCs had activated, and were characterized by enlarged nuclei (117.8 
+/- 35.1 µm2) and upregulation of Nestin, EGFR, and MCM2 (Figure 2.4A and 2.4B, Type 2).  They then 
extended processes, closely resembling cultured aNSCs in nucleus size (110.4 +/- 24.9 µm2), 
morphology and marker expression (Figures 2.4A and 2.4B, Type 3).  Activated qNSC clones did not 
proliferate extensively until 5 to 7 days after plating (Figure 2.4B).  These data reveal that spontaneous in 
vitro qNSC activation follows a stereotyped pattern similar to what we observed in vivo during 
regeneration, which can be simply quantified using Nestin immunostaining as a read-out.  Thus, this 
assay is suitable for screening for small molecule regulators of NSC quiescence.  Importantly, by 
analyzing subsequent screening assays at 4 days post plating I was able to identify compounds that 
regulate transitions between quiescence and activation at a clonal level with minimal masking from high 
levels of proliferation.  This analysis serves as a baseline for several screens I perform in this chapter and 






Figure 2.4  qNSCs Upregulate Nestin and EGFR Upon Activation in vitro 
(A) Representative images of FACS-purified qNSCs cultured in EGF, fixed at different time points, and 
immunostained for EGFR, MCM2, and Nestin. Three types of cells are present: rounded cells with a 
condensed nucleus that do not express EGFR, MCM2, or Nestin (Τype 1); rounded cells with a larger 
nucleus that express EGFR, MCM2, and Nestin (Τype 2); and EGFR+MCM2+Nestin+ cells with 
elongated processes (Τype 3). Type 3 cells resemble aNSCs after 3 days in culture. Scale bar 10µm. 
(B) Quantification of activated qNSCs in culture 2hrs, or 1, 3, 5, or 7 days after plating (n = 4, mean ± 
SEM). 
  
activation and contribute to the lineage during regeneration
in vivo.
Gene Expression Analysis of Purified qNSCs and aNSCs
Reveals Distinct Molecular Signatures
To gain insight into the biological properties of qNSCs and to
define their molecular signatures, we performedmicroarray anal-
ysis on RNA from FACS-purified populations isolated directly
from their in vivo niche (Figure 7A; Table S1). Gene ontology
(GO) and gene set enrichment analysis (GSEA) (Subramanian
et al., 2005) revealed that qNSCs and aNSCs have distinct
molecular features (Figures 7B–7D). Confirming the actively
dividing state of aNSCs in vivo, their transcriptome was enriched
in genes involved in the cell cycle, transcription and translation,
and DNA repair (Figures 7C and 7D; Tables S2 and S3). In
contrast, qNSCs were enriched in the GO categories of cell
communication, response to stimulus, and cell adhesion (Fig-
ure 7B; Table S2), underscoring the dynamic regulation of the
quiescent state via interaction with the microenvironment.
Indeed, the most represented GSEA groups for qNSCs were
related to transport, signaling, receptors, cell surface, and extra-
cellular matrix (Figure 7D; Table S3). Notably, qNSCs and aNSCs
exhibited different metabolic profiles; themajority of the differen-
tially enriched GSEAmetabolism subsets in qNSCs were related
Figure 6. qNSCs Are Nestin Negative
(A) Proportion of acutely plated purified qNSCs and aNSCs immunopositive for MCM2 and Nestin (n = 3, mean ± SEM).
(B) Images of FACS-purified qNSCs cultured in EGF, fixed at different time points, and immunostained with EGFR, MCM2, and Nestin. Three types of cells are
present: rounded cells with a condensed nucleus that do not express EGFR, MCM2, or Nestin (type 1); rounded cells with a larger nucleus that express EGFR,
MCM2, and Nestin (type 2); and EGFR+MCM2+Nestin+ cells with elongated processes (type 3). Type 3 cells resemble aNSCs after 3 days in culture. Scale bars,
10 mm.
(C) Quantification of activated qNSCs in culture after 2 hr or after 1, 3, 5, or 7 days after plating (n = 4, mean ± SEM).
(DI–EII) Confocal images showing mP2-mCherry+ cells (red) in whole mount labeled with EGF-A647 (green) and immunostained for Nestin (blue). In (D), two cells
contact the ventricle between ependymal cells, do not bind EGF-A647 (DI, arrows), and are Nestin negative in the subventricular projection (DII). In (E), an EGF-
A647-labeled cell (EI, arrow) is coimmunostained with Nestin in the subventricular projection (EII, arrowheads in inset). Notably, not all processes contained
Nestin. Scale bars, 30 mm.
See also Figure S7.
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A Candidate Screen for GPCR Regulators of Quiescence 
 We gained insight into signaling pathways that regulate quiescence in NSCs from our microarray 
analysis of qNSC and aNSC transcriptomes.  Gene Set Enrichment Analysis (GSEA) revealed that G 
protein-couple receptor (GPCR) signaling was highly enriched in qNSCs (30% of all GSEA signaling sets) 
(Codega et al., 2014).  I selected 26 GPCRs highly enriched in qNSCs (more than 10-fold over aNSCs) 
as the basis for a candidate screen for quiescence regulating signals (Table 2.5).  These included 21 
endogenous ligands, and one synthetic ligand, of the selected GPCRs for their effects on both qNSCs 
and aNSCs (Table 2.5; references for ligands in (Codega et al., 2014)).  I plated FACS purified qNSCs at 
clonal density with EGF, added ligands 24 hours later, fixed the cells on day 4 and quantified the number 
of activated Nestin+ positive clones (Figure 2.6A).  To determine the effect of compounds on aNSCs, I 
plated FACS purified aNSCs at clonal density with EGF and the ligands, fixed the cells 24hrs later, and 
quantified the number of cells which had divided at least once (activated clones) (Figure 2.6A).  The 
shorter time point was necessary for aNSCs because they divide rapidly in vitro making it difficult to 
distinguish individual clones.  Three ligands, adenosine, sphingosine-1-phosphate (S1P), and 
prostaglandin D2 (PGD2), gave significant and distinct effects between qNSCs and aNSCs (Figures 2.6B 
and 2.6C).  Adenosine decreased dividing aNSC clones by about 30%, but had no effect on qNSC 
activation.  Thus adenosine is able to induce, but unable to maintain, the quiescent state.  In contrast, 
S1P decreased qNSC activation by about 50%, but had no effect on aNSCs.  Thus, S1P can maintain, 
but is unable to induce, the quiescent state.  PGD2 potently decreased the activation of both qNSCs and 
aNSCs.  As such, PGD2 can both induce and maintain the quiescent state.  These data reveal that GPCR 
signaling is important for regulating NSC quiescence, and that GPCR ligands can differ in their ability to 






Table 2.5  GPCRs Enriched in qNSCs and Their Ligands Tested in the Candidate Screen 
All ligands are endogenous, except L-CCG-I, which agonizes all metabotropic (GPCR) glutamate 
receptors.  
Less reliable probe sets are noted with _a_ (denotes detection of a gene family), and _s_  (hybridizes to 
multiple transcript variants).  
  






1435495_at adenosine A1 receptor Adora1 10.397678 Adenosine
1434430_s_at adenosine A2b receptor Adora2b 31.048176 Adenosine
1459351_at adrenergic receptor, alpha 1a Adra1a 18.837431 Epinephrine / Norepinephrine
1433600_at adrenergic receptor, alpha 2a Adra2a 20.029146 Epinephrine / Norepinephrine
1425814_a_at calcitonin receptor-like Calcrl 18.947807 Amylin
1460513_a_at endothelin receptor type A Ednra 26.673853 Endothelin 1
1427611_at growth hormone releasing hormone receptor Ghrhr 10.390047 GRF
1451060_at G protein-coupled receptor 146 Gpr146 13.392646 Proinsulin C-Peptide
1456833_at G protein-coupled receptor 17 Gpr17 24.492632 Leukotriene D4
1450875_at G protein-coupled receptor 37 Gpr37 10.867761 Prosaptide
1430136_at glutamate receptor, metabotropic 3 Grm3 17.349558 L-CCG-I     (synthetic ligand)
1444223_at hypocretin (orexin) receptor 2 Hcrtr2 11.6158285 Orexin A
1438494_at histamine receptor H1 Hrh1 27.785969 Histamine
1421757_at 5-hydroxytryptamine (serotonin) receptor 6 Htr6 10.586905 Serotonin
1433891_at leucine-rich repeat-containing G protein-coupled receptor 4 Lgr4 13.53013 R-spondin1
1448606_at lysophosphatidic acid receptor 1 Lpar1 46.594353 1-Oleoyl lysophosphatidic acid (LPA)
1458742_at latrophilin 3 Lphn3 13.519957 α-Latrotoxin
1426054_at neuropeptide Y receptor Y1 Npy1r 29.172924 Neuropeptide Y
1420799_at neurotensin receptor 1 Ntsr1 16.52517 Neurotensin
1422171_at prostaglandin D receptor Ptgdr 10.0564 Prostaglandin D2 (PGD2)
1420349_at prostaglandin F receptor Ptgfr 10.063209 Prostaglandin D2 (PGD2)
1423571_at sphingosine-1-phosphate receptor 1 S1pr1 11.028068 Sphingosine-1-phosphate (S1P)
1438658_a_at sphingosine-1-phosphate receptor 3 S1pr3 39.406864 Sphingosine-1-phosphate (S1P)
1449365_at sphingosine-1-phosphate receptor 5 S1pr5 53.72806 Sphingosine-1-phosphate (S1P)
1443454_at secretin receptor Sctr 10.334803 Secretin
1422234_at tachykinin receptor 2 Tacr2 10.985823 Neurokinin A
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Figure 2.6  Candidate GPCR Ligand Screen 
(A) Schema of the screening assay.  qNSCs were plated at clonal density with EGF, GPCR ligands were 
added one day later, and at 4 days total culture cells were fixed and stained for Nestin.  aNSCs were 
plated at clonal density with EGF and GPCR ligands and 24hrs later fixed and stained for Nestin. 
(B) Quantification of activated Nestin+ qNSC clones as compared to controls (empty dots). 
(C) Quantification of aNSC clones (percentage of clones that underwent division) as compared to controls 
(empty dots). Data are represented as means ± SEM. n = 3. *p < 0.05; **p < 0.01, ***p < 0.001 by 

















































































































































































































































































 Here, we prospectively identified and simultaneously purified populations of qNSCs and aNSCs 
from the adult mouse V-SVZ niche.  This allowed us to begin characterizing the molecular phenotypes of 
NSCs as they transition between quiescent and activated states.  My contribution to these studies 
revealed that nestin is not expressed by qNSCs in the V-SVZ, but is upregulated upon activation in vitro 
and during regeneration in vivo.  Many dividing radial glia-like stem cells in the SGZ of the adult 
hippocampus express nestin, and nestin-negative stem cells contribute to the lineage during regeneration 
(DeCarolis et al., 2013).  Nestin is commonly used both as a marker for NSCs, as well as a means by 
which to lineage trace and genetically manipulate NSCs (Imayoshi et al., 2011).  Thus, my finding impacts 
the interpretation and design of studies based on nestin expression.   
My time-course analysis revealed that spontaneous in vitro qNSC activation was molecularly and 
chronologically stereotyped.  Based in this property, I developed a simple screening assay by which to 
search for NSC quiescence regulating signals.  In the first of such screens I tested candidate GPCR 
signaling ligands, which were implicated by our microarray analysis as potential regulators of NSC 
quiescence.  Strikingly, three of twenty-two ligands tested, adenosine, S1P, and PGD2, significantly 
inhibited activated clone formation by qNSCs or aNSCs, demonstrating that these ligands can induce 
and/or maintain the quiescent NSC state.  GPCR signaling plays a role in regulating numerous facets of 
adult neurogenesis (Doze and Perez, 2012), and these findings underscore that they are also key 






Small Molecule Screen Reveals Neurotransmitters as Activators of qNSCs 
 
Introduction 
 Quiescence is an actively maintained state from which cells can re-enter the cell cycle in 
response to a combination of cell-intrinsic factors and environmental signals (Cheung and Rando, 2013).  
Quiescent NSCs in the V-SVZ niche have access to regulating signals from numerous sources including 
direct cell-cell contact with all cell types of the niche, input from neurons, locally secreted factors, factors 
present in the CSF, and signals circulating in the blood (Silva-Vargas et al., 2013).  Thus, qNSCs reside 
in an incredibly noisy signaling environment, and any activating signal must be rather extraordinary in its 
ability to cut through the noise.  NSCs in the V-SVZ are regionally heterogeneous.  NSCs residing in 
specific regions of the V-SVZ give rise to distinct subtypes of olfactory bulb (OB) interneurons (Merkle et 
al., 2007; 2013).  It is unknown whether activating signals map onto the regional heterogeneity of NSCs 
and might thereby underlie the generation of distinct OB interneuron subtypes. 
 In this chapter, I describe an unbiased small molecule screen for activating signals that I 
performed, to identify activators of qNSCs.  Strikingly, neurotransmitters were the main class of activating 
compounds, and targeted diverse neurotransmitter receptors, including cholinergic, dopaminergic, 
GABAergic, serotonergic and opioid receptors.  I show that neurons that use these neurotransmitters 
exhibit regional patterns of innervation within the V-SVZ.  Together these data suggested that signaling 
from distinct neuron types regulates the proliferation of regional subtypes of qNSCs.  Finally, I present 




Small Molecule Screen Reveals Neurotransmitters as qNSC Activators 
 qNSCs are remarkably resistant to activation in vitro.  To identify qNSC-activating signals, I used 
an unbiased approach, and screened a library of 1307 small molecule compounds for their ability to 
modulate the baseline rate of spontaneous in vitro qNSC activation.  We selected the Tocris Mini Plus 
	 28 
library, which is enriched for compounds of known biological function, including signaling receptor 
agonists and antagonists, protein kinase and phosphatase inhibitors, bioactive molecules such as cyclic-
AMP, and FDA approved drugs such as acetaminophen and selective serotonin reuptake inhibitors.  We 
reasoned that by using compounds of known biological function we would more rapidly be able to move 
insights from the screen into investigations of in vivo qNSC biology. 
 I performed the small molecule screen in two rounds, as the rate-limiting factor was the number of 
qNSCs purified per FAC sort (an average of 60,000 cells from 15 animals per sort).  In the primary 
screen, the entire library of compounds was screened, one compound per well, in one biological replicate. 
qNSCs were FACS purified, plated at clonal density with EGF, and compounds were added 1 day later. 
Cultures were fixed for analysis on the fourth day (Fig 3.1A).  “Hits” were scored as compounds that 
significantly increased or decreased the number of activated Nestin+ clones above the DMSO controls 
(details of the statistical analyses are provided in the Methods).  The number of cells per activated 
Nestin+ clone was also quantified to identify compounds that might also affect the proliferation of NSCs 
once they had activated.   
In the primary screen, 202 compounds significantly increased, and 504 compounds significantly 
decreased, the number of activated Nestin+ clones.  I organized these 706 hits into groups based on their 
common targets.  I then selected the most potent positive and negative hits from each group for 
screening in a second biological replicate (175 compounds = 79 positive and 96 negative hits).  The 
secondary screen identified 51 compounds that repeated their effects on qNSCs.  Of these compounds, 8 
increased qNSC activation, 33 decreased qNSC activation, and 10 increased the proliferation of activated 
clones. 
Strikingly, neurotransmitter and neuromodulator receptors emerged as the largest class of targets 
for the effective compounds.  Fully 31% (16/51) of all hits targeted acetylcholine, GABA, glutamate, 
serotonin, dopamine, opioid, or cannabinoid receptors (Table 3.2).  More broadly, 57% (29/51) of all hits 
targeted genes involved in various aspects of neurotransmitter signaling including acetylcholine transport, 
GABA synthesis, chloride channels, other neuromodulators, and the common second messengers of 
neurotransmitter signaling, adenylyl cyclase, cAMP, protein kinase C, phospholipase C, and calmodulin 
(Table 3.2).  Importantly, the majority of the targeted genes were enriched in qNSCs in our microarray 
	 29 
data (Table 3.2).  These results highlight neurotransmitter signaling as a key regulator of adult NSC 
quiescence and activation. 
Given that endogenous neurotransmitters function as agonists, I reasoned that agonists that 
increased, and antagonists that decreased, qNSC activation would be most indicative of endogenous 
activating signals.  Eight compounds targeting neurotransmitter receptors affected qNSCs in this way 
(Table 3.2, compounds highlighted in blue), including agonists against nicotinic acetylcholine, GABA-A, 
and kappa opioid receptors, and antagonists against serotonin and dopamine receptors.  All but one of 
these compounds repeated their effect on qNSCs in additional biological replicates (Figures 3.1B and 
3.1C).  Moreover, endogenous acetylcholine, GABA, dopamine, and the endogenous opioid peptide 
enkephalin, all significantly increased the number of activated Nestin+ qNSC clones (Figure 3.1D).  
Serotonin had no effect in this assay, possibly because agonizing 5-HT1B, and antagonizing 5-HT3 
receptors decreased qNSC activation (Figure 3.1D, and Table 3.2).  Nonetheless, serotonin promotes 
proliferation in the V-SVZ in vivo (Tong et al., 2014).  I tested whether these ligands may be acting on 
distinct subsets of qNSCs by applying them in combination.  Although qNSC activation was significantly 
increased, there was no additive affect from the combination of the effective ligands (Figure 3.1D).  
Interestingly, compounds targeting glutamate, GABA, and cannabinoid receptors had multiple effects.  
Agonists of AMPA sensitive glutamate receptors both decreased qNSC activation, as well as increased 
the proliferation of activated clones (Table 3.2).  Agonists of GABAB receptors decreased qNSC 
activation (Table 3.2).  Agonizing the cannabinoid receptor-1 (CB1) decreased qNSC activation, while 
antagonizing cannabinoid receptor-2 (CB2) increased activated clone proliferation (Table 3.2).  These 
data reveal that neurotransmitters can regulate multiple aspects of quiescence, activation, and 
proliferation.  Specifically, these data identify the neurotransmitters acetylcholine, dopamine, and GABA, 
and the opioid peptide enkephalin as activators of adult qNSCs, and implicate a role for serotonin in 
quiescence regulation. 
A common affect of neurotransmitters is the depolarization of the signal-receiving cell’s 
membrane potential.  Both acetylcholine and serotonin can depolarize V-SVZ NSCs (Paez-Gonzalez et 
al., 2014; Tong et al., 2014).  Notably, GABA depolarizes neural progenitor cells during development, and 
during adulthood in both the V-SVZ and SGZ via GABA-A receptors (Ben-Ari, 2002; Tozuka et al., 2005; 
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Young et al., 2014).  Dopamine can have positive and negative modulatory effects on neuronal 
membrane potential (Yasumoto et al., 2002).  Several of the activating compounds identified in the screen 
target ion channel receptors, including nicotinic acetylcholine, GABA-A, and serotonin 5-HT3 receptors.  
Strikingly, depolarization of qNSCs with 15mM KCl increased qNSC activation more potently than any of 
the neurotransmitters individually or in combination (Figure 3.1D).  These data suggest that depolarization 






Figure 3.1  Small Molecule Screen Identifies Neurotransmitters as qNSC Activators 
(A) Schema of the screening assay.  qNSCs were plated at clonal density with EGF, compounds were 
added one day later, and at 4 days cells were fixed and stained for nestin. 
(B) Small molecule screen. Quantification of activated Nestin+ qNSC clones as compared to controls 
(empty dots).  ADMP: Non-selective nicotinic agonst, PNU 282987: Chrna7-selective nicotinic agonist, 
Nafadotride: Dopamine receptor D3 antagonist, Eticlopride: Dopamine receptor D2/D3 antagonist, CGS 
20625: GABA-A partial agonist at benzodiazepine site, ICI 204448: Kappa opioid receptor agonist, 
TDMB: Serotonin receptor 5-HT3 antagonist, SB 203186: Serotonin receptor 5-HT4 antagonist. Mean ± 
SEM, n=3. 
(C) Representative images of activated qNSC clones treated with cholinergic agonists in the small 
molecule screen, and immunostained for Nestin, MCM2, and DAPI to label nuclei.  Scale bar 20µm. 
(D) Quantification of activated Nestin+ qNSC clones as compared to controls (empty dots). ADEG is the 
combination of the four effective endogenous ligands. Mean ± SEM, n=3.   























































































































































Table 3.2  Small Molecule Screen Hits Related to Neurotransmitter Signaling 
Compounds and their descriptions are listed, as well as their effect on qNSCs in the small molecule 
screen.  Compounds increased (+, green) or decreased (–, red) the number of Nestin+ qNSC clones, or 
increased the number of cells per Nestin+ qNSC clone (+, yellow).   
Target genes that could be identified are listed along with their enrichment in qNSCs relative to aNSCs in 
the microarray expression data from Codega et al., 2014.  A positive value indicates enrichment in 
















4-Acetyl-1,1-dimethylpiperazinium Nicotinic agonist + ns Chrna3 1.8852771
(ADMP) Chrnb4 8.7934034
PNU 282987 Selective α7 nAChR agonist + Chrna7 2.0678313
CGS 20625 Selective benzodiazepine (GABAA) partial agonist + ns Gabra2 4.4408627
Gabrb1 44.897544
Gabrg1 15.361538
ICI 204,448 κ agonist, acts peripherally + ns Oprk1 1.0493498
NPPB Chloride channel blocker + ns
Forskolin Adenylyl cyclase activator + ns
Dibutyryl-cAMP Cell-permeable cAMP analog + ns
(S)-AMPA Selective AMPA agonist. – ns Gria1 2.5620333
Gria2 8.7273219
(RS)-Baclofen Selective GABAB agonist – ns Gabbr1 9.366274
SKF 97541 Extremely potent GABAB agonist – ns Gabbr1 9.366274
Tropanyl-3,5-dimethylbenzoate (TDMB) 5-HT3 antagonist – ns Htr3b 3.8967283
CGS 12066B 5-HT1B agonist – ns Htr1b 5.349157
SB 203186 5-HT4 antagonist – ns Htr4 3.0945084
Paroxetine Highly potent and selective 5-HT uptake inhibitor – ns
Eticlopride Selective D2/D3 antagonist – ns Drd2 -1.58269
Nafadotride Highly potent, preferential D3 antagonist – ns Drd3 -1.1982167
Lylamine CB1 agonist – ns Cnr1 2.9487731
L-Canavanine NOS inhibitor – ns Nos1 2.3357166
NPC 15437 Selective protein kinase C inhibitor – ns
U 73122 Phospholipase C inhibitor – ns
Calmidazolium Calmodulin antagonist – ns
3-Methyl-GABA Activator of GABA amino-transferase ns + Abat 4.4326897
Methyllycaconitine α7 neuronal nicotinic receptor antagonist ns + Chrna7 2.0678313
Cl-HIBO Subtype-selective AMPA agonist (GluR1 and GluR2) ns + Gria1 2.5620333
Gria2 8.7273219
(±)-Vesamicol Inhibits ACh transport ns +
RS 45041-190 High affinity I2 ligand. Highly selective ns +
GR 135531 High affinity melatonin MT3 ligand ns + Mtnr1c no probe
JTE 907 Selective CB2 receptor antagonist/inverse agonist ns + Cnr2 -1.307982
SQ 22536 Adenylyl cyclase inhibitor ns +
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Distinct Regional Patterns of Dopaminergic, GABAergic, and Cholinergic V-SVZ Innervation 
 The small molecule screen identified dopamine, GABA, and acetylcholine as qNSC activators.  
The screen also implicated serotonin as a regulator of NSC quiescence.  These neurotransmitters identify 
distinct populations of neurons in the brain, suggesting that distinct neuronal circuits might activate 
regional subtypes of qNSCs.  Indeed, several recent studies have identified the sources of dopaminergic, 
GABAergic, cholinergic and serotonergic input to the V-SVZ (summarized in Figure 3.3).  Notably, all of 
these neurotransmitter signals promote the proliferation of NSCs in vivo (Höglinger et al., 2004; 
Lennington et al., 2011; Paez-Gonzalez et al., 2014; Tong et al., 2014; Young et al., 2012).  However, the 






Figure 3.3  Summary of Known Sources of Innervation to the V-SVZ Niche 
Striatal GABAergic medium spiny neurons (MSN, red) send projections to the V-SVZ (Young et al., 2014). 
Cholinergic interneurons (black) reside in the V-SVZ and send projections locally within the niche (Paez-
Gonzalez et al., 2014). 
Dopaminergic neurons (purple) in the substantia nigra (SN) send projections to the dorsal V-SVZ, and 
dopaminergic neurons ventral tegmental area (VTA) send projections to both dorsal and ventral V-SVZ 
via the striatum (Lennington et al., 2011, Hoglinger et al., 2014). 
Serotonergic neurons (green) in the dorsal raphe nucleus of the hindbrain send projections that run over 














 To investigate whether these activating signals corresponded to the regional heterogeneity of 
NSCs, I quantified the density of dopaminergic, GABAergic, and cholinergic neuronal fibers in six regions 
spanning the dorsal-ventral and anterior-posterior axes of the V-SVZ niche (details of the density 
calculation are provided in the methods).  Intriguingly, each of these types of neurons displayed a distinct 
regional bias in their V-SVZ innervation density.  Dopaminergic fibers, labeled with tyrosine hydroxylase 
(TH), were present to a limited extent in all regions of the V-SVZ, but showed significant enrichment in the 
middle-dorsal V-SVZ (Figure 3.4).  These TH+ fibers did not co-stain with dopamine beta-hydroylase 
(DBH), indicating they were true dopaminergic fibers, rather than adrenergic fibers (not shown).  In fact, 
no DBH staining was observed in any part of the V-SVZ (not shown).  GABAergic fibers were also 
present to a limited extant in all regions of the V-SVZ, but showed enrichment in the middle-ventral V-SVZ 
(Figure 3.5).  The pattern of cholinergic innervation in the V-SVZ was more complex, showing a general 
decrease in density from anterior to posterior, but having three distinct zones of significant enrichment 
(Figure 3.6).  Cholinergic fibers were most dense in the anterior-dorsal V-SVZ, and also showed 
enrichment in middle-ventral over middle-dorsal V-SVZ, and enrichment in posterior-dorsal over posterior-
ventral V-SVZ (Figure 3.6B).  The zones of increased cholinergic fiber density corresponded to the 
position of V-SVZ cholinergic interneuron somas within the niche (Figure 3.6C).  Each of these types of 
input is enriched in one region compared to the other types of input: cholinergic in AD, dopaminergic in 
MD, and GABAergic in MV V-SVZ (Figure 3.7A,B).  The density of all types of input is similar in AD, PV, 
and PD V-SVZ (Figure 3.7B).  Thus, these different sources of innervation to the V-SVZ show the 
greatest density in unique regions.  Despite these regional biases, some innervation from cholinergic, 
dopaminergic, and GABAergic neurons is present in all regions of the V-SVZ.  Thus, for example, most 
qNSCs in the anterior-dorsal V-SVZ might be responsive to cholinergic signals, but some may also be 






Figure 3.4  Dopaminergic Fiber Density is Greatest in the Middle-Dorsal V-SVZ 
(A) Representative confocal z-stack projections through the entire depth of the SVZ niche, 
immunostained for Tyrosine hydroxylase (TH). Scale bar 40µm. 
(B) Quantification of the density of dopaminergic fibers in the SVZ niche. *p < 0.05 by 2-way ANOVA with 
Bonferroni post test, n=2. 

















































Figure 3.5  GABAergic Fiber Density is Greatest in the Middle-Ventral V-SVZ 
(A) Representative confocal z-stack projections through the entire depth of the SVZ niche, 
immunostained for GAD67. Scale bar 40µm. 
(B) Quantification of the density of GABAergic fibers in the SVZ niche.  2-way ANOVA with Bonferroni 
post test, n=2. 




















































Figure 3.6  Cholinergic Fiber Density is Greatest in the Anterior-Dorsal V-SVZ 
(A) Representative confocal z-stack projections through the entire depth of the SVZ niche, 
immunostained for choline acetyl-transferase (Chat). Scale bar 40µm. 
(B) Quantification of the density of cholinergic fibers in the SVZ niche.  *p < 0.05 by 2-way ANOVA with 
Bonferroni post test, n=2. 
(C) Schema representing the cholinergic innervation pattern in the V-SVZ.  Green dots show the position 





















































Figure 3.7  Distinct Innervation Patterns in the V-SVZ 
(A) Representative schema’s of the cholinergic (gray), GABAergic (red), and dopaminergic (purple) 
innervation patterns in the V-SVZ.  Green dots on cholinergic schema show locations of V-SVZ 
cholinergic interneuron somas. AD: anterior-dorsal, MD: middle-dorsal, PD: posterior-dorsal, AV: anterior-
ventral, MV: middle-ventral, PV: posterior-ventral. 
(B) Quantification of the density of cholinergic, GABAergic, and dopaminergic fibers in regions of the V-
SVZ.  *p < 0.05 by 2-way ANOVA with Bonferroni post test, n=2. 
  







































Cholinergic Antagonists Block Regeneration in the V-SVZ Regions that Receive Densest 
Cholinergic Input 
  To test whether distinct neurons activate regional qNSCs in vivo, I focused on the V-SVZ 
cholinergic system.  I found that acetylcholine activated qNSCs in vitro, and that cholinergic innervation of 
the V-SVZ was regionally biased.  Three additional aspects of the V-SVZ cholinergic system suggested it 
as ideal for in vivo manipulations: 1) NSC proliferation is increased or decreased by V-SVZ cholinergic 
interneuron activity or silencing, respectively, 2) V-SVZ cholinergic activity depolarizes NSCs, and 3) the 
cholinergic antagonists mecamylamine (nicotinic) and atropine (muscarinic) completely block NSC 
depolarization (Paez-Gonzalez et al., 2014).  Therefore, I tested whether cholinergic antagonists could 
block the activation of qNSCs during regeneration.  
Infusion of the antimitotic drug Ara-C in the lateral ventricle for six days ablates all dividing cells of 
the V-SVZ lineage (Doetsch et al., 1999a; Pastrana et al., 2009).  qNSCs survive AraC treatment, and 
within 12 hours of AraC removal re-enter the cell cycle and regenerate the lineage (Pastrana et al., 2009).  
Thus, I infused either artificial cerebrospinal fluid (aCSF) or Ara-C for six days in GFAP::GFP mice.  On 
the sixth day, the first infusion was removed and replaced with a second infusion of either aCSF or the 
combination of mecamylamine and atropine for 24 hours (Figure 3.8A).  I quantified the proportion of 
proliferating NSCs (GFAP::GFP+MCM2+) in whole mount preparations of the V-SVZ immunostained for 
GFP, MCM2, and Dcx.  Strikingly, cholinergic antagonists significantly decreased qNSC proliferation after 
AraC removal in regions that receive the densest cholinergic innervation: anterior-dorsal (AD), middle-
ventral (MV), and posterior-dorsal (PD) V-SVZ (Figure 3.6, and Figures 3.8B-D).   There was a trend 
towards a decrease in anterior-ventral (AV) V-SVZ, where cholinergic innervation density is equal to that 
of PD V-SVZ, but no effect in posterior ventral (PV) V-SVZ where cholinergic density is lowest (Figure 3.6, 
and Figures 3.8C,D).  NSC proliferation also significantly decreased in middle-dorsal (MD) V-SVZ, though 
this may be due to the proximity of the infusion site (Figures 3.8C,D).   The same pattern of decreased 
NSC proliferation was observed in animals infused with cholinergic antagonists as compared to aCSF 
infusion alone (Figures 3.8B,C).  These data do not exclude the possibility of non-autonomous affects on 
NSC proliferation. However, because it was shown that NSCs respond directly to cholinergic signaling 
(Paez-Gonzalez et al., 2014), the observed affect of cholinergic antagonists is in part NSC-specific.  
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Thus, these data argue that cholinergic signaling activates regional qNSCs in vivo during regeneration, 
and promotes regional NSC proliferation during homeostasis.  
 
Figure 3.8  Cholinergic Antagonists Block Regeneration in V-SVZ Regions that Receive Densest 
Cholinergic Input 
(A) Schema of the experiment.  Either artificial cerebrospinal fluid (aCSF) or AraC, followed by either 
aCSF or the cholinergic antagonists mecamylamine and atropine were infused into the lateral ventricle of 
GFAP::GFP mice for 6 days (first infusion), then 24 hours (second infusion). 
(B) Representative confocal images in the anterior-dorsal (AD) V-SVZ of whole mount preparations 
stained for GFAP::GFP, MCM2, and Dcx. Scale bar 20µm. 
(C) Schema indicating regions analyzed. AD: anterior-dorsal, MD: middle-dorsal, PD: posterior-dorsal, 
AV: anterior-ventral, MV: middle-ventral, PV: posterior-ventral. Representative locations of V-SVZ 
cholinergic interneuron somas are indicated (white dots). 
(D) Quantification of the percent of GFAP::GFP+MCM2+ NSCs in six regions of the V-SVZ.  
*p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t-test. Comparisons were made by region between aCSF - 
aCSF and aCSF - Antagonist treated, or AraC - aCSF and AraC - Antagonist treated animals.  
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Nicotinic Agonist Increases NSC Proliferation in Anterior-Dorsal and Middle-Dorsal V-SVZ 
 To test whether activating cholinergic signaling would promote regional NSC proliferation, I 
infused the nicotinic agonist ADMP, or DMSO control, into the lateral ventricle of GFAP::GFP mice for 
four days (Figure 3.9).  The small molecule screen identified ADMP as an activator of qNSCs in vitro 
(Figure 3.1).  I quantified the number of proliferating NSCs (GFAP::GFP+MCM2+) in whole mount 
preparations of the V-SVZ immunostained for GFP, MCM2, and beta-catenin to visualize ependymal cell 
pinwheels.  Strikingly, ADMP infusion increased NSC proliferation in the AD V-SVZ, the region where V-
SVZ cholinergic interneurons and innervation are most abundant (Figure 3.7, and Figures 3.9B-D).  NSC 
proliferation was also increased in the MD V-SVZ, though this may be due to the proximity of the infusion 
site (Figures 3.9C,D).  NSC proliferation was unchanged in all other V-SVZ regions (Figure 3.9C).  ADMP 
increased numbers of proliferating NSCs at the ventricle surface in the center of ependymal cell 
pinwheels, where qNSCs are normally located (Figure 3.8B) (Codega et al., 2014).  ADMP also increased 
numbers of proliferating NSCs deeper within the V-SVZ niche (Figure 3.8B).  Although I cannot exclude 
the possibility of non-autonomous affects on NSCs from infusion of ADMP, there was near perfect 
correspondence of the regional increase in NSC proliferation with the densest region of cholinergic 
innervation.  Moreover, the appearance of proliferating NSCs in the ependymal layer strongly suggests 
that ADMP infusion activated qNSCs.  Taken together with the antagonist infusion experiment above, 
these data reveal that cholinergic signaling activates regional subtypes of qNSCs in vivo during 






Figure 3.9  Nicotinic Agonist Increases NSC Proliferation in Anterior-Dorsal and Middle-Dorsal     
V-SVZ 
(A) Schema of the experiment.  Either DMSO or ADMP was infused into the lateral ventricle of 
GFAP::GFP mice for 4 days. 
(B) Representative confocal images in the anterior-dorsal (AD) V-SVZ of whole mount preparations 
stained for GFAP::GFP, MCM2, and beta-catenin. Top images are taken at the ventricle surface. Note the 
ependymal cell pinwheel structure (dashed white line).  Bottom images are taken deeper in the niche, 
where most proliferative NSCs (arrows) are found. Scale bar 20µm. 
(C) Schema indicating regions analyzed. AD: anterior-dorsal, MD: middle-dorsal, PD: posterior-dorsal, 
AV: anterior-ventral, MV: middle-ventral, PV: posterior-ventral. Representative locations of V-SVZ 
cholinergic interneuron somas are indicated (white dots). 
(D) Quantification of the percent of GFAP::GFP+MCM2+ NSCs in six regions of the V-SVZ.  
*p < 0.05 by Student’s t-test. Comparisons were made by region. 
  





































I introduced this chapter by highlighting that signals able to activate qNSCs must be extraordinary 
in their ability to cut through the extremely noisy signaling environment of the V-SVZ niche. The small 
molecule screen I performed identified acetylcholine, dopamine, as GABA activators of qNSCs.  Neurons 
using these neurotransmitters are known to innervate the V-SVZ, promote NSC proliferation, and make 
synaptic contact on NSCs.  I showed, by infusing cholinergic agonist or antagonists, that cholinergic 
signaling activates qNSCs in vivo during homeostasis and regeneration. Neurotransmitter signaling, 
focused at the synapse, can provide a clear and robust activating signal able to overcome the otherwise 
noisy V-SVZ niche. 
The screen revealed that several neurotransmitters could have different effects on quiescence 
and activation via the use of different receptor subtypes.  For example, the screen implicated signaling via 
GABA-A receptors as activating qNSCs, while signaling via GABA-B receptors as maintaining 
quiescence.  These results are consistent with reports that GABA-A signaling promotes proliferation in the 
V-SVZ and SGZ, while GABA-B promotes quiescence in the SGZ (Alfonso et al., 2012; Giachino et al., 
2013; Tozuka et al., 2005; Young et al., 2012).  The screen also implicated cannabinoid signaling as 
quiescence promoting via CB1 receptors, and proliferation promoting via CB2 receptors.  Agonists of 
AMPA glutamate receptors both promoted quiescence, and increased the proliferation of activated 
clones.  The receptors for GABA, cannabinoid, and glutamate signaling are highly expressed in qNSCs 
relative to aNSCs in our microarray data, suggesting there may be differential expression of receptor 
subtypes as NSCs transition between quiescent and activated states.  Therefore, the same 
neurotransmitter could have distinct affects on NSCs depending on the combination of receptor subtypes 
expressed at different stages of the cell cycle.  
The identification of several neurotransmitters as activators suggested that these signals might 
map onto the regional heterogeneity of V-SVZ NSCs.  I mapped the patterns of dopaminergic, 
GABAergic, and cholinergic innervation in the V-SVZ and found that each type of innervation showed a 
distinct regional bias.  My infusion experiments demonstrated that cholinergic signaling activates qNSCs 
in regions where cholinergic innervation is densest.  The nicotinic agonist ADMP did not affect NSC 
proliferation in as many V-SVZ regions as infusion of both nicotinic and muscarinic antagonists (Figure 
	 45 
3.7), suggesting there might be regional differences in cholinergic receptor subtype expression.  
Specifically, nicotinic receptors likely mediated the effects on NSC proliferation in AD and MD V-SVZ, 
while muscarinic receptors likely mediated the effects on NSC proliferation in MV and PD V-SVZ.  Taken 
together these data highlight the importance of neurotransmitter signaling in regulating NSC quiescence, 
activation, and proliferation.  My data reveal, at a proof-of-concept level, that neurotransmitter signaling 
maps onto the regional heterogeneity of stem cells, and suggest the potential of identifying and 




Hypothalamic Regulation of Regional Adult qNSCs 
 
Introduction 
 NSCs in the V-SVZ are regionally heterogeneous.  That is, regional subtypes of NSCs give rise to 
distinct subtypes of olfactory bulb interneurons.  In the last chapter I presented proof-of-concept evidence 
that signaling from dopaminergic, GABAergic, and cholinergic neurons regulates the proliferation of 
regional subtypes of qNSCs.  In this chapter I investigate whether opioidergic neuronal signals also map 
onto the regional heterogeneity of qNSCs and might thereby underlie the generation of distinct OB 
interneuron subtypes.  I detail the regional distribution of opioid signaling components in the V-SVZ, and 
identify a hypothalamic neuronal source of the endogenous opioid ligand beta-endorphin.  I present loss-
of-function evidence that these hypothalamic neurons promote the proliferation of regional qNSCs.  I then 
detail my investigation into the regulation of regional qNSC proliferation by hunger and satiety states.  




Opioid Signaling Components are Enriched in the Anterior-Ventral V-SVZ 
 The small molecule screen I described in the last chapter also identified an agonist of the kappa 
opioid receptor as an activator of qNSCs in vitro (Figures 4.1A,B).  The endogenous opioid peptides 
enkephalin and endomorphin also increased qNSC activation in vitro (Figures 4.1C,D).  I investigated 
whether opioid signaling components are expressed in the V-SVZ by immunostaining for the opioid ligand 
beta-endorphin (bEnd) and the kappa (Oprk1), delta (Oprd1), and mu (Oprm1) opioid receptors in coronal 
brain sections of GFAP-GFP mice (Figure 4.2).  Strikingly, bEnd expression was only observed in the AV 
V-SVZ, but not in other V-SVZ regions (Figures 4.2A, and 4.3).  Oprk1 and Oprm1 were expressed in 
NSCs in the AV V-SVZ, but Oprd1 was not expressed in NSCs (Figure 4.2A).  Oprd1 and Oprm1 
expression was detected in clusters of GFAP::GFP- cells, suggesting expression in neuroblasts (Figure 
4.2A).  bEnd expression was punctate, and some bEnd+ puncta were in close apposition to Opkr1+ 
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puncta on NSCs (Figure 4.2A).  Further, some bEnd+ puncta colocalized with synaptophysin on NSCs in 
the AV V-SVZ (Figure 4.2B).  These data suggest that bEnd+ neurons may regulate the proliferation of 




Figure 4.1  Endogenous Opioids Activate qNSCs 
(A) Schema of the screening assay.  qNSCs were plated at clonal density with EGF, compounds were 
added one day later, and at 4 days cells were fixed and stained for nestin.  
(B) Small molecule screen. Quantification of activated Nestin+ qNSC clones as compared to control 
(empty dots). ICI 204448: Selective agonist of the kappa opioid receptor.  Mean ± SEM, n=3. 
(C) Quantification of activated Nestin+ qNSC clones as compared to control (empty dots). Mean ± SEM, 
n=3. 
(D) Representative images of activated qNSC clones treated with the endogenous opioid peptide 
Enkephalin or Endomorphin, and immunostained for Nestin, MCM2, and DAPI to label nuclei.  Scale bar 
30µm. 
























































































Figure 4.2  Opioid Signaling Components are Expressed in Regional Patterns 
(A) Representative 3µm confocal projections of V-SVZ stained for GFAP::GFP, beta-endorphin (bEnd), 
and opioid receptor kappa (Oprk1), mu (Oprm1), or delta (Oprd1).  Images at right: No 1° antibody control 
for the opioid receptors.  Scale bars 20µm.  Top Panels: AD V-SVZ, note low expression of Oprk1.  
Oprm1 and Oprd1 appear to be expressed in neuroblast clusters. Scale bars 20µm. Middle panels: AV V-
SVZ, Oprk1 and Oprm1 are expressed in some GFAP::GFP+ cells, but Oprd1 is not. Orange boxes show 
area included in high magnification in lower panels.  Scale bars 20µm.  Bottom panels: High magnification 
of middle panels images. GFAP::GFP+ NSCs express Oprk1 and Oprm1, but not Oprd1.  Note that 
bEnd+ fibers co-localize on GFAP::GFP+ NSCs.  Scale bars 5µm. 
(B) 1µm optical section in AV V-SVZ showing a bEnd+ puncta (orange arrow) co-localizing with 
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The Nkx2.1 NSC Domain is Innervated by beta-endorphin+ Neurons 
 The anterior-ventral V-SVZ harbors a microdomain of Nkx2.1+ NSCs (Merkle et al., 2013).  I 
investigated the correspondence between the expression domains of bEnd+ neuronal fibers and Nkx2.1+ 
NSCs in the AV V-SVZ by immunostaining.  The bEnd domain (bregma +1.5 to -0.15 mm) and Nkx2.1+ 
NSC domain (bregma +0.86 to -0.15 mm) showed near perfect overlap (Figure 4.3).  bEnd+ fibers 
contacted Nkx2.1+ NSCs throughout the Nkx2.1 domain (Figure 4.3).  Furthermore, Nkx2.1+ NSCs 
expressed Opkr1 (Figure 4.4).  Finally, I did not observe bEnd+ neuronal somas in the AV V-SVZ, or in 
any other brain region from bregma +1.5 to -0.15 mm.  Taken together with my in vitro data, these data 








Figure 4.3  The Nkx2.1 NSC Domain is Innervated by beta-endorphin+ Neurons 
Upper Images: Merged images showing the V-SVZ in coronal sections from bregma +1.5 mm to -0.46 
mm, stained with GFAP::GFP (red), Nkx2.1 (green), and bEnd (white). Scale bar 100µm. Note bEnd+ 
fibers target only the ventral V-SVZ.   
Lower Images: High magnification images of ventral V-SVZ from upper merged images. Scale bar 40µm. 
Note that beta-endorphin+ fibers contact Nkx2.1+ NSCs in the ventral V-SVZ. The beta-endorphin 
domain extends from approximately bregma +1.5 to -0.15 mm, and completely encompasses the Nkx2.1+ 
NSC domain (~bregma +0.86 mm to -0.15 mm). Note that Nkx2.1 expression is limited to ependymal 
cells at bregma -0.15 mm and more posteriorly. 
Bottom schemas show the expression domains of Nkx2.1+ NSCs, and beta-endorphin+ fibers in the 
ventral V-SVZ. 
  










Figure 4.4  Nkx2.1+ NSCs Express Oprk1 
Representative 2µm confocal projection in the AV V-SVZ showing an Oprk1 puncta (orange arrow) co-




Hypothalamic Arcuate Pomc+ Neurons Innervate the Anterior-Ventral V-SVZ 
 Beta-endorphin is a post-translational cleavage product of the proopiomelanocortin (POMC) 
protein.  In the brain, Pomc is expressed by two groups of projection neurons: Pomc+ neurons in the 
arcuate nucleus (ARC) of the hypothalamus, and Pomc+ neurons in the nucleus tractus solitarius (NTS) 
of the medulla (Wang et al., 2015).  NTS Pomc+ neurons largely project to hindbrain regions (Wang et al., 
2015).  However, ARC Pomc+ neurons project to numerous forebrain regions including the lateral septum 
and accumbens nucleus, which are located near the AV V-SVZ (Wang et al., 2015).  To investigate 
whether ARC Pomc+ neurons innervate the AV V-SVZ, I injected the hypothalamus of Pomc-cre mice 
with an adeno-associated virus (AAV) that expresses YFP in a cre-dependent manner (AAV-EF1a-DIO-
eYFP, hereafter called AAV-Flex-YFP) (Figure 4.5A) (Atasoy et al., 2008; Kunwar et al., 2015).  6wks 
after viral injection I observed YFP+bEnd+ neurons in the ARC (Figures 4.5B,C).  YFP was not expressed 
in bEnd-negative ARC cells (Figure 4.5C), or in any hypothalamic cell in WT mice injected with AAV-Flex-
YFP (not shown). YFP+ axons were present in the AV V-SVZ, and extended from approximately bregma 
+1.18 mm to bregma +0.26 mm (Figure 4.5D).  YFP+ axons projected up the septal wall of the ventricle at 
bregma +1.10 mm and more anteriorly (Figure 4.5D).  These data reveal that ARC Pomc+ neurons are 












Figure 4.5  Hypothalamic Arcuate Pomc+ Neurons Innervate the Anterior-Ventral V-SVZ 
(A) Schema of experiment.  AAV-Flex-YFP was unilaterally injected into the arcuate nucleus of the 
hypothalamus of Pomc-cre mice.  Orange box shows location of image in (B). 
(B) Low magnification image showing YFP+ cells in the arcuate nucleus.  Scale bar 200µm. 
(C) 3µm confocal projection image of YFP+bEnd+ cells in the arcuate nucleus. Scale bar 20µm. 
(D) Low magnification images of the entire V-SVZ stained for YFP, Ki67, and DAPI.  Note YFP+ axons in 
the anterior-ventral V-SVZ but not in dorsal, or posterior V-SVZ.  In the images, medial is to the left, and 
























bregma +1.15 mm +0.98 mm -0.22 mm
	 53 
ARC Pomc+ Neuron Ablation Decreases NSC Proliferation in Anterior-Ventral V-SVZ 
 I used viral approaches to selectively ablate ARC Pomc+ neurons to test whether they regulate 
the proliferation of NSCs in the AV V-SVZ.  I injected either an AAV that expresses cleaved caspase-3 in 
a cre-dependent manner (AAV-flex-taCasp3-TEVp; hereafter called AAV-Flex-Casp3) (Yang et al., 2013), 
or AAV-Flex-YFP into the hypothalamus of Pomc-cre mice (Figure 4.6A).  3wks after AAV-Flex-Casp3 
injection, the number of bEnd+ ARC cells was reduced by 76% (Figures 4.6B,C).  NSC proliferation 
(GFAP+Ki67+) decreased by 59% in the AV V-SVZ of AAV-Flex-Casp3 injected animals, while there was 
no change in NSC proliferation in the anterior-dorsal (AD) V-SVZ (Figures 4.7A-D).  There was no change 
in the proportion of transit amplifying cells (Ki67-only+) in AAV-Flex-Casp3 injected animals, arguing that 
Pomc+ neurons specifically affect NSCs, but not their lineage (Figure 4.7E).  The total proportion of 
GFAP+ V-SVZ cells was unchanged between AAV-Flex-Casp3 and control animals, suggesting that 
NSCs did not suffer cell death, but rather returned to the quiescent state in the absence of ARC Pomc+ 
neurons (Figure 4.7F).  Moreover, Ki67 is expressed in all active stages of the cell cycle but not in G0 
(quiescence) (Solovjeva et al., 2012).  Thus these data reveal that ARC Pomc+ neurons promote the 
proliferation of qNSCs specifically in the AV V-SVZ. 
 
 
Figure 4.6  Ablation of Arcuate Pomc+ Neurons 
(A) Schema of the experiment.  AAV-Flex-YFP, or AAV-Flex-Casp3 was unilaterally injected into the 
hypothalamic arcuate of Pomc-Cre mice. 
(B) Representative 3µm confocal projection images in the arcuate of AAV-Flex-YFP or AAV-Flex-Casp3 
injected Pomc-Cre mice, stained for bEnd and DAPI.  Scale bar 20µm. 
(C) Quantification of bEnd+ cells in the arcuate of AAV-Flex-YFP or AAV-Flex-Casp3 injected animals. 






























Figure 4.7 Ablation of Arcuate Pomc+ Neurons Decreases NSC Proliferation in Anterior-Ventral, 
but not Anterior-Dorsal, V-SVZ 
(A) Schema of coronal brain section at bregma +0.86 mm with detail of lateral ventricle and V-SVZ (blue 
and gray). Blue represents areas imaged in (B) and analyzed in (C-F). AD: anterior-dorsal, AV: anterior-
ventral. 
(B) Representative 4µm confocal projection images in AD and AV V-SVZ of AAV-Flex-YFP or AAV-Flex-
Casp3 injected Pomc-Cre mice stained for GFAP, Ki67, Dcx, and DAPI. Scale bar 20µm. 
(C) Quantification of NSC proliferation (GFAP+Ki67+) in the AD V-SVZ of AAV-Flex-YFP and AAV-Flex-
Casp3 injected animals. 
(D) Quantification of NSC proliferation (GFAP+Ki67+) in the AV V-SVZ of AAV-Flex-YFP and AAV-Flex-
Casp3 injected animals. 
(E) Quantification of the number of transit amplifying cells (Ki67-only+) in the AV V-SVZ of AAV-Flex-YFP 
and AAV-Flex-Casp3 injected animals. 
(F) Quantification of total GFAP+ cells in the AD V-SVZ of AAV-Flex-YFP and AAV-Flex-Casp3 injected 
animals. 



































































































Hunger and Satiety States Regulate qNSC Proliferation in the Anterior-Ventral V-SVZ 
 Hypothalamic ARC Pomc+ neurons are a key component of a neural circuit that regulates feeding 
behavior during hunger and satiety states (Figure 4.8A) (Aponte et al., 2011; Zeltser et al., 2012).  The 
activity of ARC Pomc+ neurons inhibits feeding behavior in satiated (e.g. fed) animals (Figure 4.8A) 
(Aponte et al., 2011).  However, ARC Pomc+ neuron activity decreases in hungry (e.g. fasted) animals 
due to inhibition from agouti-related protein/neuropeptide Y-expressing (AgRP/NPY) neurons that 
promote feeding behavior (Figure 4.8A) (Aponte et al., 2011; Tong et al., 2008).  I therefore hypothesized 
that NSC proliferation would decrease in the AV V-SVZ of fasted animals.  I analyzed the proliferation of 
NSCs in the AV and AD V-SVZ in GFAP::GFP mice that were either ad libitum fed, fasted for 24hrs, or 
fasted for 24hrs then re-fed (Figure 4.8B).  I confirmed that ARC Pomc+ neuron activity (bEnd+c-fos+) 
was decreased by 56% in fasted animals (Figures 4.8C-E).  NSC proliferation (GFAP::GFP+MCM2+) 
decreased by 68% in the AV V-SVZ of fasted animals, but was unchanged in the AD V-SVZ (Figures 
4.9A-D).  There was no change in transit amplifying cell numbers (MCM2-only+), or in total GFAP::GFP+ 
cells in the AV V-SVZ of fasted animals (Figures 4.9E,F).  Thus, these data reveal that hunger/satiety 







Figure 4.8  Fasting Decreases Arcuate Pomc+ Neuron Activity 
(A) Schema detailing arcuate circuit that regulates feeding behavior.  Note that Pomc neuron activity 
decreases when animals are hungry (e.g. fasting), and increases when animals are sated (e.g. fed). 
(B) Schema of the experiment. Three cohorts of GFAP::GFP mice were either fed ad libitum, fasted for 
24hrs, or fasted for 24hrs then re-fed for 24hrs before sacrificing and analysis. 
(C) Schema showing coronal brain section at bregma -1.5 mm with detail of the hypothalamic arcuate 
nucleus (Arc). Orange box represents location of images in (D). 
(D) Representative 4µm confocal projection images of the arcuate of Fed, Fast, and Re-Fed animals, 
stained for bEnd, cFos, and DAPI. Scale bar 20µm. 
(E) Quantification of bEnd+cFos+ cells in the arcuate of Fed, Fast, and Re-Fed animals. 



























































Figure 4.9  Fasting Decreases NSC Proliferation in Anterior-Ventral, but not Anterior-Dorsal, V-SVZ 
(A) Schema of coronal brain section at bregma +0.86 mm with detail of lateral ventricle and V-SVZ (blue 
and gray). Blue represents areas imaged in (B) and analyzed in (C-F). AD: anterior-dorsal, AV: anterior-
ventral. 
(B) Representative 2µm confocal projection images of the AD or AV V-SVZ of Fed, Fast, and Re-Fed 
animals, stained for GFAP::GFP, MCM2, Dcx, and DAPI. Scale bar 20µm. 
(C) Quantification of GFAP::GFP+MCM2+ cells in the AD V-SVZ of Fed, Fast, and Re-Fed animals. 
(D) Quantification of GFAP::GFP+MCM2+ cells in the AV V-SVZ of Fed, Fast, and Re-Fed animals. 
(E) Quantification of MCM2-only+ cells in the AV V-SVZ of Fed, Fast, and Re-Fed animals. 
(F) Quantification of total GFAP::GFP+ cells in the AV V-SVZ of Fed, Fast, and Re-Fed animals. 

















































































































Hunger/Satiety State Hormones and Neuropeptides Do Not Affect NSCs 
  Circulating levels of the hormones leptin and ghrelin modulate ARC Pomc+ and AgRP/NPY+ 
neuron activity during hunger and satiety states (Zeltser et al., 2012).  ARC Pomc+ and AgRP/NPY+ 
neurons regulate feeding behaviors during hunger and satiety states, in part, via signaling with the 
neuropeptides alpha-melanocyte stimulating hormone (αMSH), AgRP, and NPY (Cowley et al., 1999; 
2001).  Moreover, ARC AgRP/NPY+ neurons project to brain regions near the ventral V-SVZ (Wang et 
al., 2015).  Thus, the effect on AV V-SVZ qNSC proliferation in the fasting paradigm may be due to 
actions of these hormone and neuropeptide signals on qNSCs.  However, none of the receptors for leptin 
(Lepr), ghrelin (Ghsr), or αMSH and AgRP (melanocortin receptors Mc1r, Mc2r, Mc3r, Mc5r) were 
expressed in qNSCs or aNSCs in our microarray data (Figure 4.10A).  Further, none of leptin, ghrelin, 
αMSH, or AgRP affected qNSC activation, or the size of activated qNSC clones in vitro (Figures 4.10B,C), 
suggesting that both qNSCs and aNSCs are refractory to these signals.  Expression of NPY receptor Y1 
(Npy1r) was enriched in qNSCs in our microarray data, however NPY had no affect on qNSCs or aNSCs 
in vitro (see Table 2.5, and Figures 2.6B,C in Chapter 2).  Thus, these data argue that hunger/satiety 
states regulate AV V-SVZ qNSC proliferation via the modulation of ARC Pomc+ neuron activity, rather 






Figure 4.10  Hunger/Satiety State Hormones and Neuropeptides Do Not Affect qNSCs 
(A) Mircoarray expression in qNSCs and aNSCs of the receptors for leptin (Lepr), ghrelin (Ghsr), and 
melanocortins αMSH and AgRP (Mc1r, Mc2r, Mc3r, Mc4r).  The glial marker GLAST (glutamate aspartate 
transporter) is provided as a positive control. 
(B) Quantification of activated Nestin+ qNSC clones. Mean ± SEM, n=2. 








































































































Hunger/Satiety States Regulate the Proliferation of Nkx2.1+ qNSCs 
 ARC Pomc+ neurons innervate the entire Nkx2.1+ NSC domain in the AV V-SVZ (Figures 4.3 
and 4.5).  Moreover, both ablation of ARC Pomc+ neurons, and decreasing their activity in the fasting 
paradigm, reduced the proliferation of qNSCs specifically in the AV V-SVZ.  Together, these data suggest 
that Nkx2.1+ NSC proliferation might be regulated by ARC Pomc+ neurons.  To test this idea, I analyzed 
the proliferative status of Nkx2.1+ and Nkx2.1- NSCs in the AV V-SVZ of fasted animals (Figure 4.11).  
Strikingly, the decrease in NSC proliferation was specific to Nkx2.1+ NSCs, while Nkx2.1- NSCs were 
unaffected (Figures 4.11A,B).  Additionally, the total proportion of Nkx2.1+ NSCs in the AV V-SVZ was 
unchanged in fasted animals, arguing that the decrease in Nkx2.1+ NSC proliferation was not due to cell 
death.  Thus, these data reveal that hunger/satiety states regulate Nkx2.1+ qNSC proliferation via 





Figure 4.11  Fasting Decreases Nkx2.1+ NSC Proliferation 
(A) Representative 2µm confocal projection images of AV V-SVZ in GFAP::GFP animals that were either 
ad libitum fed (Fed) or fasted for 24 hours (Fast). Scale bar 20µm. 
(B) Quantification of Nkx2.1+ and Nkx2.1- proliferating NSCs (GFAP::GFP+MCM2+) in the AV V-SVZ of 
Fed and Fast animals. 
(C) Quantification of the total GFAP::GFP+Nkx2.1+ cells in the AV V-SVZ of Fed and Fast animals. 





























































ARC Pomc+ Neurons Regulate the Production of a Single Subtype of Olfactory Bulb Interneuron 
 Adult Nkx2.1+ progenitors in the AV V-SVZ generate deep granule cell layer (GRL) interneurons, 
but no other known OB interneuron subtype (Delgado and Lim, 2015; Merkle et al., 2013).  Therefore, I 
hypothesized that ARC Pomc+ neurons might regulate the production of deep GRL interneurons.  To test 
this hypothesis I again ablated ARC Pomc+ neurons with AAV-Flex-Casp3, and measured the 
proportions of known adult-born OB interneuron subtypes (Figure 4.12).  At 7wks post viral injection there 
was a 66% decrease in ARC Pomc+ neuron numbers, and a 61% decrease in proliferating NSCs in the 
AV V-SVZ of AAV-Flex-Casp3 injected animals (not shown), consistent with the effects at 3wks post viral 
injection (Figures 4.6 and 4.7).  There are three subtypes of adult-born GRL interneurons that are 
distinguished by their soma position in the deep or superficial GRL and the non-overlapping expression of 
neurogranin (Nrgn) or calretinin (CalR) (Gribaudo et al., 2009; Merkle et al., 2007).  These are Nrgn+ 
deep GRL, Nrgn+ superficial GRL, and CalR+ superficial GRL interneurons.  Intriguingly, there was a 
28% decrease in numbers of mature NeuN+Nrgn+ deep GRL interneuron, but no change in other GRL 
interneuron subtypes, in AAV-Flex-Casp3 injected animals (Figures 4.12A,B,C,F, and G).  I also observed 
a small proportion of Nrgn+ and CalR+ interneurons with somas located in the internal plexiform layer 
(ICL), and mitral cell layer (MCL) of the OB, but found no change in their numbers in AAV-Flex-Casp3 
injected animals (Figures 4.12A,F, and G).  These cells may correspond to so-called Type 2 and Type 3 
adult-born OB interneurons whose somas are restricted to within or below the MCL, and which are not 
generated by adult Nkx2.1+ progenitors (Merkle et al., 2013).  In addition to adult-born GRL interneurons, 
there are three subtypes of adult-born glomerular layer (GL) interneurons that are distinguished by their 
non-overlapping expression of CalR, calbindin (CalB), or tyrosine-hydroxylase (TH).  There was no 
change in numbers of any GL interneuron subtype in AAV-Flex-Casp3 injected animals (Figures 
4.12A,D,E, and H-J), consistent with reports that these cells are not generated by adult Nkx2.1+ 
progenitors (Delgado and Lim, 2015; Merkle et al., 2007; 2013).  Therefore, these data reveal that ARC 
Pomc+ neurons regulate the production of Nrgn+ deep GRL interneurons by promoting the proliferation of 






Figure 4.12    Ablation of Arcuate Pomc+ Neurons Decreases Deep Granule Cell Layer Interneuron 
Numbers 
(A) Coronal section of olfactory bulb stained for DAPI to show OB cell layers.  GL: Glomerular layer, EPL: 
External plexiform layer, MCL: Mitral cell layer, IPL: Internal plexiform layer, GRL: Granule cell layer, 
Core: Olfactory bulb core into which V-SVZ-born neuroblasts migrate.  Scale bar 50µm. 
(B) Representative confocal images of the Deep GRL of AAV-Flex-YFP and AAV-Flex-Casp3 injected 
Pomc-cre animals, stained for Neurogranin, NeuN, Dcx, and DAPI. Scale bar 20µm. 
(C) Representative confocal images of the Superficial GRL of AAV-Flex-YFP and AAV-Flex-Casp3 
injected Pomc-cre animals, stained for CalR, NeuN, and DAPI. Scale bar 20µm.  
(D) Representative confocal images of the GL of AAV-Flex-YFP and AAV-Flex-Casp3 injected Pomc-cre 
animals, stained for CalB, TH, and DAPI. Scale bar 20µm. 
(E) Representative confocal images of the GL of AAV-Flex-YFP and AAV-Flex-Casp3 injected Pomc-cre 
animals, stained for CalR, and DAPI. Scale bar 20µm. 
(F) Quantification of Neurogranin+NeuN+ cells in the GRL, IPL, and MCL of AAV-Flex-YFP and AAV-
Flex-Casp3 injected animals. 
(G) Quantification of CalR+NeuN+ cells in the Superficial GRL, IPL, and MCL of AAV-Flex-YFP and AAV-
Flex-Casp3 injected animals. 
(H) Quantification of CalB+ cells in the GL of AAV-Flex-YFP and AAV-Flex-Casp3 injected animals. 
(I) Quantification of TH+ cells in the GL of AAV-Flex-YFP and AAV-Flex-Casp3 injected animals. 
(J) Quantification of CalR+ cells in the GL of AAV-Flex-YFP and AAV-Flex-Casp3 injected animals.   
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In this chapter I presented compelling evidence that a distinct neural circuit regulates the 
quiescence and activation of regional adult NSC subtype, and thereby underlies the generation of a single 
type of adult-born OB interneuron.  Specifically, hypothalamic ARC Pomc+ neurons innervate the entire 
Nkx2.1+ NSC domain in the AV V-SVZ, and can presynaptically contact NSCs therein.  Ablation of ARC 
Pomc+ neurons decreased NSC proliferation in the AV V-SVZ, as well as numbers of deep GRL 
interneurons, which are the progeny of Nkx2.1+ NSCs.  Interestingly, ARC Pomc+ neurons regulate 
feeding behavior during hunger/satiety states, and fasting decreased both the activity of ARC Pomc+ 
neurons, and the proliferation of Nkx2.1+ NSCs.  Thus, my evidence suggest that hunger/satiety states 
regulate the production of deep GRL interneurons via activity-dependent signaling from ARC Pomc+ 
neurons to Nkx2.1+ NSCs in the AV V-SVZ.  Notably, my evidence does not reveal the exact in vivo 
identity of the signal(s) from ARC Pomc+ neurons that regulates NSC quiescence and activation.  
However, endogenous opioids activated qNSCs in vitro, Nkx2.1+ NSCs expressed Oprk1, and AV V-SVZ 
NSCs received beta-endorphin+ presynaptic input.  Thus, these data strongly suggest that beta-
endorphin regulates Nkx2.1+ NSC quiescence and activation in vivo.  In the future it will be important to 
determine the identity of the qNSC-regulating signal(s) from ARC Pomc+ neurons, as well as whether the 
release of these signals is truly activity-dependent.  Finally, in the future it will be very interesting to 
investigate whether the regulation of a single OB interneuron subtype by hunger/satiety states has an 







Discussion and Future Directions 
 My thesis research presented here has been guided by the goal of identifying signals that 
regulate adult neural stem cell quiescence and activation.  Maintaining a balance of quiescent and 
activated NSCs is essential for homeostasis, protecting from stem cell loss, and ensuring the lifelong 
ability to regenerate after injury.  I began my research by characterizing molecular features of qNSCs and 
aNSCs, and I found that adult qNSCs do not express Nestin, but upregulate Nestin upon activation in vivo 
and in vitro.  I then used this molecular feature of NSC activation in an in vitro screening assay with which 
I identified several GPCR signals that promote NSC quiescence, and several neurotransmitter signals 
that activate qNSCs.  I found that the neurons that use these neurotransmitters display regional biases in 
their patterns of V-SVZ innervation, suggesting that these signals map onto the regional heterogeneity of 
qNSCs.  Consistent with this hypothesis, infusions of cholinergic agonist and antagonists into the lateral 
ventricle resulted in regional changes in NSC proliferation.  Moreover, cholinergic antagonists blocked the 
activation of qNSCs during regeneration, providing evidence that cholinergic signaling activates qNSCs in 
vivo.  I then showed that hypothalamic Pomc-expressing neurons innervate the anterior-ventral V-SVZ 
and promote the activation of Nkx2.1+ qNSCs.  Ablation of Pomc+ neurons resulted in decreased 
proliferation of NSCs in the anterior-ventral, but not anterior-dorsal, V-SVZ.  Moreover, both the activity of 
Pomc+ neurons, and the proliferation of Nkx2.1+ NSCs in the anterior-ventral V-SVZ decreased in fasted 
animals.  Finally, ablation of Pomc+ neurons resulted in a loss of a single subtype of OB interneuron that 
is generated by Nkx2.1+ NSCs.  Together, my findings suggest that both local and long-range neurons 
regionally innervate the V-SVZ and mediate neural stem cell activation from the quiescent state. 
 
Nestin is Not Expressed in Adult V-SVZ qNSCs 
 Analysis of Nestin expression in adult qNSCs and aNSCs during homeostasis and regeneration 
revealed that Nestin is not expressed in qNSCs, but is upregulated upon activation.  We found that 
Nestin-negative qNSCs contribute to the V-SVZ lineage during regeneration.  In the SGZ, Nestin-negative 
NSCs also participate in regeneration, while Nestin+ NSCs do not (DeCarolis et al., 2013).  Moreover, 
although Nestin is expressed by neuroepithelial stem cells and radial glial progenitors during 
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development, its expression is cell-cycle regulated (Sunabori et al., 2008).  Nestin is also highly 
expressed by ependymal cells, and TACs in the V-SVZ, thus is not even an aNSC specific marker 
(Codega et al., 2014).  However, Nestin is commonly used as a marker for NSCs, and a means by which 
to lineage trace and genetically manipulate NSCs (Imayoshi et al., 2011).  Thus, my finding impacts the 
interpretation and design of studies based on Nestin expression.  In the future, it will be wise to avoid 
using Nestin-CreERT2 lines to genetically manipulate NSC lineages in the V-SVZ, as nonautonomous 
effects are likely (Kuo et al., 2006). 
 
GCPR Signals Promote NSC Quiescence 
 The candidate GPCR screen revealed that adenosine, S1P, and PGD2 regulate NSC quiescence 
in vitro.  Interestingly, these signals had different effects on NSC quiescence.  Adenosine induced, but did 
not maintain, NSC quiescence.  In contrast, S1P maintained, but did not induce, NSC quiescence.  PGD2 
both induced and maintained NSC quiescence.  These results highlight that quiescence is an actively 
maintained state, and that NSCs respond to signals in distinct ways depending on their intrinsic cell cycle 
status.  Further, these signals might identify distinct subtypes of NSCs, as none of adenosine, S1P, or 
PGD2 affected all NSCs in vitro.  In the future it will be interesting to determine whether these signals 
regulate the quiescence of different NSC subtypes in vivo.  
 S1P, PGD2, and adenosine are mediators of reactive gliosis during inflammatory responses to 
neurodegenerative disease and brain injury.  Reactive gliosis is thought to be a major contributor to the 
pathology of these conditions.  For example, S1P and PGD2 signaling both increase reactive gliosis in 
demyelination models of Multiple Sclerosis (Farez and Correale, 2016; Mohri et al., 2006).  In contrast, 
adenosine signaling reduces reactive gliosis in a chronic inflammation model of Alzheimer’s disease, and 
following stroke (Lubitz et al., 2001; Rosi et al., 2003).  Thus, increasing S1P, PGD2, or adenosine 
signaling to recruit qNSCs for regenerative therapies of central nervous system disease and injury may 
also attenuate or enhance reactive gliosis.  In the future it will be important to investigate the effects of 
these signals on both neurogenesis and reactive gliosis in models of neurodegenerative disease and 




Regional Innervation of the V-SVZ 
The small molecule screen I performed to identify activators of qNSCs unexpectedly identified 
several neurotransmitters as activators of qNSCs, including dopamine, GABA, acetylcholine, serotonin, 
and opioids.  Recently, dopaminergic, GABAergic, cholinergic, and serotonergic neurons were shown to 
innervate the V-SVZ and promote the proliferation of NSCs (Höglinger et al., 2004; Lennington et al., 
2011; Paez-Gonzalez et al., 2014; Tong et al., 2014; Young et al., 2012; 2014).  I found that cholinergic, 
dopaminergic, GABAergic, and opioidergic neurons innervate the V-SVZ in unique regional patterns, 
which suggests that signaling from these neurons might activate regional subtypes of qNSCs.  Indeed, 
my data suggest that cholinergic signaling activates qNSCs specifically in regions where cholinergic 
innervation is most dense.  Ablation of Pomc+ neurons reduced NSC proliferation specifically in the 
anterior-ventral V-SVZ where they innervate.  Importantly, ablation of Pomc+ neurons did not reduce the 
total number of GFAP+ cells in the anterior-ventral V-SVZ, suggesting that Pomc+ neurons promote the 
activation of qNSCs.  Pomc+ neuron ablation also resulted in reduced numbers of a single subtype of OB 
interneuron.  Moreover, ablation of dopaminergic neurons in the SN / VTA decreased proliferation in the 
dorsal V-SVZ, where I found the highest density of dopaminergic innervation (Lennington et al., 2011).  
These data strongly suggest that distinct neurons regulate the quiescence and activation of regional 
subtypes of NSCs, and thereby underlie the production of different OB interneuron subtypes.  In the 
future we could use optogenetics to activate the dopaminergic, cholinergic, and GABAergic neurons that 
innervate the V-SVZ, and determine whether NSC proliferation is increased in specific V-SVZ regions.  If 
this is the case, ablation of these types of neurons might result in the loss of specific subtypes of OB 
interneurons.  In contrast, serotonergic innervation appears to be evenly distributed over the entire 
ependymal surface of the V-SVZ (Tong et al., 2014).  Thus, serotonergic signaling may influence the 
proliferation of several regional NSC subtypes.   
 It is interesting to consider whether the neurons that innervate the V-SVZ might be connected to 
each other.  Thus, their activities may be coordinated such that qNSCs throughout the entire V-SVZ niche 
receive activating signals simultaneously.  This could result in the generation of consistent proportions of 
OB interneuron subtypes.  Connections between these neurons can be traced with monosynaptic-
jumping rabies viruses, variants of which can transfer in the anterograde or retrograde direction (Reardon 
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et al., 2016; Zampieri et al., 2014).  Further, a new strain of monosynaptic rabies virus has reduced 
neurotoxicity, thus optogenetics could be used to determine the effects of circuit activity on regional NSC 
proliferation (Reardon et al., 2016).   
 The neurons that innervate the V-SVZ are associated with behaviors that are cyclic in nature.  
The striatum and SN/VTA are involved in motor function and reward; serotonergic dorsal raphe neurons 
regulate sleep/wake cycles; hypothalamic Pomc+ neurons are involved in hunger/satiety states 
(Höglinger et al., 2004; Tong et al., 2014; Zeltser et al., 2012).  Animals go through continuous cycles of 
exercise and stillness, desire and satisfaction, sleep and wake, hunger and satiety, during which the 
neurons that innervate the V-SVZ might be more active then less active.  Indeed, I found that Pomc+ 
neuron activity and NSC proliferation decreased with fasting, but returned to normal levels upon re-
feeding.  Thus, cyclic activity of neurons that innervate the V-SVZ might ensure a steady supply of qNSC-
activating signals, which would fulfill the homeostatic requirement of continuous OB neurogenesis 
throughout life.  In the future it will be very interesting to test whether motor and sleep/wake behaviors 
result in cyclic changes in NSC proliferation in the V-SVZ.  
 
Neurotransmitter Receptors and Regional Subtypes of qNSCs 
The drugs identified in the small molecule screen as regulators of NSC quiescence and activation 
target multiple subtypes of neurotransmitter receptors (see Table 3.2).  This suggests that 
neurotransmitter receptor expression profiles might identify regional subtypes of stem cells.  I found that 
agonism of nicotinic acetylcholine receptors increased NSC proliferation in the anterior- and middle-dorsal 
V-SVZ, while antagonism of nicotinic and muscarinic acetylcholine receptors decreased NSC proliferation 
in multiple regions.  Thus, NSCs in the anterior- and middle-dorsal V-SVZ likely express nicotinic 
receptors, while NSCs in other V-SVZ regions likely express muscarinic receptors.  Further, an agonist of 
GABA-A receptors increased qNSC activation, while an agonist of GABA-B receptors promoted NSC 
quiescence.  Thus, neurotransmitter receptor expression may also be dynamically regulated during the 
cell cycle, and/or receptors could be asymmetrically inherited during the self-renewing division.  In the 
future, we could perform single cell RNAseq on regionally purified qNSCs and aNSCs to determine their 
neurotransmitter receptor expression profiles.  This would shed light on whether regional NSC subtypes 
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are responsive to one or multiple types of neurotransmitters.  Moreover, it might be possible to use 
neurotransmitter receptor promoters and/or enhancers to create specific tools for manipulating regional 
subtypes of qNSCs in vivo.  Identifying qNSC specific enhancers is feasible using ATACseq, because this 
method does not require excessive cell numbers to achieve optimal signal-to-noise ratios (Buenrostro et 
al., 2013).  
 
 My data also have important implications for human neurodegenerative disease, and aging.  In 
the human, adult V-SVZ neurogenesis provides new neurons to the striatum, and SGZ neurogenesis 
provides new neurons to the dentate gyrus of the hippocampus (Ernst et al., 2014; Spalding et al., 2013).  
Dopaminergic neuron fibers are present in the human V-SVZ and SGZ, and neurogenesis in both regions 
is reduced in Parkinson’s disease (PD), which is characterized by a progressive loss in dopaminergic 
neurons (Höglinger et al., 2004).  V-SVZ and SGZ neurogenesis also decline with aging, likely due to 
increased NSC quiescence (Ernst et al., 2014; Macas et al., 2006; Spalding et al., 2013).  Impairments in 
motor control and cognitive function are hallmarks of PD, and aging, and the striatum and hippocampus 
mediate these functions (Ernst et al., 2014; Höglinger et al., 2004).  Thus, it is possible that decreased 
adult neurogenesis contributes to the pathology these conditions.  It may be possible to reactivate 
neurogenesis in PD and aging with qNSC-activating neurotransmitter receptor agonists, and perhaps 
improve motor and cognitive functions.  In the future, we could test if drugs identified in the small 
molecule screen improve motor and cognitive function in aged mice and models of PD.  Additionally, we 
could test whether the most common drug used to treat PD, Levodopa (or L-DOPA), increases 
neurogenesis in mouse models of PD (Foster and Hoffer, 2004). 
 
 The identification of neurotransmitters as activators of qNSCs also has important implications for 
brain cancer.  Specifically glioblastoma multiforme (GBM), which is the most common, aggressive, and 
lethal form of brain cancer (Parsons et al., 2008).  GBM tumors often express markers that are also 
expressed by proliferative NSCs, including Nestin, EGFR, and Sox2 (Park et al., 2013).  Thus, GBM 
tumors might arise from NSCs, or mature glia, which acquire mutations that disrupt NSC quiescence 
and/or that normally allow aNSCs and their progeny to proliferate and migrate through the brain.  My data 
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suggest that neurotransmitter receptors might be upregulated, and/or adenosine, S1P, and PGD2 
receptors might be downregulated, in GBM.  It will be important to determine whether GBM cell lines 
express neurotransmitter and adenosine, S1P, and PGD2 receptors.  If so, my data argue that 
antagonizing neurotransmitter receptors, or agonizing adenosine, S1P or PGD2 receptors might limit the 
aggressive growth of GBM tumors.  The current treatment for GBM is surgical resection, followed by 
radiation therapy, and chemotherapy; recurrence is common, and median survival is only 15 months 
(Stupp et al., 2009).  Thus, inhibiting GBM growth before surgery might increase the likelihood that 
surgery captures all GBM cells, which might decrease recurrence.  Importantly, the majority of drugs in 
the small molecule screening library (Tocris Mini Plus) are FDA approved.  Therefore, if neurotransmitter 
antagonists inhibit growth in GBM cell lines and mouse models, the drugs might be quickly moved 
through clinical trials. 
 
Hunger and Satiety States Regulate the Production of Deep Granule Cell Layer OB Interneurons 
 My data presented in Chapter 4 strongly suggest that hunger and satiety states regulate the 
production of deep granule cell layer (GRL) OB interneurons.  Specifically, my data suggest that 1) when 
animals are hungry the production of deep GRL interneurons decreases due to decreased Nkx2.1+ NSC 
proliferation, and 2) when animals are satiated the production of deep GRL interneurons increases due to 
increased Nkx2.1+ NSC proliferation.  Olfaction is used to locate food and evaluate food quality, and as 
such is a key part of feeding behaviors.  However, what could be the adaptive benefit of hunger/satiety 
states regulating the production of a specific subtype of OB interneuron?  We can only speculate on this, 
but we can start from what is known about V-SVZ neurogenesis and the function of the adult-born 
interneurons.  First, there can be no immediate adaptive benefit to olfactory function during acute hunger 
due to decreased Nkx2.1+ NSC proliferation, simply because a meaningful reduction in deep GRL 
interneurons will not be realized for 2 – 4 wks.  However, if feeding bouts were rare the animal might 
experience prolonged hunger spells, which could reduce the overall numbers of deep GRL interneurons 
over time.  For example, this could occur during the winter months, or a drought, when food sources are 
scarce.  The vast majority of adult-born interneurons are deep GRL interneurons (Imayoshi et al., 2008).  
Optogenetic activation of adult-born interneurons enhances the ability of mice to discriminate between 
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highly similar odors, increases the speed in which the animal can form an olfactory associative memory, 
and increases the length of time that associative memory will be retained (Alonso et al., 2012).  Thus, 2 – 
4 weeks into a period of food scarcity we might expect olfactory discrimination, learning, and memory 
ability to be reduced.  Fine discriminatory ability for odors may simply not be needed during the winter 
when the complexity of the odor environment is likely reduced.  However, decreased olfactory learning 
and memory could benefit the animal because it might be less likely to associate a particular odor 
environment with a rare food source, and thus be more likely to range farther for food.   
This model is appealing because it is testable, and it need not be specific to odors of food.  
Specifically, animals could be placed on a low-calorie diet, or access to food could be limited to one 
feeding bout per day, for a period of several months.  We could then test if arcuate Pomc+ neuron 
activity, Nkx2.1+ NSC proliferation, and deep GRL interneuron numbers were reduced compared to freely 
fed animals.  If so, we could then perform olfactory behavior experiments specifically testing for the ability 
to form and retain olfactory associative memories. 
Modulating NSC quiescence might result in future adaptive benefits for olfactory function.  
Consistent with this idea, pregnancy increases V-SVZ proliferation transiently at gestation day 7 and 
again at post-partum day 7 in female mice, in part via circulating prolactin.  This results in increased 
numbers of adult-born interneurons in the OB 2 – 4 weeks later at birth and weaning (Shingo et al., 2003).  
Maternal care behaviors in mice are known to involve olfactory discrimination (Kendrick et al., 1997), and 
female mice with ablated neurogenesis do not recognize or feed their pups, which all die 24hrs after birth 
(Sakamoto et al., 2011).  It stands to reason that the transient increases in V-SVZ proliferation in 
pregnant mice are preparative for the future need of enhanced olfactory function during maternal care at 
birth and weaning.  Similarly, a preparative increase in adult neurogenesis for enhanced olfactory function 
in feeding behaviors might occur each spring.  Survival of adult-born interneurons would increase as the 
odor environment becomes more complex (Rochefort et al., 2002), and neurogenesis would increase as 
food sources become more common as the new growing season returns.  Thus, quiescence and 




 My research presented in this thesis argues that neurotransmitter signaling from regionally 
distributed local and long-range neurons activates qNSCs throughout the entire V-SVZ niche, and thereby 
underlies the production of all OB interneuron subtypes.  These local and long-range neurons govern 
cyclic behaviors, thus they might provide continuous on/off pulses of activating signals that would ensure 
the homeostatic requirement of continuous lifelong neurogenesis.  My data suggest that regulation of OB 
neurogenesis by hunger/satiety states might allow for long-term adaptive benefits to olfactory functions in 
feeding behavior.  Given the importance of olfaction in feeding behavior, hunger/satiety state regulation of 
OB neurogenesis might have arisen early in vertebrate evolution.  My results also have broad implications 
for human brain cancer, aging, neurodegenerative disease, and injury.  Specifically, the qNSC activating 
signals I identified are candidates for future therapies designed to combat glioblastoma multiforme, or to 








Animal use  
Two to three month-old CD1 (Charles River), hGFAP::GFP ((Zhuo et al., 1997); Jackson Labs), 
hGFAP::CreERT2; R26RCAG-tdTomato, or Pomc-Cre ((McHugh et al., 2007); Jackson Labs) were used 
in accordance with institutional guidelines.  
 
FACS Purification Strategy 
The SVZs from 2-3 month old heterozygous GFAP::GFP mice and wild-type CD1 mice (Charles River 
Laboratories) were dissected, digested with papain (Worthington, 1,200 units per 5 mice, 10 min at 37ºC) 
in PIPES solution (120 mM NaCl, 5 mM KCl, 50 mM PIPES (SIGMA), 0.6% glucose, 1x Pen/Strep 
(Gibco) in water, pH adjusted to 7.6) and mechanically dissociated to single cells after adding ovomucoid 
(Worthington, 0.7 mg per 5 mice) and DNAse (Worthington, 1,000 units per 5 mice).  Cells were 
centrifuged for 10 min at 4ºC without brakes in 22% Percoll (SIGMA) to remove myelin and incubated for 
15 min with PE-conjugated rat anti-mCD24 (1:1000; BD Pharmingen), A647-complexed EGF (1:300; 
Molecular Probes) and biotinylated rat anti-mCD133 (1:300, clone 13A4, eBioscience), washed by 
centrifugation and incubated for 15 min with PE-Cy7-conjugated streptavidin (1:1000; eBioscience).  All 
stainings and washes were carried out on ice in 1% BSA, 0.1% Glucose HBSS solution.  To avoid 
clumping, cells were passed through a 40-µm filter. To assess cell viability, 4’,6-diamidino-2-phenylindole 
(DAPI; 1:1000; SIGMA) was added to the cells before sorting.  All cell populations were isolated in a 
single sort using a Becton Dickinson FACS Aria II using 13 psi pressure and 100-µm nozzle aperture. 
Cells were collected in neurosphere medium (details below) without growth factors.  Gates were set 
manually by using control samples (see appendix).  Data was analyzed with FlowJo 9.3 data analysis 





RNA was purified from FACS sorted populations by the miRNeasy kit, which allows the extraction of both 
large RNA and enriches for smaller RNAs such as miRs (Qiagen).  cDNA was generated using WT- 
Ovation Pico System (NuGEN). The total SVZ sample consisted of all live cells.  For qRT-PCR, all 
reactions were carried out in duplicate on 4 biological replicates using Brilliant III Ultra Fast SYBR Green 
QPCR Master Mix (Agilent) in a Stratagene Mx3000P machine with an annealing temperature of 60ºC. 
Data was normalized to GAPDH expression and analyzed by the 2-ΔΔCt method which normalizes 
expression to both a control sample (here, total SVZ) and a reference gene (GAPDH) (Livak and 
Schmittgen, 2001).  Primers used for qPCR:   
GAPDH:  Forward: AACTTTGGCATTGTGGAAGG,  Reverse: ACACATTGGGGGTAGGAACA 
Nestin:  Forward: GGGCCCAGAGCTTTCCCACG,  Reverse: GGGCATGCACCAGACCCTGTG 
 
Immunostaining 
For V-SVZ whole mounts, deeply anesthetized mice were perfused with 30mL 0.1% sterile saline, brain 
was removed and the wall of the lateral ventricle exposed.  Whole mounts were then fixed overnight in 
3.2% paraformaldehyde, washed in PBS, incubated in primary antibodies in blocking solution (10% serum 
with 0.1% Triton-X) for 48hrs at 4°C, washed 6 times in PBS and incubated in secondary antibodies 
overnight.  Whole mounts were then further dissected and the SVZ removed, prior to mounting in Aqua 
Polymount (Polysciences, Inc.), and imaged using a Zeiss LSM 510, Zeiss LSM 610, or Leica TCS SP5 II 
confocal microscope.  
For coronal section staining, deeply anesthetized mice were perfused with 30mL 0.1% sterile saline 
followed by 20mL 3.2% paraformaldehyde, brain was removed and fixed in 3.2% paraformaldehyde 
overnight at 4°C.  Brain was then cut in the coronal plane into 30µm sections on a Leica vibratome.  
Sections were stored in PBS with 0.05% NaN3 at 4°C until use.  For staining sections were incubated in 
primary antibodies in blocking solution (10% serum with 0.1% Triton-X) for 48hrs at 4°C, washed 3 times 
in PBS and incubated in secondary antibodies overnight.  Sections were then mounted in Aqua 
Polymount (Polysciences, Inc.), and imaged using a Zeiss LSM 510, or Zeiss LSM 800 confocal 
microscope. 
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For acute immunostaining, FACS-purified populations were plated with 20 ng/ml EGF (Upstate) on 16-
well Lab-Tek chamber slides (Thermo Scientific) coated with poly-D-lysine (Sigma, 10 µg/ml) and 
Fibronectin (Sigma, 2 µg/ml) for 2 hours, then fixed for 20 min with 3.2% paraformaldehyde, incubated in 
primary antibodies in blocking solution (10% serum with 0.1% Triton-X) for 24hrs at 4°C, washed 3 times 
in PBS and incubated in secondary antibodies overnight.   
For EGF-ligand labeling, 0.5 µl of a 40 µg/ml of EGF-A647 (Invitrogen) was stereotaxically injected into 
the lateral ventricle of deeply anesthetized mice 10 minutes before sacrifice as previously described 
(Pastrana et al., 2009).  
 
Cloning of mP2-mCherry  
The mP2-mCherry plasmid was generated by cloning the mouse P2 element, homologous to the human 
P2 element (Shmelkov et al., 2004) of the Prominin1 promoter into the CherryPicker control vector 
(Clontech), using the XhoI and AgeI digestion sites.  The following primers were used to amplify the mP2 
element by PCR from mouse genomic DNA: Forward: ACTCTCGAGGGTCCAATCAGTGCGCTCAGAC 
Reverse: ATGACCGGTCCTCTCCGGTCCAGCTCTCCT  
 
Electroporation  
The electroporation protocol was adapted from Barnabé-Heider et al., 2008. Briefly, 1 µl of a solution 
containing 5 mg/ml of plasmid in 0.9% saline was injected into the ventricle using the following 
coordinates relative to bregma: anterior-posterior, 0.0; lateral, 0.85; ventral, -2.5 mm.  Holding the 
cathode of a square electroporator towards the ipsilateral V-SVZ, five 200 V electrical pulses of 50 ms 
duration were administered, with 950 ms of pause between each.  Electroporation of PDGFRβ::mCherry 
plasmid was performed on CD1 or hGFAP::GFP mice, and these were sacrificed 7 days post 
electroporation (dpe). Electroporation of PDGFRβ::iCre plasmid was performed on R26RCAG-tdTomato 




Tamoxifen injections  
Tamoxifen (Sigma) was diluted in 90% sunflower seed oil, 10% ethanol to a concentration of 30 mg/ml. 
Mice were I.P. injected with 3mg (0.1mL) tamoxifen for 3 consecutive days and sacrificed at different time 
points. 
 
Ara-C, Cholinergic Agonist, and Cholinergic Antagonists Infusion 
A micro-osmotic pump (ALZET, 1007D) filled with artificial CSF (aCSF, see below), 2% Ara-C (Sigma) in 
aCSF, 0.5% DMSO, 10µM ADMP in 0.5% DMSO, or 40µM mecamylamine and 5µM atropine in aCSF 
was implanted onto the surface of the brain (Ara-C) or into the ventricles as described elsewhere 
(Doetsch et al., 1999a; Doetsch et al., 2002).  After 6 days of Ara-C infusion, mice were sacrificed either 
immediately or 12hr after pump removal.  
aCSF formulation (alzet.com): Mix sterile filtered Solution A and Solution B to 1:1 before use.   
Solution A: Dissolve 8.66g NaCl, 0.224g KCl, 0.206g CaCl2 • 2H2O, and 0.163g MgCl2 • 6H2O in 500mL 
sterile dH2O.   
Solution B: Dissolve 0.214g Na2HPO4 • 7H2O and 0.027g Na2HPO4 • H2O in 500mL sterile dH2O.  
 
In vitro qNSC Activation Timecourse 
qNSCs were FACS purified and plated at clonal density (300 cells per well) in 96-well plates coated with 
poly-D-lysine (Sigma, 10 µg/ml) and Fibronectin (Sigma, 2 µg/ml).  Cells were grown in Neurosphere (NS) 
medium, composed of DMEM/F12 (Life Technologies) supplemented with 0.6% Glucose (Sigma), 1x 
Hepes (Life Technologies), 1x Insulin-Selenium-Transferrin (Life Technologies), N-2 (Life Technologies) 
and B-27 (Life Technologies) supplement in the presence of 20 ng/ml EGF (Upstate).  Cells were fixed at 
2hrs, and 1, 3, 5, and 7 days post plating. 
 
RNA Isolation and Microarray Hybridization  
RNA was purified from FACS-sorted populations with the miRNeasy kit (QIAGEN) from three biological 
replicates. cDNA was synthesized with the Nugen Pico amplification kit and hybridized to Affymetrix 
MOE430.2 chips. 
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Bioinformatic analysis  
Normalization, quality control, differential expression, and gene ontology analysis were carried out using 
Genespring GX 11.  Differentially expressed probesets were filtered by average expression level greater 
than 50 in at least 1 population, at least 2-fold differential expression and corrected p-value less than 0.05 
by Benjamini-Hochberg multiple testing correction.  GO categories were obtained with p-value less than 
0.05.  GSEA sets with FDR (q value) < 0.05 were hand-curated into thematic categories to highlight 
transcriptional differences between populations.  Analysis was carried out with GSEA software from the 
Broad Institute, using MSigDB v3.0.  
 
GPCR Compound Screen  
qNSCs and aNSCs were isolated by FACS and plated at clonal density (300 qNSCs/well, 50 aNSCs/well) 
on poly-D-lysine- and fibronectin- coated 96-well plates in NS medium with EGF.  To assay the effect on 
qNSCs, compounds were added 1 day after plating, and cells were fixed and immunostained at day 4.  
To assay the effect on aNSCs, cells were plated with compounds and fixed and immunostained 1 day 
later.  The following compounds were tested (final concentration is noted, also see (Codega et al., 2014)): 
Sphingosine-1-phosphate, 1µM; 1-Oleoyl lysophosphatidic acid sodium salt, 100nM; Adenosine, 
10µM; Neuropeptide Y, 1µM; Histamine dihydrochloride, 100µM; Endothelin 1, 1µM; Leukotriene D4, 
1µM; (-)-Epinephrine, 10µM; (-)-Norepinephrine, 10µM; Amylin, 1µM; L-CCG-I, 10µM; Neurotensin, 1µM; 
R-spondin1, 100nM; α-Latrotoxin, 1nM; Proinsulin C-Peptide, 1nM; Orexin A, 10µM; Neurokinin A, 1µM; 
Prosaptide, 1µM; Serotonin Hydrochloride, 1µM; GRF, 100nM; Secretin, 100nM; Prostaglandin D2, 1µM.  
 
Small Molecule Screen and in vitro Endogenous Neurotransmitter Tests 
qNSCs were isolated by FACS and plated at clonal density (300 cells/well) on poly-D-lysine- and 
fibronectin- coated 96-well plates in NS medium with EGF.  To assay the effect on qNSCs, compounds 
were added 1 day after plating, and cells were fixed and immunostained at day 4.  All compounds were 
added to a final concentration of 10µM in 0.5% DMSO.  Two types of control wells were plated: EGF-only, 
and 0.5% DMSO.  The Tocris Mini Plus library, consisting of 1307 compounds was screened. 
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In the primary round of screening, all 1307 compounds were screened at one compound per well.  The 
percent of activated Nestin+ clones per well, and the number of Nestin+ cells per clone, was quantified.  
All wells were treated as individual replicates.  The average percent of Nestin+ clones across all EGF-
only control wells, termed µ, (usually 6 – 12 wells per plate) was calculated, and then the percent of 
Nestin+ clones for all compound treated wells and DMSO control wells was normalized to µ.  Then the 
95% confidence interval of the mean of the normalized %Nestin+ clones from DMSO control wells 
(usually 6 – 12 per plate) was calculated.  Compounds were then scored as a “positive hit” or “negative 
hit” if the compound’s normalized %nestin+ clone value was above or below the 95% confidence interval 
of the mean normalized %Nestin+ clones from DMSO control wells, respectively.  The same 
normalization and analysis was used for the number of Nestin+ cells per clone metric (activated clone 
size).  Statistical comparisons were made between cells isolated in the same sort, due to biological 
variability in the baseline rate of spontaneous qNSC activation.  This analysis is equivalent to performing 
a two-tailed Student’s t-test with positive and negative hits having p < 0.05.   
In the secondary round of screening, 175 compounds were screened.  Each of these 175 compounds 
thus was tested in two biological replicates (i.e. one from each round of screening).  The same metrics 
(%Nestin+ clones, and activated clone size) were quantified and normalized as in the primary round of 
screening.  Statistical comparisons were then made between the DMSO and compound treated wells (2 
biological replicates each) using a two-tailed Student’s t-test. 
For the in vitro assays with endogenous neurotransmitters, cells were plated and neurotransmitters were 
added as above.  The percent of activated Nestin+ clones and the number of Nestin+ cells per clone was 
quantified, and these values were normalized as above.  Tests were performed in 3 biological replicates 
and statistical comparisons made using a two-tailed Student’s t-test.  The following neurotransmitters 
were used (final concentration is indicated): acetylcholine, 10µM; dopamine, 10µM; GABA, 100 µM; 




Quantification of Innervation Density 
V-SVZ whole mounts were prepared and immunostained to label cholinergic, dopaminergic, or 
GABAergic neuronal fibers.  Confocal z-stack images were taken through the entire depth of the V-SVZ 
(ependymal surface to underlying vasculature).  Z-stacks were projected onto 2 dimensions.  The total 
length of neuronal fibers was measured using the NeuriteTracer plugin in ImageJ (Pool et al., 2008).  The 
total length of fibers was then divided by the total volume of the Z-stack to estimate fiber density (1/µm2). 
 
Viral Injections 
Mice were anesthetized with isoflurane and placed into a stereotaxic apparatus.  The skull was exposed 
via a small incision, and a small hole was drilled for unilateral injection.  For injection into the 
hypothalamic arcuate (ARC), a pulled-glass pipette with 10 – 20 µm tip diameter was inserted into the 
brain, and three 60nl injections of either rAAV5-EF1a-DIO-eYFP (AAV-Flex-YFP in the text; UNC Vector 
Core) or rAAV1-flex-taCasp3-TEVp (AAV-Flex-Casp3 in the text; UNC Vector Core) were made at 
different depths from the skull surface (coordinates, bregma: 1.5 mm; midline: 0.2 mm; skull surface: 5.7 
mm, 5.5 mm, 5.3 mm).  
 
Antibodies 
The following antibodies were used:  rat anti-GFP (1:2000, Nacalai Tesque); mouse anti-Nestin (1:5, rat-
401 DSHB); guinea pig anti-DCX (1:1000, Millipore); rabbit anti-EGFR (1:200, Millipore); goat anti-MCM2 
(1:50, Santa Cruz Biotechnology); mouse anti-β-Catenin (1:200, BD Bioscience); sheep anti-tyrosine 
hydroxylase (1:500, Millipore); mouse anti-dopamine beta-hydoxylase (1:1000, Alpha Diagnostic 
International); mouse anti-GAD67 (1:1000, Jessell Lab); rabbit anti-Choline acetyltransferase (1:1000, 
Jessell Lab); mouse anti-beta-endorphin (1:500, Millipore clone 3E7); goat anti-Oprk1 (1:100, Santa 
Cruz); rabbit anti-Oprm1 (1:1500, Millipore); rabbit anti-Oprd1 (1:250, Millipore); rabbit anti-Ki67 (1:500, 
Abcam); chicken anti-GFAP (1:600, Millipore); mouse anti-NeuN (1:250, Millipore); rabbit anti-calretinin 
(1:1000, SWANT); rabbit anti-calbindin (1:1000, Chemicon); rabbit anti-neurogranin (1:100, Millipore); 
rabbit anti-Nkx2.1 (1:250, Santa Cruz); rabbit anti-Synaptophysin (1:100, Abcam); rabbit anti-c-fos 
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(1:2000, Santa Cruz).  Secondary antibodies were used at 1:500 (Alexa fluor-conjugated, Jackson 
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cells; however, their in vivo identity has been elusive.
Here, we prospectively isolate GFAP+CD133+ (quies-
cent neural stem cells [qNSCs]) and GFAP+CD133+
EGFR+ (activated neural stem cells [aNSCs]) from
the adult ventricular-subventricular zone. aNSCs are
rapidly cycling, highly neurogenic in vivo, and en-
riched in colony-forming cells in vitro. In contrast,
qNSCs are largely dormant in vivo, generate olfac-
tory bulb interneurons with slower kinetics, and only
rarely form colonies in vitro. Moreover, qNSCs are
Nestin negative, a marker widely used for neural
stemcells. Upon activation, qNSCs upregulateNestin
and EGFR and become highly proliferative. Notably,
qNSCs and aNSCs can interconvert in vitro. Tran-
scriptome analysis reveals that qNSCs share features
with quiescent stem cells from other organs. Finally,
small-molecule screening identified the GPCR li-
gands, S1P and PGD2, as factors that actively main-
tain the quiescent state of qNSCs.
INTRODUCTION
Quiescent and actively dividing (activated) stem cells coexist in
adult stem cell niches (Li and Clevers, 2010). Stem cell quies-
cence and activation play an essential role in many organs, un-
derlying tissue maintenance, regeneration, function, plasticity,
aging, and disease. Quiescent stem cells dynamically integrate
extrinsic and intrinsic signals to either actively maintain their
dormant state or become activated to divide and give rise to
differentiated progeny (Cheung and Rando, 2013). To illuminate
their biology and their molecular regulation, it is essential to be
able to prospectively identify and purify quiescent stem cells.
However, this has been exceedingly difficult in any organ,
including the adult brain.
Adult neural stem cells (NSCs) continuously generate neurons
throughout life in two brain regions: the subgranular zone (SGZ)
of the hippocampus and the ventricular-subventricular zone
(V-SVZ), adjacent to the lateral ventricles. The V-SVZ is the
largest germinal region in the adult mammalian brain and gener-
ates olfactory bulb interneurons and oligodendrocytes. Within
the V-SVZ, glial fibrillary acidic protein (GFAP)-positive type
B cells with hallmark features of astrocytes are stem cells and
have multipotent self-renewing capacity in vitro (Doetsch et al.,
1999a; Laywell et al., 2000; Imura et al., 2003; Garcia
et al., 2004; Sanai et al., 2004; Ahn and Joyner, 2005; Mirzadeh
et al., 2008; Beckervordersandforth et al., 2010; Lee et al.,
2012). In vivo, actively dividing V-SVZ stem cells are eliminated
by antimitotic treatment (Pastrana et al., 2009). In contrast, slowly
dividing astrocytes are label-retaining cells (LRCs), survive treat-
ment with antimitotic drugs and regenerate the V-SVZ, and give
rise to neurons under homeostasis (Doetsch et al., 1999a; Ahn
and Joyner, 2005; Giachino and Taylor, 2009; Nam and Benezra,
2009; Kazanis et al., 2010; Basak et al., 2012).
Recently, novel features of the anatomical organization of the
V-SVZ stem cell niche have been uncovered. GFAP+ type B1
cells have a radial morphology and span different compartments
of the stem cell niche (Silva-Vargas et al., 2013). Their apical pro-
cesses contact the lateral ventricle at the center of pinwheel
structures formed by ependymal cells, exhibit a primary cilium,
and are exposed to signals in the cerebrospinal fluid (CSF)
(Doetsch et al., 1999a, Mirzadeh et al., 2008, Beckervordersand-
forth et al., 2010, Kokovay et al., 2012). Their basal processes
contact blood vessels, which are an important proliferative niche
in the adult V-SVZ (Shen et al., 2008; Mirzadeh et al., 2008; Ta-
vazoie et al., 2008; Kazanis et al., 2010; Kokovay et al., 2010, La-
car et al., 2011, 2012).
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Variousmolecular markers have been used for the in vivo iden-
tification of V-SVZ stem cells and their purification (reviewed in
Pastrana et al., 2011). Nestin and Sox2 are widely used as
NSC markers in both the embryonic and adult brain (Lendahl
et al., 1990; Graham et al., 2003; Kazanis et al., 2010; Imayoshi
et al., 2011; Marqués-Torrejón et al., 2013). CD133 (Prominin),
a transmembrane glycoprotein expressed on primary cilia of
neural progenitors (Uchida et al., 2000; Marzesco et al., 2005;
Pinto et al., 2008; Cesetti et al., 2011) has been used to distin-
guish GFAP+CD133+ stem cells from niche astrocytes (Mirzadeh
et al., 2008, Beckervordersandforth et al., 2010). Combinations
of markers are beginning to be identified that allow the purifica-
tion of different subpopulations of V-SVZ cells, in particular of
activated stem cells, including epidermal growth factor receptor
(EGFR) (Doetsch et al., 2002; Pastrana et al., 2009), and brain
lipid binding protein (BLBP) (Giachino et al., 2014). To date, how-
ever, combinations of markers have not been identified that
allow the prospective isolation of quiescent V-SVZ stem cells.
This is crucial to illuminate the functional properties and gene
regulatory networks of quiescent adult NSCs.
Herein, we prospectively identify and isolate quiescent adult
NSCs from their niche. Our findings reveal that CD133+ astro-
cytes comprise two functionally distinct populations, quiescent
NSCs (qNSCs) and activated NSCs (aNSCs), which differ
dramatically in their in vivo cell cycle status and lineage kinetics,
their in vitro colony-forming efficiencies, and their molecular
signatures. Notably, qNSCs only rarely form colonies in vitro
Figure 1. Two Populations of CD133+ V-SVZ
Astrocytes Contact the Ventricle
(A and B) A subset of GFAP+ cells at the center of
pinwheels express EGFR. (A) Confocal image of a
whole mount immunostained for b-catenin ([bCat]
red) to visualize pinwheels, GFAP (blue), and
EGFR (green). (B) Schematic representation of
whole mount shown in (A). Individual pinwheels
are highlighted in different colors, and EGFR-
expressing cells are green.
(C–F) Optical slice of a confocal z stack at the
ventricular surface of a whole mount showing
endogenous GFP expression (C) under the control
of the human GFAP promoter and immunostained
for (D) CD133 and (E) EGFR. (F) Merged image.
Note that astrocytes contacting the ventricle with
diffuse CD133 staining are EGFR+ (arrowheads),
whereas those with CD133 restricted to the pri-
mary cilium are EGFR! (arrow).
(G) Schema showing type B1 astrocytes contact-
ing the ventricle at the center of a pinwheel
structure formed by ependymal cells (gray).
CD133 (Prominin, magenta) is detected on the cilia
of ependymal cells, some primary cilia of some
type B1 astrocytes (blue), and is diffusely ex-
pressed on the apical surface of EGFR+ type B1
astrocytes (cyan). Scale bars, 30 mm.
See also Figures S1 and S2.
and are natively Nestin negative but
upregulate both Nestin and EGFR on
activation. qNSCs also share common
molecular features with their counter-
parts in other organs. Finally, we identify GPCR ligands that
actively maintain the quiescent state of qNSCs.
RESULTS
Two Populations of CD133+ V-SVZ Astrocytes Contact
the Lateral Ventricle
The intermediate filament GFAP is one of the few markers of type
B1 astrocytes (Doetsch et al., 1997; Mirzadeh et al., 2008). How-
ever, due to its filamentous nature, it is difficult to perform colocal-
ization studieswithGFAP,and itcannotbeused for livecell sorting.
GFAP::GFP mice, in which GFP is expressed under the control
of the human GFAP promoter (Zhuo et al., 1997), are a useful
tool for visualizingV-SVZastrocytes invivoand for theirpurification
by fluorescence-activated cell sorting (FACS) (Tavazoie et al.,
2008; Platel et al., 2009, Shen et al., 2008, Pastrana et al., 2009;
Beckervordersandforth et al., 2010). Whole-mount preparations
allow the pinwheel architecture of the walls of the lateral ventricle
to be clearly visualized. We confirmed that, in GFAP::GFP mice,
type B1 astrocytes contacting the ventricle at the center of pin-
wheels were GFP+ and GFAP+, and frequently had a primary
cilium, but lacked S100b expression, a marker of mature astro-
cytes that are found deeper in the tissue at the interface with the
striatum (Figures S1A, S1C, and S1D available online).
Notably, a subset of cells localized within individual pinwheels
was EGFR+ (11.4% ± 1.3%; n = 129 pinwheels) (Figures 1A
and 1B). These ventricle-contacting EGFR+ cells coexpressed
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both GFAP protein and GFP in GFAP::GFP mice (Figure S1B;
Pastrana et al., 2009) and were observed throughout the rostro-
caudal axis of the V-SVZ, with 45.7% ± 4.4% of pinwheels con-
taining EGFR+ cells.
To define markers for EGFR-negative type B1 cells contacting
the ventricle, we examined the expression of CD133 (Prominin),
which is expressed by ependymal cells and on the primary cilium
of some type B1 cells (Coskun et al., 2008; Mirzadeh et al., 2008;
Beckervordersandforth et al., 2010). We immunostained whole
mounts of GFAP::GFP mice for EGFR and CD133 in conjunction
with b-catenin (to label pinwheels) or acetylated tubulin (to detect
primary cilia). We thereby identified two CD133+ astrocyte pop-
ulations: GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+
(Figure 1G). GFAP::GFP+CD133+ cells had a primary cilium
with CD133 staining localized to its tip (Figures 1C–1F; Figures
S2A and S2C). In contrast, GFAP::GFP+CD133+EGFR+ cells ex-
hibited diffuse CD133 staining over their apical surface and
lacked a primary cilium (Figures 1C–1F; Figures S2B and S2D).
Finally, we also observed GFAP::GFP+ cells contacting the
ventricle, which had a primary cilium that was CD133 negative
(Figures S2A and S2C).
Visualizing the in vivo morphology of CD133+ type B1 cells is
not feasible by immunostaining. To this end, we cloned and elec-
troporated a construct that expresses membrane-targeted
mCherry under the control of the mouse minimal P2 (Prominin-1)
Figure 2. Both Quiescent and Activated
CD133+ V-SVZ Astrocytes Have Radial
Morphology and Contact the Ventricle and
Blood Vessels
(A) Confocal images of whole mounts immuno-
stained with b-catenin ([b-cat] green, superficial
optical slice) showing cells labeled by in vivo
electroporation of the mP2-mCherry construct
(red, z stack projection). Labeled cells are either
radial cells that contact the ventricle at the center
of pinwheels (open arrowheads in insets) or
ependymal cells (asterisks).
(BI–CIII) Confocal images of whole mounts immu-
nostained with Laminin (cyan), b-catenin (green),
and MCM2 (blue) showing projections of mP2-
mCherry+ cells (BI and CI). Insets show superficial
(BII and CII) and deep (BIII and CIII) optical slices.
Both MCM2! and MCM2+ cells contact the
ventricle at the center of pinwheels as well as
blood vessels.
(DI–EIII) Confocal images of whole mounts immu-
nostained with MCM2 (cyan) and b-catenin (blue)
and labeled with EGF-A647 (green) showing pro-
jections of mP2-mCherry+ cells (DI and EI). Insets
show superficial (DII and EII) and deep (DIII and EIII)
optical slices. Note that EGF-negative cells are
MCM2!. Scale bars, 30 mm.
See also Figure S3.
promoter (mP2-mCherry; Figure S3A)
into the lateral ventricle and analyzed
whole mounts 2 days later. Both multicili-
ated flat ependymal cells possessing
typical cuboidal morphology and radial
cells with B1 morphology were labeled by this construct (Fig-
ure 2A), and all coexpressed CD133 protein (23/23 cells; Figures
S3B–S3D). Radial mP2-mCherry+ cells expressed CD133 either
at the tip of their primary cilium (Figure S3C) or diffusely on their
apical surface (Figure S3D) and were GFAP+ (data not shown).
To define the cell cycle status and relationship of radial mP2-
mCherry+ cells with ependymal cells and blood vessels, electro-
porated whole mounts were immunostained for combinations of
EGF-A647, MCM2, b-catenin, and Laminin to label activated
stem cells, dividing cells, pinwheels, and blood vessels, respec-
tively. All radial mP2-mCherry+ cells, regardless of MCM2
expression or epidermal growth factor (EGF)-ligand binding,
had a typical B1 morphology with an apical process contacting
the ventricle at the center of pinwheels and a long basal process
extending away from the surface, which frequently terminated on
blood vessels (Figures 2BI–2BIII; Figures 2CI–2CIII; Figures S3E–
S3N). Importantly, all MCM2+ radial mP2-mCherry+ astrocytes
were colabeled with EGF-ligand (70/70 cells MCM2! and
EGF!; 5/5 cells MCM2+ and EGF+; Figures 2DI–2DIII; Figures
2EI–2EIII).
Prospective Purification of V-SVZ Astrocytes
The aforementioned in vivo characterization suggests that
CD133 and EGFR could be used as markers to prospectively
purify quiescent and activated NSCs directly from their in vivo
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niche using FACS. We previously developed a simple strategy
to simultaneously isolate activated stem cells (GFAP::GFP+
EGFR+), transit-amplifying cells (EGFR+), and neuroblasts
(CD24+) by combining EGF-A647 and CD24 in GFAP::GFP
mice (Pastrana et al., 2009). By including CD133 in this sorting
strategy, we separated two CD133+ astrocyte populations,
GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+, from the
remaining GFAP::GFP+-only cells (Figures 3A and 3B; Figures
S4A–S4I). GFAP::GFP+CD133+ (ranging from 25% to 30% of
total GFP+ cells) and GFAP::GFP+CD133+EGFR+ (20%–25% of
total GFP+ cells) were both abundant but differed in their GFP
brightness (Figure 3C).
We assessed the purity of the sorted populations using qRT-
PCR and acute immunostaining. qRT-PCR confirmed that sorted
populations were appropriately enriched in Gfap, GFP, Prom1,
and Egfr expression (Figures S4Q–S4T). Acute immunostaining
showed that both GFAP::GFP+CD133+ and GFAP::GFP+
CD133+EGFR+ populations were highly enriched in GLAST and
GLT1 (Figures S4J and S4K)—glutamate aspartate transporters
expressed in astrocytes—as well as BLBP (Figure S4M), that
they largely or completely lacked S100b (Figure S4L) and that
they were almost completely negative for the neuroblast markers
DCX and bIII tubulin (Figures S4O and S4P). Notably, more than
90% of GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+
populations expressed the NSC transcription factor Sox2
(Figures S4N and S4U). High Sox2 levels are related to a more
proliferative state (Marqués-Torrejón et al., 2013); of note,
92.8% ± 1.5% of GFAP::GFP+CD133+EGFR+ cells expressed
high levels of Sox2 protein, whereas only 38.4% ± 3.5% of
GFAP::GFP+CD133+ cells were Sox2 bright, with the remainder
being Sox2 dim. In contrast, the GFAP::GFP+-only population
was more heterogeneous with significant neuroblast contamina-
tion, likely due to perdurance of GFP in neuroblasts (Figures S4O
and S4P). We therefore focused our functional analyses below
on GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+ popu-
lations (all data regarding the GFAP::GFP+-only population are
included in Figure S6).
Purified GFAP+CD133+ V-SVZ Cells Have Different Cell
Cycle Properties
Quiescent stem cells are largely dormant and lack markers of
proliferation such as Ki67 and MCM2 that are expressed in
actively dividing cells, but not during the quiescent G0 state
(Maslov et al., 2004). Both markers are expressed during G1,
with MCM2 being expressed earlier than Ki67. Cycling GFAP+
V-SVZ cells in vivo have a fast cell cycle (Ponti et al., 2013). To
determine the cell cycle properties of CD133+ astrocyte sub-
populations in vivo, we used multiple approaches. First, we
determined the instantaneous cell cycle status of FACS-purified
cells by acute immunostaining for proliferation-associated
markers. GFAP::GFP+CD133+EGFR+ cells were highly enriched
in both Ki67 and MCM2 (64% ± 5.2% and 87.3% ± 1.2%,
Figure 3. Prospectively Purified CD133+
Astrocyte Subpopulations Exhibit Different
Cell Cycle Properties
(A and B) Representative FACS plots showing
gating strategy. In (A), the gate used to select
GFAP::GFP+CD24- cells, which are then gated on
EGF-A647 and CD133-PE-Cy7. In (B), three pop-
ulations are clearly defined: GFAP::GFP+ (gray),
GFAP::GFP+CD133+ (blue), and GFAP::GFP+
CD133+EGFR+ (cyan).
(C) Histogram showing the intensity of GFP
signal in GFAP::GFP+, GFAP::GFP+CD133+, and
GFAP::GFP+CD133+EGFR+ populations (gray,
blue, and cyan, respectively) compared to other
V-SVZ cells (GFP!, black). Note that GFAP::
GFP+CD133+EGFR+ cells are dimmer than
GFAP::GFP+ and GFAP::GFP+CD133+ cells.
(D) Proportion of each CD133+-purified astrocyte
subpopulation that expresses Ki67 and MCM2
(n = 3; **p < 0.01, unpaired Student’s t test;
mean ± SEM).
(E) Proportion of each CD133+-purified astrocyte
subpopulation labeled after a single pulse of BrdU
(light green) or after 14 days of BrdU in the drinking
water (dark green) (n = 3 and n = 4, respectively,
**p < 0.01, unpaired Student’s t test, mean ± SEM).
(F) LRC fraction in the CD133+-purified astrocyte
populations 14 or 30 days after 14 days of BrdU
administration (n = 4, mean ± SEM).
(G) Representative FACS plots of CD133+ astro-
cyte subpopulations from saline- and Ara-C-
treated mice.
(H) Summary of markers expressed by CD133+-
purified astrocytes.
See also Figures S4 and S6.
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respectively) whereas these two markers were almost absent in
GFAP::GFP+CD133+ cells (1.4% ± 0.9% and 0.0% ± 0.0%,
respectively) (Figure 3D). Similar patterns of proliferation were
observed after a single in vivo pulse of bromodeoxyuridine
(BrdU) 1 hr prior to FACS isolation: 35.5% ± 1.8% of
GFAP::GFP+CD133+EGFR+ cells were BrdU+, in contrast to
0.8% ± 0.8% of GFAP::GFP+CD133+ cells (Figure 3E). Thus, at
any given moment, the vast majority of GFAP::GFP+CD133+
cells are not proliferating.
LRCs are slowly cycling cells whose DNA remains labeled
after prolonged administration of thymidine analogs and a long
chase period (Wilson et al., 2008). To label dividing cells and to
identify LRCs, we administered BrdU via drinking water for
2 weeks and analyzed the proportion of each population that
was BrdU+. Immediately after BrdU treatment, almost all
GFAP::GFP+CD133+EGFR+ cells were labeled, whereas only
3.9% ± 0.4% of GFAP::GFP+CD133+ cells had incorporated
BrdU, reflecting their much slower rate of division (Figure 3E).
Fourteen days after ceasing BrdU treatment, GFAP::GFP+
CD133+EGFR+ cells had already almost completely lost BrdU
labeling (Figure 3F). In contrast, 52.4% ± 17.3% of GFAP::GFP+
CD133+ cells were still BrdU+ 30 days after BrdU withdrawal
(Figure 3F).
Finally, we confirmed the different proliferation characteristics
of both populations in vivo by infusing cytosine-b-D-arabinofur-
anoside (Ara-C) directly on the brain surface to eliminate dividing
cells (Doetsch et al., 1999b). GFAP::GFP+CD133+ cells survived
6 days of Ara-C treatment, whereas the more rapidly dividing
GFAP::GFP+CD133+EGFR+ cells were eliminated (Figure 3G).
Thus, although CD133 is regulated in a cell-cycle-dependent
manner in dividing neural cell lines (Sun et al., 2009), in the
V-SVZ niche, CD133 is expressed in both dividing and nondi-
viding cells in vivo.
Together, these findings reveal that GFAP::GFP+CD133+ cells
are largely quiescent in vivo, whereas GFAP::GFP+CD133+
EGFR+ cells are actively dividing. Based on their cell cycle prop-
erties and the functional studies described below, hereafter we
refer to these populations as qNSCs and aNSCs, respectively
(Figure 3H).
qNSCs and aNSCsAreBothNeurogenic In Vivo butDiffer
in Their Kinetics
To assess the in vivo potential of quiescent and activated stem
cells, we transplanted purified qNSCs (1 week, n = 8; 1 month,
n = 5) and aNSCs (1 week, n = 5; 1 month, n = 11) isolated
fromGFAP::GFP;b-Actin-PLAPmice (Zhuo et al., 1997; DePrimo
et al., 1996) into the SVZ of wild-type recipient mice (Figure 4A).
The donor cells were histochemically visualized based on their
expression of the reporter human placental alkaline phospha-
tase (PLAP). In mice transplanted with aNSCs, many migrating
neuroblasts were present in the V-SVZ, the rostral migratory
stream (RMS), and the olfactory bulb after only 1 week (Figures
4E–4G), confirming their activated state. However, in mice trans-
planted with qNSCs, no neuroblasts were observed at this time
point, and PLAP+ cells were only present in the V-SVZ (Figures
4B–4D). In contrast, after 1 month, both populations generated
mature olfactory bulb interneurons (Figures 4J and 4M), and
PLAP+ cells were still present in the V-SVZ in all transplants (Fig-
ures 4H and 4K). Interestingly, migrating neuroblasts were also
present in the RMS in 3 out of 5 qNSC and 3 out of 11 aNSC
transplanted brains, demonstrating that both populations
continue to generate neurons after 1 month in vivo (Figures 4I
and 4L). Oligodendrocytes were also formed by both trans-
planted populations (data not shown). These data show that
both qNSCs and aNSCs can give rise to neurons and retain
long-term neurogenic potential in vivo but exhibit very different
kinetics of cell generation.
qNSCs and aNSCs Differ in Their In Vitro Behavior and
Can Interconvert States
Two in vitro assays are widely used to assess stem cell proper-
ties and to enumerate in vivo stem cells: adherent colony forma-
tion and neurospheres (Pastrana et al., 2011). With the ability to
now prospectively purify qNSCs, we directly tested their in vitro
behavior in both assays, as compared to aNSCs.
qNSCs and aNSCs were plated as single cells under adherent
conditions in the presence of EGF or EGF/basic fibroblast
growth factor (bFGF). Whereas aNSCs were enriched in colony
formation (47.9% ± 11.9% in EGF and 41.4% ± 1.8% in EGF/
bFGF), in striking contrast, qNSCs only rarely gave rise to
colonies (1.2% ± 0.1% in EGF and 0.7% ± 0.2% in EGF/bFGF)
(Figure 5A) and did so with much slower growth kinetics than
aNSCs. Importantly, although rare, the colonies formed by single
qNSCs were large and multipotent, giving rise to neurons, oligo-
dendrocytes, and mature astrocytes (Figures 5B and 5C).
We next compared the ability of qNSCs and aNSCs to form
neurospheres and assessed self-renewal by serial passaging.
Again, qNSCs only rarely gave rise to neurospheres (0.85% in
EGF, 0.82% in EGF/bFGF) in contrast to aNSCs, which robustly
generated neurospheres (Figure S5B). Moreover, the prolifera-
tion of the qNSC population was delayed by 6 days compared
to aNSCs (Figures 5D and S5A). However, once activated,
qNSCs exhibited similar rates of division to aNSCs. Neuro-
spheres from both populations could be serially passaged
more than three times and were multipotent, giving rise to
neurons, astrocytes, and oligodendrocytes (Figures S5B and
S5E). Finally, we examined whether more qNSCs were recruited
to form neurospheres during in vivo regeneration, at 12 hr post-
Ara-C removal when stem cell astrocytes start to divide (Doetsch
et al., 1999a, 1999b; Pastrana et al., 2009). Notably, the effi-
ciency of neurosphere formation of qNSCs purified after Ara-C
treatment did not increase (Figure 5K). However, as previously
shown, total neurosphere formationwas almost completely elim-
inated after Ara-C treatment (Doetsch et al., 2002; Imura et al.,
2003;Morshead et al., 2003; Garcia et al., 2004; data not shown),
confirming that the vast majority of neurospheres arise from
actively dividing cells.
Together, these results reveal that aNSCs are highly enriched
in colony formation. In contrast, the qNSC population rarely
forms colonies and does so more slowly than aNSCs. However,
once activated, qNSCs are highly proliferative and multipotent,
almost indistinguishable from aNSCs (Figure S5B). We therefore
assessedwhether qNSCs and aNSCs can interconvert in vitro by
dissociating and analyzing primary spheres by flow cytometry.
Intriguingly, the vast majority of cells in neurospheres derived
from qNSCs expressed both EGFR and CD133 (Figures 5E
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and 5G), revealing that qNSCs give rise to GFAP::GFP+CD133+
EGFR+ cells in vitro. Conversely, aNSCs gave rise to both
GFAP::GFP+CD133+ and GFAP::GFP+ populations (Figures 5F
and 5H). Moreover, when primary spheres were dissociated
and GFAP::GFP+CD133+, GFAP::GFP+CD133+EGFR+, and
GFAP::GFP+ cells were reisolated, each population exhibited
similar sphere formation efficiencies to primary isolated cells,
with the GFAP::GFP+CD133+EGFR+ population being greatly
enriched in neurosphere formation compared to GFAP::GFP+
CD133+ andGFAP::GFP+ populations (Figures 5I and 5J; Figures
S5C and S5D). Therefore, qNSCs and aNSCs can interconvert
between more quiescent and activated states, with each popu-
lation giving rise to all other populations in vitro.
Figure 4. qNSCs and aNSCs Are Neuro-
genic In Vivo
(A) Schema of experimental design.
(B–G) Horizontal brain sections showing PLAP+
cells (purple, arrowheads) 1 week after trans-
plantation of qNSCs (B–D) and aNSCs (E–G). At
this time point, aNSCs generated numerous
migrating neuroblasts, whereas no cells were de-
tected in the RMS or in the olfactory bulb of brains
transplanted with qNSCs.
(H–M) Horizontal brain sections showing PLAP+
cells (purple, arrowheads) 1 month after trans-
plantation of (H–J) qNSCs and (K–M) aNSCs. In
transplants from both populations, cells were
present in the V-SVZ and RMS and had generated
mature olfactory bulb interneurons. Scale bars,
200 mm. STR, striatum; CP, choroid plexus; LV,
lateral ventricle; GCL, granular cell layer; PGL,
periglomerular layer.
qNSCs Do Not Express Nestin but
Upregulate EGFR and Nestin on
Activation
Nestin is an intermediate filament protein;
its expression is widely considered a
hallmark of NSCs, both during develop-
ment and in the adult (Lendahl et al.,
1990; Imayoshi et al., 2011). Unexpect-
edly, our microarray analysis (see below)
suggested that qNSCs express very low
to no levels of Nestin mRNA, in contrast
to aNSCs, in which Nestin mRNA is highly
expressed. We confirmed this observa-
tion by qRT-PCR (Figure S8E) as well as
by immunostaining of acutely purified
cells (Figure 6A). Out of 1,582 plated
qNSCs, none were Nestin protein posi-
tive. Finally, to assess the Nestin status
of NSCs in vivo, we electroporated mice
with the mP2-mCherry construct and
coimmunostained whole mounts with
Nestin and EGF-ligand. In vivo, Nestin is
highly expressed by ependymal cells
(Doetsch et al., 1997; Figures 6DI and
6EI) as well as SVZ cells (Figures 6DII
and 6EII). All radial EGF-ligand-negative mP2-mCherry+ cells
were Nestin protein negative (Figures 6DI and 6DII; 0/79 cells
in seven whole mounts). In contrast, only EGF-ligand-positive
cells coexpressed Nestin protein (Figures 6EI and 6EII; 32/34
cells in seven whole mounts).
To investigate whether qNSCs upregulate Nestin protein on
activation, we performed a time-course analysis of qNSCs
cultured in adherent conditions and immunostained for Nestin,
EGFR, and MCM2 (Figures 6B and 6C). When first isolated and
plated, qNSCswere small and round and did not express Nestin,
EGFR, or MCM2 (type 1). As qNSCs became activated in vitro,
they underwent morphological and molecular changes,
enlarging their nuclei and upregulating all three markers
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(type 2). They then extended processes (type 3) (Figures 6B and
6C) and began to proliferate extensively, closely resembling
cultured aNSCs.
To independently confirm the lack of Nestin expression in
qNSCs and its upregulation on activation, we usedNestin::Kusa-
bira Orange reporter mice (Kanki et al., 2010; Ishizuka et al.,
2011) to FACS-purify CD133+Nes::OR!EGFR!CD24! (Nestin-
and EGFR-negative) cells (Figure S7A). Acutely plated cells all
lacked Nestin protein (Figure S7B) and, when cultured, only
rarely gave rise to neurospheres (Figures S7C and S7E). Impor-
tantly, CD133+Nes::OR-EGFR!CD24! cells, which originally
lacked Nestin::Kusabira Orange reporter expression, upregu-
lated the reporter in all neurospheres that formed (Figure S7C).
In contrast, purified CD133+Nes::OR+EGFR+CD24! cells were
very efficient in neurosphere formation (Figures S7D and S7E).
Finally, we examined whether Nestin-negative qNSCs
contribute to the lineage during regeneration. At present, it is
not feasible to directly trace the lineage of qNSCs in vivo
due to the lack of specific markers. We therefore adminis-
tered tamoxifen to adult GFAP::CreERT2;Rosa26tdTomato mice
to induce recombination in GFAP-expressing cells and chased
for 10 days after the first injection to allow actively dividing
cells to progress down the lineage (Figure S7F). We then
infused Ara-C for 6 days to eliminate dividing cells (Fig-
ure S7F) and confirmed that all remaining lineage-labeled
cells were Nestin negative (0 of 951; Figure S7G) immediately
after termination of treatment. Six days after Ara-C removal,
tdTomato+Nestin+ cells were present (Figures S7H and S7I), as
well as tdTomato+DCX+ neuroblasts (Figure S7I). These data
reveal that qNSCs upregulate Nestin, as well as EGFR, during
Figure 5. Purified qNSCs and aNSCs Give Rise to Neurospheres with Different Proliferative Properties and Kinetics
(A) Single cell colony formation efficiency of FACS-purified qNSCs and aNSCs in adherent cultures (n = 3, mean ± SEM).
(B) Representative phase contrast image of an adherent colony from a single qNSC after 12 days in the presence of EGF. Scale bar, 100 mm.
(C) Confocal image of neurons (bIII Tubulin [b III Tub], red), astrocytes (GFAP, green) and oligodendrocytes (O4, blue) derived from qNSCs plated under adherent
conditions. Scale bar, 10 mm.
(D) Quantification of cell proliferation when plated at 1.4 cells per microliter with EGF under nonadherent conditions after 6 or 12 days (n = 5; **p < 0.01 compared
to qNSCs at the same time point, unpaired Student’s t test, mean ± SEM).
(E–H) Representative FACS plots of, in (E) and (F), purified CD133+ astrocytes immediately resorted after isolation from the brain and, in (G) and (H), of primary
neurospheres (NS) derived from each population after 12 days for qNSCs and 6 days for aNSCs cultured in EGF.
(I and J) Clonal activation efficiency of purified GFAP::GFP+, GFAP::GFP+CD133+, and GFAP::GFP+CD133+EGFR+ cells, isolated from primary neurospheres of
each population (in EGF, n = 3; *p < 0.05, **p < 0.01, unpaired Student’s t test; mean ± SEM).
(K) Neurosphere formation 12 hr (12h) after Ara-C treatment as compared to saline-treated controls (n = 6, mean ± SEM).
See also Figures S5 and S6.
Neuron
Purification of Adult Quiescent Neural Stem Cells




activation and contribute to the lineage during regeneration
in vivo.
Gene Expression Analysis of Purified qNSCs and aNSCs
Reveals Distinct Molecular Signatures
To gain insight into the biological properties of qNSCs and to
define their molecular signatures, we performedmicroarray anal-
ysis on RNA from FACS-purified populations isolated directly
from their in vivo niche (Figure 7A; Table S1). Gene ontology
(GO) and gene set enrichment analysis (GSEA) (Subramanian
et al., 2005) revealed that qNSCs and aNSCs have distinct
molecular features (Figures 7B–7D). Confirming the actively
dividing state of aNSCs in vivo, their transcriptome was enriched
in genes involved in the cell cycle, transcription and translation,
and DNA repair (Figures 7C and 7D; Tables S2 and S3). In
contrast, qNSCs were enriched in the GO categories of cell
communication, response to stimulus, and cell adhesion (Fig-
ure 7B; Table S2), underscoring the dynamic regulation of the
quiescent state via interaction with the microenvironment.
Indeed, the most represented GSEA groups for qNSCs were
related to transport, signaling, receptors, cell surface, and extra-
cellular matrix (Figure 7D; Table S3). Notably, qNSCs and aNSCs
exhibited different metabolic profiles; themajority of the differen-
tially enriched GSEAmetabolism subsets in qNSCs were related
Figure 6. qNSCs Are Nestin Negative
(A) Proportion of acutely plated purified qNSCs and aNSCs immunopositive for MCM2 and Nestin (n = 3, mean ± SEM).
(B) Images of FACS-purified qNSCs cultured in EGF, fixed at different time points, and immunostained with EGFR, MCM2, and Nestin. Three types of cells are
present: rounded cells with a condensed nucleus that do not express EGFR, MCM2, or Nestin (type 1); rounded cells with a larger nucleus that express EGFR,
MCM2, and Nestin (type 2); and EGFR+MCM2+Nestin+ cells with elongated processes (type 3). Type 3 cells resemble aNSCs after 3 days in culture. Scale bars,
10 mm.
(C) Quantification of activated qNSCs in culture after 2 hr or after 1, 3, 5, or 7 days after plating (n = 4, mean ± SEM).
(DI–EII) Confocal images showing mP2-mCherry+ cells (red) in whole mount labeled with EGF-A647 (green) and immunostained for Nestin (blue). In (D), two cells
contact the ventricle between ependymal cells, do not bind EGF-A647 (DI, arrows), and are Nestin negative in the subventricular projection (DII). In (E), an EGF-
A647-labeled cell (EI, arrow) is coimmunostained with Nestin in the subventricular projection (EII, arrowheads in inset). Notably, not all processes contained
Nestin. Scale bars, 30 mm.
See also Figure S7.
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to metabolism of lipids (Figure S8A), which are emerging as
important signals in NSC regulation (Knobloch et al., 2013),
whereas those in aNSCs were DNA/RNA-related metabolism
and proteasome activity (Figure S8B).
Functional studies have implicated numerous genes in the
regulation of adult neurogenesis. Many of these were differen-
tially expressed in qNSCs and aNSCs (Table S5). Moreover,
direct comparison of qNSC and aNSC transcription profiles
with those of purified GFAP::GFP+CD133+ V-SVZ stem cells
(Beckervordersandforth et al., 2010) revealed that we have
resolved two distinct subsets of NSCs with different molecular
and functional properties within their data (Figures S8C and
Figure 7. Gene Expression Analysis of qNSCs and aNSCs Reveals Distinct Molecular Signatures
(A) Volcano plot of differentially expressed probesets in qNSCs and aNSCs. Probes have at least 2-fold change in expression and a corrected p value < 0.05.
(B and C) Pie charts showing representative GO categories for differentially expressed probesets in (B) qNSCs and (C) aNSCs, as determined in (A).
(D) GSEA for qNSCs versus aNSCs. Sets have a false discovery rate (q value) <0.05 and are hand curated into thematic categories.
(E and F) Percentage of overlap with signatures of quiescent and dividing stem cells from other organs: (E) long-term (LT)/quiescent signatures and (F) short-term
(ST)/proliferative signatures as determined by fold-change analysis of published lists compared to qNSC and aNSC populations. Qui, quiescent; HSC,
hematopoietic stem cells; qMuSC, quiescent muscle stem cells; qBulgeSC, quiescent bulge stem cells; qISC, quiescent intestinal stem cells.
(G–J) Targeted GPCR ligand screen. (G) Quantification of qNSC activation (fold change in % Nestin+ clones) as compared to controls (empty dots). (H) Quan-
tification of percentage of MCM2+ cells within activated Nestin+ clones. (I) Quantification of aNSC clones (fold change of percentage of clones that underwent
division) as compared to controls (empty dots). (J) Quantification of percentage of MCM2+ aNSCs. Data are represented as means ± SEM.
n = 3. *p < 0.05; ***p < 0.001. ns, not significant.
See also Figure S8 and Tables S1, S2, S3, S4, S5, S6, S7, and S8.
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S8D; Table S8). Indeed, we found that neurogenic transcription
factors such as Dlx1, Dlx2, Sox4, Sox11, and Ascl1, which
were proposed to be hallmarks of NSCs (Beckervordersandforth
et al., 2010), were in fact primarily expressed by or restricted to
aNSCs (Table S4). We confirmed enrichment ofDlx2 andAscl1 in
aNSCs by qRT-PCR (Figures S8F and S8G), as well as enrich-
ment of Dll1 (Figure S8H), which is expressed in aNSCs (Kawa-
guchi et al., 2013). In contrast, qNSCs expressed high levels of
factors reported to be markers of quiescent stem cells in the
adult V-SVZ, such as Vcam1 (Figure S8I and Table S5; Kokovay
et al., 2012), and in other organs, such as Lrig1 (Figure S8J and
Table S1; Jensen and Watt, 2006; Jensen et al., 2009; Powell
et al., 2012).
We then performed comparative analysis of our gene expres-
sion data with transcriptional signatures from quiescent or prolif-
erative hematopoietic, muscle, skin, and intestinal stem cells
(Ivanova et al., 2002; Venezia et al., 2004; Forsberg et al.,
2010; Pallafacchina et al., 2010; Powell et al., 2012; Blanpain
et al., 2004: Fukada et al., 2007; Cheung and Rando, 2013).
The majority of genes in long-term/quiescent populations were
upregulated in our quiescent V-SVZ stem cells, whereas those
in the short-term/proliferative stem cell lists from other tissues
were upregulated in our activated population (Figures 7E and
7F; Table S6). Together, this suggests that common transcrip-
tional programs for quiescence or activation are shared between
stem cell lineages in different tissues.
GPCR Signaling Maintains the Quiescent State
To gain insight into signaling pathways that modulate quies-
cence in qNSCs, we mined our transcriptome data. G protein-
coupled receptor (GPCR) signaling was highly enriched in
qNSCs (30% of all GSEA signaling sets; Table S3). We selected
25 GPCRs that were more than 10-fold enriched in qNSCs over
aNSCs (Table S7) as a basis for a functional screen to assess
Figure 8. In Vivo and In Vitro Properties of
V-SVZ Stem Cells and Their Progeny
Quiescent stem cells (GFAP+CD133+) are Nestin
negative, label-retaining (blue line), and neuro-
genic in vivo (magenta line) but only very rarely give
rise to neurospheres and adherent colonies in vitro
(light blue line). Activated stem cells (GFAP+
CD133+EGFR+) are highly proliferative (green line)
and rapidly generate neurons in vivo and are en-
riched in neurosphere/colony formation. Previous
work has shown that EGFR+ transit amplifying cells
are also highly proliferative in vivo and give rise to
neurospheres. Of note, quiescent stem cells were
also present among CD133- astrocytes. Niche
astrocytes have a branched morphology.
their role in the regulation of qNSCs.
FACS-purified qNSCs were plated under
adherent conditions for 4 days in the
presence of different ligands, and their
activation (number of Nestin+ clones)
was quantified (Figure S8K). Two com-
pounds, sphingosine-1-phosphate (S1P)
and prostaglandin D2 (PGD2), had a significant effect, with both
decreasing the activation of qNSCs by approximately one half
(Figures 7G and S8L). Both ligands also decreased the number
of MCM2+ qNSCs (Figure 7H). PGD2 exerted a more potent
effect, completely abolishing MCM2 expression. To determine
whether these compounds act specifically on qNSCs or also
affect aNSCs, we plated FACS-purified aNSCs in the presence
of S1P or PGD2 and fixed the cells after 24 hr. This shorter
time course is necessary as aNSCs divide very rapidly, making
it difficult to distinguish individual clones (Figure S8K). S1P did
not alter the number of aNSC clones (Figure 7I) or percentage
of MCM2+ cells (Figure 7J). As such, S1P selectively targets
qNSCs and appears to act at the level of qNSC recruitment
(Figure 7H). In contrast, PGD2 had a potent inhibitory effect
on the number of clones formed by aNSCs (Figure 7I). PGD2
also reduced the percentage of MCM2+ aNSCs (Figure 7J).
As such, PGD2 acts on both qNSCs and aNSCs. Thus,
these GPCR ligands actively maintain the adult NSC quiescent
state.
DISCUSSION
Here, we prospectively identified and isolated quiescent
adult NSCs by defining a combination of markers (CD133,
GFAP, and EGFR) that allows the simultaneous purification of
quiescent and activated populations of stem cell astrocytes.
Together, our analyses of their cell cycle properties, their
morphological and anatomical localization, their in vitro and
in vivo functional behavior, and their gene expression profiles
highlight the distinct functional and molecular properties of
qNSCs and aNSCs (Figure 8). Our functional analyses reveal
important features of quiescent NSCs, which affect the interpre-
tation of commonly used in vitro NSC assays and lineage-tracing
strategies.
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In the adult mouse brain, CD133 was originally proposed to be
exclusively expressed by ependymal cells, with FACS-purified
CD133+ cells giving rise to neurospheres in vitro and generating
neurons in vivo (Coskun et al., 2008). However, CD133 is also
expressed by a subset of astrocytes, which behave as NSCs
(Mirzadeh et al., 2008; Beckervordersandforth et al., 2010), sug-
gesting that the earlier findings can be attributed to CD133+
astrocytes instead of ependymal cells. Here, we show that
CD133 is expressed by both quiescent and activated V-SVZ
stem cells.
The neurosphere assay is widely used as a readout of in vivo
stem cells (reviewed in Pastrana et al., 2011). Neurospheres
were originally proposed to arise from relatively quiescent stem
cells in vivo (Morshead et al., 1994). With the ability to prospec-
tively purify cells at different stages of the stem cell lineage, it is
now feasible to directly assess the potential of distinct popula-
tions to give rise to neurospheres. Here, we show that qNSCs
only very rarely give rise to either neurospheres or adherent
colonies and do not increase their neurosphere-forming effi-
ciency during regeneration. In contrast, aNSCs are enriched in
neurosphere and adherent colony formation. Together, our
current findings and previous reports highlight that the major
source of neurosphere-initiating cells are actively dividing in vivo,
and include both GFAP+ aNSCs and EGFR+GFAP- transit-ampli-
fying cells (Doetsch et al., 2002, Imura et al., 2003; Morshead
et al., 2003; Garcia et al., 2004, Pastrana et al., 2009; data not
shown). Thus, the neurosphere assay is a useful tool for assess-
ing the in vitro stem cell potential of proliferative populations but
does not allow the identification and enumeration of in vivo
quiescent stem cells. This emphasizes the need to develop novel
assays, or identify additional niche factors, that allow qNSCs to
be expanded in vitro.
Nestin is frequently usedboth as amarker of NSCs and for their
geneticmanipulation and lineage tracing in the embryonic (Lend-
ahl et al., 1990; Zimmerman et al., 1994) and adult brain (reviewed
in Imayoshi et al., 2011). Nestin+ cells have also been implicated
as putative glioblastoma-forming cells (Holland et al., 2000, Chen
et al., 2012). Notably, we found that adult V-SVZ qNSCs do not
express Nestin but upregulate it on activation in vitro, as well
as during regeneration in vivo. These data are consistent with
previous observations that Nestin!/CD133+ cells are neurogenic
in vivo and give rise to Nestin+ neurospheres in vitro (Coskun
et al., 2008). Recently, both Nestin-negative and Nestin-positive
radial glia-like stem cells have also been described in the hippo-
campus (DeCarolis et al., 2013). Aswe show here in the V-SVZ, in
the SGZ, almost all of the dividing radial glia-like stem cells
express Nestin (DeCarolis et al., 2013). It is interesting that, in
embryonic development, Nestin expression is also regulated in
a cell-cycle-dependent manner (Sunabori et al., 2008). Thus,
Nestin expression is dynamically regulated in NSCs. Importantly,
our study highlights that Nestin immunostaining cannot be used
to identify adult qNSCs in vivo. Thus, whether recombination and
reporter expression occur in qNSCs needs to be carefully
assessed when using Nestin transgenes for in vivo targeting of
adult NSCs, V-SVZ lineage tracing, genetic manipulation, or
purification. Moreover, interpretation of such assays is further
complicated by the high expression of Nestin in ependymal cells,
which can lead to nonautonomous effects.
qNSCs are multipotent and self-renewing in vitro. In vivo,
qNSCs are long-term neurogenic and exhibit delayed kinetics
of neuron formation compared to aNSCs. Interestingly, some
aNSC transplants also continue to make neurons 30 days after
transplantation. These may arise from a more quiescent sub-
population of aNSCs or from aNSCs that have reverted back
to the quiescent state, as occurs in vitro. We also observed
oligodendrocyte formation by both transplanted qNSCs and
aNSCs (data not shown). In vivo, adult V-SVZ NSCs have
regional identity and generate distinct neuronal subtypes, or
oligodendrocytes (Merkle et al., 2007; Ventura and Goldman,
2007; Young et al., 2007; Ortega et al., 2013). At present, we
cannot distinguish whether neurons and oligodendrocytes arise
from regionally distinct subpopulations of NSCs in the trans-
planted populations or whether some, or all, NSCs are multipo-
tent in vivo. The extent of in vivo V-SVZ stem cell heterogeneity
and population dynamics of qNSCs and aNSCs, as well as their
lineage relationships and potential under homeostasis and dur-
ing regeneration, will require the identification of novel markers
allowing the specific targeting of qNSCs and aNSCs. Impor-
tantly, our present strategy allows qNSCs to be isolated
irrespective of their regional origin. Of note, the GFAP::GFP+
CD133- population also contains quiescent stem cells. By
combining different reporter mice, it is emerging that V-SVZ
stem cells are molecularly heterogeneous (Giachino et al.,
2014). The iterative identification of additional markers that
allow subpopulations of NSCs to be isolated and targeted in vivo
is a key future step.
Recent findings suggest that quiescent and activated states
are differentially regulated at multiple levels, including cell-cell
and extracellular matrix interactions, diffusible signals and
distinct transcriptional programs coupling cell cycle regulators,
quiescence, self-renewal, and differentiation (Kazanis et al.,
2010; Young et al., 2011; Le Belle et al., 2011; Alfonso et al.,
2012; Basak et al., 2012; Marqués-Torrejón et al., 2013;
Kokovay et al., 2012; Porlan et al., 2013; Giachino et al.,
2014; Kawaguchi et al., 2013, López-Juárez et al., 2013;
Martynoga et al., 2013). Our transcriptome data of qNSCs
and aNSCs isolated directly from their in vivo niche provide
a platform to functionally assess the gene regulatory networks
active in each state. Interestingly, our GSEA analysis reveals
that GPCR signaling is specifically enriched in qNSCs. While
GPCRs modulate many different facets of adult neurogenesis
(Doze and Perez, 2012), our findings highlight that they
are also key regulators of qNSCs. Strikingly, both functional
ligands we identify in our GPCR screen, S1P and PGD2, inhibit
the activation of qNSCs, suggesting that stem cell quiescence
is an actively maintained state. Both S1P and PGD2 are present
in the CSF (Sato et al., 2007; Kondabolu et al., 2011), which
is emerging as a reservoir of factors in the embryo and the
adult important for stem cell regulation (Silva-Vargas et al.,
2013). As such, the CSF may be a key niche compartment
mediating quiescence in the adult V-SVZ. Interestingly, PGD2
has been implicated in promoting the quiescent phase of the
hair follicle cycle (Garza et al., 2012), which is consistent with
our transcriptome data suggesting that quiescent and activated
stem cells in different tissues share common molecular
pathways.
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As additional mediators of stem cell quiescence and activation
are uncovered, it will be important to investigate how clinical
drugs targeting these pathways impact NSCs in vivo. For
instance, fingolimod, an immunomodulatory drug approved by
the Food and Drug Administration for the treatment of multiple
sclerosis (Kappos et al., 2006), acts on S1P receptors. Recent
studies have shown that fingolimod also acts on multiple CNS
cell types (Groves et al., 2013), including astrocytes. Our identi-
fication of S1P as a regulator of stem cell quiescence suggests
that this drug may have an effect on NSCs in the adult brain.
The ability to purify quiescent NSCs from the adult brain opens
new vistas into elucidating the biology of stem cell quiescence,
enabling studies in their intrinsic and extrinsic molecular regula-
tion and defining their dynamics during development and aging.
V-SVZ GFAP+ stem cells are also present in humans, where they
are largely quiescent (Sanai et al., 2004, 2011; van den Berge
et al., 2010). Understanding the biology of stem cell quiescence
and activation will ultimately lead to insight into how NSCs




Experiments were performed in accordance with Columbia University institu-
tional and national guidelines for animal use. All mice usedwere between 2 and
3 months old.
FACS
The FACS strategy was adapted from Pastrana et al. (2009). Briefly, the V-SVZ
was microdissected from GFAP::GFP mice and dissociated with papain, the
single cell suspension was immunostained, and cell populations were purified
by FACS as described in the detailed protocol in Supplemental Experimental
Procedures.
Immunostaining
Whole mounts were dissected and processed as described elsewhere
(Doetsch et al., 1999b; Tavazoie et al., 2008; Mirzadeh et al., 2010). Briefly,
whole mounts were blocked in 10% serum, incubated with primary antibodies
for 48 hr at 4!C, revealed with secondary antibodies, and imaged with a Zeiss
LSM510 or Leica TCS SP5 II confocal microscope. All immunostainings were
performed in triplicate. Immunostaining details for whole mounts and cell
cultures are in the Supplemental Experimental Procedures.
In Vitro Assays
For neurosphere assays, FACS-purified cells were collected in neurosphere
medium without growth factors and plated at clonal density with EGF
(20 ng/ml) or EGF/bFGF (20 ng/ml each). For adherent cultures, purified cells
were collected in neurosphere medium and plated on poly-D-lysine and fibro-
nectin-coated 96-well plates as single cells or at clonal density and cultured
with EGF or EGF/bFGF. Further details are given in the Supplemental Experi-
mental Procedures.
Ara-C Infusion
A micro-osmotic pump (ALZET, 1007D) filled with 2% Ara-C (Sigma) in 0.9%
saline was implanted on to the surface of the brain as described elsewhere
(Doetsch et al., 1999b). After 6 days of Ara-C infusion, mice were sacrificed
either immediately or 12 hr after pump removal.
Electroporation
One microliter of a solution containing 5 mg/ml of the mP2-mCherry plasmid in
0.9% saline was electroporated according to Barnabé-Heider et al. (2008),
using the following coordinates: anterior-posterior (AP), 0.0; lateral (L), 0.85;
ventral (V), "2.5 mm relative to bregma. The mP2-mCherry plasmid was
made by cloning the mouse P2 element of the Prominin1 promoter into the
CherryPicker control vector (Clontech), using the XhoI and AgeI digestion
sites. See the Supplemental Information for details.
Transplants
Three injections of 0.2 ml delivering 1,000–3,000 cells purified from
GFAP::GFP/b-actin-PLAP mice were performed in the SVZ of wild-type recip-
ient mice, using the following coordinates: (1) AP, 0.0; L, 1.4; V, "2.1; (2) AP,
0.5; L, 1.1; V,"2.2; (3) AP, 1.0; L, 1.0; V,"2.5mm relative to bregma. Recipient
mice were sacrificed 1 week or 1 month after transplantation. Transplanted
cells were revealed by NBT/BCIP staining.
RNA Isolation and Microarray Hybridization
RNA was purified from FACS-sorted populations with the miRNeasy kit
(QIAGEN) from three biological replicates. cDNA was synthesized with the
Nugen Pico amplification kit and hybridized to Affymetrix MOE430.2 chips.
See Supplemental Information for details of the bioinformatic analysis.
qRT-PCR
RNA was purified from FACS-sorted populations with the miRNeasy kit
(QIAGEN) and cDNA generated using WT-Ovation Pico System (NuGEN).
See Supplemental Information for details on primer sequences.
GPCR Compound Screen
Cells were isolated by FACS and plated on poly-D-lysine- and fibronectin-
coated 96-well plates in the presence of EGF. To assay the effect on qNSCs,
compounds were added 1 day after plating, and cells were fixed and immuno-
stained at day 4. To assay the effect on aNSCs, cells were plated with com-
pounds and fixed and immunostained 1 day later. Further details are in the
Supplemental Experimental Procedures.
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